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The establishment of in vitro culture models utilizes tissue engineering principles 
to design functional mimics of in vivo environments in vitro. Advantages for the use of in 
vitro culture models include ethical alleviation of animal models for therapeutic testing, 
cost efficiency, and a greater ability to study specific mechanisms via a systematic, 
ground-up approach to development. In this thesis, alginate hydrogels are utilized in the 
development of in vitro culture models of porcine embryo elongation and growth plate 
cartilage development. First, the effect of scaffold and modifications to the scaffold were 
explored in both projects. In order to modulate cell-scaffold interactions, the alginate 
molecule was covalently modified with the arginine-glycine-aspartic acid (RGD) peptide, 
which has been extensively used to promote cell adhesion in vitro. In the porcine embryo 
elongation studies, a previously established culture system was used as a tool to 
encapsulate embryos and explore the effect of soluble factors on embryo survivability, 
rate of morphological changes, gene expression and hormone production by using RGD-
modified alginate and alginate mixed with osteopontin (SPP1), a glycoprotein known to 
be secreted in the uterus. RGD-alginate encapsulation led to significant increases in 
embryo survivability and morphological changes along with corresponding cellular 
outputs. In the growth plate cartilage development model, chondrocytes were 
 encapsulated in alginate and RGD-alginate to elucidate effects of cell adhesion, 
mimicking cell-matrix interactions within the growth plate, on chondrocyte phenotype. 
Additionally, alginate encapsulation was utilized to culture chondrocytes in media 
supplemented with parathyroid hormone (PTH) or Indian hedgehog (IHH) to begin to 
study the mechanisms behind these two molecules on the establishment of the zonal 
architecture and column formation that is unique to the growth plate. Cell cycle 
distribution, gene expression immunofluorescence and fluorescent in situ hybridization 
techniques together indicated our ability to suppress hypertrophy using alginate hydrogel 
scaffolds and/or signaling molecules. Overall, utilization of these in vitro culture models 
as tools to study developmental mechanisms can be used to advance both the fields of 
porcine embryology and cartilage developmental biology to improve pregnancy 
outcomes in pigs and to engineer therapies for the treatment of growth plate injuries and 
diseases. 
 
i 
 
ACKNOWLEDGEMENTS 
To Angie: I would first like to thank you for the opportunity to be a part of such a 
great team of scientists and people; I could not be more honored to call myself a Pannier 
Lab member. Throughout my time in the lab, I have learned such valuable skills that 
extend way beyond science that I will carry with me throughout my professional career 
and life. I have learned truly what work ethic is and how to stay motivated to do all I can 
do to achieve my goals. I’ve gone through a few life changes during my time in the 
Pannier lab, and I am forever grateful for your mentoring through it all. 
To Sarah: Short and sweet: I would not be writing this page today without you 
and your support both personally and professionally. You have helped in more ways than 
I could ever explain or thank you enough for. 
To the Pannier Lab members: Each of you has certainly brought a unique style to 
the lab and without that, it would not be as fun as it has been during my time here. From 
splitting my cells and hearing about the science downers to some of the biggest 
breakthroughs in each of our projects, we are always there for each other, and that 
support is what makes this lab so successful. Thank you for being there through the highs 
and lows of science and life. 
To my collaborators at UNMC, Andy, Alek, Krishna and Sarah, the time I spent 
doing science in your lab provided some of the biggest gains in my enthusiasm and 
knowledge of science throughout our time together and to Jeremy and Elane at U.S. 
MARC, I never knew I would love pig reproduction as much as I have come to love it 
ii 
 
and your enthusiasm about learning more every experiment kept me going. Thank you to 
all for helping me grow as a scientist. 
Lastly, to my family and friends, for raising me to be strong willed, stubborn, 
curious and persistent, all qualities I believe helped me to achieve this milestone in my 
education. Mom, Dad, Sam, Grandma DD, Katie and Ashley in particular, thanks for 
dealing with me and keeping me positive through it all.
iii 
 
LIST OF ABBREVIATIONS 
 
2-D Two-dimensional 
3-D 
ALG 
Three-dimensional 
Alginate hydrogel 
ANOVA Analysis of variance 
BMP Bone morphogenic protein 
CaCl2 Calcium chloride 
CaCO3 Calcium carbonate 
CaSO4 Calcium sulfate 
Col1 Collagen type 1 
Col2 Collagen type 2 
Col4 Collagen type 4 
Col6 Collagen type 6 
ColX Collagen type 10 
CONT Control (no encapsulation) 
CT Threshold cycle 
CYP19A1 Aromatase 
iv 
 
D20 Duterium oxide 
ddPCR Digital droplet polymerase chain reaction 
DMEM Dulbecco’s modified Eagle Medium 
E2 Estradiol 17-β 
ECM Extracellular matrix 
EDC 1-ethyl-(dimethylaminopropyl) carbodiimide   
EDTA 
FACS 
Ethylenediaminetetraacetic acid 
Fluorescence-activated cell sorting 
FBS 
FDA 
Fetal bovine serum 
U.S. Food and Drug Administration 
FGF7  Fibroblast growth factor 7 
FISH Fluorescent in situ hybridization 
FN Fibronectin 
G α-L-guluronic acid  
GAPDH 
GPS 
Glyceraldehyde 3-phosphate dehydrogenase 
Glutamine-penicillin-streptomycin 
GRGDSP Glycine-arginine-glycine-aspartic acid-serine-proline  
HA Hydroxyapatite 
v 
 
IHH Indian hedgehog 
IL1B 
IF 
Interleukin-1β  
Immune fluorescence 
LN Laminin 
LSM Least square mean 
M β-D-mannuronic acid  
MW Molecular weight 
NaCl Sodium chloride 
PBS Phosphate buffered saline 
PCR Polymerase chain reaction 
PLA Poly-l-lactic acid 
PKA Protein kinase A 
Ptc Patched 
PTH Parathyroid hormone 
PTH1r Parathyroid hormone receptor 
PTHrP Parathyroid hormone-related protein 
qPCR Quantatative polymerase chain reaction 
RGD Arginine-glycine-aspartic acid 
vi 
 
ROI Region of interest 
RQ Relative quantity 
SEM Standard error of the mean 
Smo Smoothened 
SPP1 Osteopontin 
STAR Steroidogenic acute regulatory protein  
Sulfo-NHS N-hydroxy-sulfosuccinimide 
TBS Tris-buffered saline 
TCP Tricalcium phosphate 
TGFB Transforming growth factor- beta 
USDA 
UNMC 
U.S. Department of Agriculture 
University of Nebraska Medical Center 
USMARC U.S.  Meat Animal Research Center 
VEGF Vascular endothelial growth factor 
WB Wash buffer 
wcRNA Whole-cell RNA 
 
  
vii 
 
TABLE OF CONTENTS 
CHAPTER 1- Thesis Introduction and Background .................................................... 1	
1.1. Introduction ........................................................................................................... 1	
1.1.2. Alginate ........................................................................................................... 7	
1.1.2.1. Properties of Alginate .............................................................................. 8	
1.1.2.2. Modulation of Alginate Mechanical Properties ...................................... 9	
1.1.2.3. Alginate Modifications .......................................................................... 11	
1.1.3. In Vitro Culture Models ............................................................................... 13	
1.2. In Vitro Model of Porcine Embryo Elongation ................................................ 16	
1.3. In Vitro Model of Growth Plate Cartilage ........................................................ 20	
1.4. Thesis Objectives ................................................................................................. 25	
CHAPTER 2- Using 3-D Alginate In Vitro Culture System to Explore the Role of 
SPP1 and RGD on the Initiation of Preimplantation Porcine Embryo Elongation . 27	
2.1. Introduction ......................................................................................................... 27	
2.2. Materials and Methods ....................................................................................... 29	
2.2.1. Production and Collection of Embryos ....................................................... 29	
viii 
 
2.2.2. Alginate Solution and Modification ............................................................ 30	
2.2.3. Embryo Encapsulation and Culture ............................................................ 31	
2.2.4. Characterization of Embryo Viability and Morphology ............................. 33	
2.2.5. Cellular Proliferation ................................................................................... 34	
2.2.6. Transcript Expression Analysis ................................................................... 35	
2.2.7. Estradiol-17β and Protein Assays ................................................................ 37	
2.2.8. Statistical Analyses ....................................................................................... 37	
2.3. Results .................................................................................................................. 39	
2.3.1. Confirmation of RGD Modification ............................................................ 39	
2.3.2. Evaluation of Embryo Viability, Morphology and Morphometry .............. 40	
2.3.3. Cellular Proliferation ................................................................................... 46	
2.3.4. Transcript Expression Analysis ................................................................... 48	
2.3.5. Analysis of E2 and Protein Content ............................................................ 50	
2.4. Discussion ............................................................................................................. 51	
CHAPTER 3- 3-D In Vitro Culture Model of Growth Plate Cartilage using Alginate 
Hydrogel Scaffolds .......................................................................................................... 59	
3.1. Introduction ......................................................................................................... 59	
ix 
 
3.2. Materials and Methods ....................................................................................... 65	
3.2.1. Alginate Formulation ................................................................................... 65	
3.2.2. Chondrocyte Isolation .................................................................................. 66	
3.2.3. Alginate Encapsulation ................................................................................ 67	
3.2.4. Culture Conditions ....................................................................................... 69	
3.2.5. Evaluation of Viability ................................................................................. 69	
3.2.6. Immunofluorescent Imaging ....................................................................... 70	
3.2.7. Transcript Expression Analysis ................................................................... 70	
3.2.8. Flow Cytometry ............................................................................................. 72	
3.2.9. FISH ............................................................................................................. 73	
3.2.9.1. Hybridization Technique ....................................................................... 73	
3.2.9.2. Statistical Analysis for FISH ................................................................. 74	
3.3. Results .................................................................................................................. 75	
3.3.1. RGD Conjugation Confirmation ................................................................. 75	
3.3.2. The effect of scaffold on chondrocyte behavior .......................................... 76	
3.3.2.1. Encapsulation and Viability .................................................................. 76	
3.3.2.2. IF Visualization of Matrix Deposition .................................................. 77	
x 
 
3.3.2.3. FACS Analysis ...................................................................................... 79	
3.3.2.4. Transcript Expression ............................................................................ 81	
3.3.2.5. FISH Analysis ....................................................................................... 84	
3.3.3. The effect of soluble factors on chondrocyte behavior ............................... 85	
3.3.3.1. PTH ........................................................................................................ 85	
3.3.3.2. IHH ........................................................................................................ 93	
3.4. Discussion and Conclusion ............................................................................... 101	
CHAPTER 4- Future Directions and Conclusions .................................................... 114	
4.1. Introduction ....................................................................................................... 114	
4.2. Future directions for the in vitro porcine embryo elongation model ........... 115	
4.3. Future directions for the in vitro culture system of growth plate cartilage 
development .............................................................................................................. 123	
4.4. Conclusions ........................................................................................................ 139	
REFERENCES .............................................................................................................. 141	
 
xi 
 
LIST OF FIGURES 
 
Fig. 1-1. Chemical structure and ionic crosslinking of alginate. Alginate is made of M 
and G blocks and it ionically crosslinks with divalent cations such as Ca2+ to form 
hydrogels (Reprinted from Andersen et al., Carbohydr. Chem, 2012) ....................... 8	
Fig. 1-2. Mechanical properties of alginate are modulated by changing percentage in 
solution. The stiffness of the alginate hydrogels used in this thesis range from 5- to 
20-kPa. ...................................................................................................................... 10	
Fig. 1-3. The principles of in vitro culture models. Tissue engineering techniques, or the 
combination of cells, scaffolds and signals, are utilized in the development of in 
vitro culture models. These models act as the bridge between cell culture models and 
animal models, giving researchers another tool for studying pharmaceutical, 
diagnostic or developmental mechanisms. ............................................................... 14	
Fig. 1-4. Schematic of the timeline of porcine embryo elongation. Embryo elongation 
begins at any point between days 9 and 10. By day 12, the embryo has elongated and 
is now filamentous with a length of over a centimeter. Additionally, the secretion of 
estrogen and the secretion of steroidogenic transcripts increase as the embryo 
elongates while the total protein and rate of proliferation remains constant 
throughout the process. ............................................................................................. 17	
Fig. 1-5. A) Schematic of growth plate showing zonal arrangement. B) Depiction of an 
overview of the signaling pathways between PTHrP and IHH. (Recreatd from 
Deckelbaum et al., 2002) .......................................................................................... 21	
xii 
 
Fig. 2-1. (1) After flushing from the uterus, embryos are placed in RPMI media. A single 
embryo is pipetted up and (2and 3) is pipetted into an alginate droplet. (4) The 
droplet is pipetted into calcium solution to crosslink. (5) The formed bead is washed 
twice in RPMI before (6) being placed into another droplet of alginate solution. (7) 
The droplet including the bead is pipetted up and into calcium solution for 
crosslinking. (8) The entire layered construct is washed in RPMI before (9) being 
placed into one of the four wells of the plate for culture. (Recreated from Sargus-
Patino et al.) .............................................................................................................. 38	
Fig. 2-2. 1H-NMR spectra to confirm conjugation of RGD peptide to ALG molecule. 
ALG (top) and RGD (bottom) with peaks noted for possible corresponding amino 
acids: glycine (G), arginine (R), aspartic acid (D), serine (S), proline (P) and 
potential β–hydrogens (β). ........................................................................................ 39	
Fig. 2-3. Representative images of embryo morphological changes in culture. Embryos 
were cultured without encapsulation (CONT) or within double-layered, 0.7% 
alginate hydrogels: unmodified alginate hydrogel (ALG), alginate with SPP1 
(SPP1), or RGD-modified alginate (RGD). Images are taken of each embryo every 
24 hours for 96 hours. Scale bar is 1-mm in length. ................................................. 41	
Fig. 2-4. Survival rates and percent of embryos showing morphological changes in 
culture for all treatment groups.  A) Survival rates for all treatment groups. 
Encapsulation in RGD facilitates significantly higher survivability than non-
encapsulation, as does encapsulation in SPP1. B) Percent of all embryos that 
underwent morphological changes. No CONT embryos showed morphological 
xiii 
 
changes. Encapsulation in RGD demonstrated a significant increase in the 
percentage of embryos showing morphological changes over ALG while it only 
tended to be increased over SPP1. C) Percent of surviving embryos that underwent 
morphological changes. Encapsulation in RGD tended to lead to an increase in 
morphological changes over ALG. (*indicates a tendency with p< 0.10, ** indicates 
significance with p< 0.05) ........................................................................................ 42	
Fig. 2-5. Representative images and quantitative data for proliferation. A) Representative 
images of embryos at 60x magnification stained for DAPI to visualize nuclei, 
rhodamine-phalloidin to visualize F-actin and Ki-67 to visualize proliferating cells. 
Images are shown for embryos that underwent morphological changes (+) an those 
that did not (-) for all treatment groups. Blue arrows point to examples of Ki-67 
negative nuclei while green arrows point to examples of Ki-67 positive nuclei. Scale 
bar is 20 µm. B) Representative image at 10x magnification of potential embryonic 
disc on an embryo encapsulated in ALG that underwent morphological changes by 
96h. Scale bar is 100 µm. C) Quantitative cellular proliferation data indicating total 
µg of DNA per embryo in each treatment group. ..................................................... 47	
Fig. 2-6. Transcript expression of A) STAR, B) CYP19 and C) IL1B determined by qPCR 
from in vitro produced embryos encapsulated in modified or unmodified ALG 
hydrogels. (n=3) ........................................................................................................ 48	
Fig. 2-7. A) Estradiol secretion by 96h in all treatment groups as determined by RIA 
assay. B) Total protein production by 96h in all treatment groups, as well as an 
additional culture media control. .............................................................................. 50	
xiv 
 
Fig. 3-1. Schematic of zonal architecture during growth plate development. The name of 
the zone is to the left of the schematic and major markers of each zone are shown to 
the right, with a depiction of the PTHrP/IHH feedback loop overlaid on the 
proliferative zone. ..................................................................................................... 60	
Fig. 3-2. Schematic of the “drop” method to produce homogenous chondrocyte-alginate 
beads. ........................................................................................................................ 76	
Fig. 3-3. Representative images of Live/Dead stain of chondrocytes encapsulated in 
beads. A-D) Chondrocytes are encapsulated in alginate and are stained A) 
immediately after encapsulation, or are cultured and stained after B) 1 day, C) 4 
days or D) 7 days in culture. E-H) Chondrocytes are encapsulated in RGD-alginate 
and are stained E) immediately after encapsulation, or are cultured and stained after 
F) 1 day, G) 4 days or H) 7 days in culture. Scale bar = 50-µm. (n=3) .................... 77	
Fig. 3-4. Representative images of immunofluorescence visualization of ECM deposition. 
Neither ALG nor RGD encapsulation cause any disruptions of either Col4 or Col 6 
matrix deposition over time in culture. However, a slight difference in actin 
organization between ALG and RGD is observed, and is highlighted by the white 
arrows.  Scale bar = 5 µm. ........................................................................................ 78	
Fig. 3-5. FACS analysis of cell cycle of chondrocytes encapsulated in ALG and RGD. D0 
is representative of chondrocytes that were encapsulated ALG and were briefly held 
in culture media before being harvested for analysis. D1, D4 and D7 are 
representative of chondrocytes cultured for 1, 4 or 7 days, respectively, in their 
respective scaffold: Right: ALG, Left: RGD. ............................................................ 79	
xv 
 
Fig. 3-6. Ratio of Col2 to Col1 to explore the differentiation status of chondrocytes. Cells 
were encapsulated in either ALG or RGD. (n=2) ..................................................... 81	
Fig. 3-7. Gene expression of chondrocytes cultured in ALG or RGD over time. Data are 
reported as fold changes over the control of that gene (D1 ALG). Fold changes are 
shown for A) ColX, B) PTHrP, C) PTH1r and D) IHH. (n=2) ................................ 82	
Fig. 3-8. FISH analysis to visualize distribution of A) ColX gene expression and B) Col2 
gene expression within the ALG bead on D0. C) Ratio of the count of Col2 positive 
cells to the count of ColX positive cells. Scale bar is 500 µm. ................................ 84	
Fig. 3-9. FACS analysis of cell cycle of chondrocytes encapsulated in ALG cultured in 
cartilage culture media (NT) or with increasing PTH treatments on D1 (left) and D4 
(right). D0 is representative of chondrocytes that were encapsulated in ALG and 
immediately processed for FACS. ............................................................................ 85	
Fig. 3-10. Ratio of Col2 to Col1 to explore the differentiation status of chondrocytes. In 
ALG on D1 (left) and D4 (right). Cells were encapsulated in RGD and treated with 
varying concentrations of PTH. ................................................................................ 88	
Fig. 3-11. Gene expression of chondrocytes cultured in ALG with or without PTH 
treatments over time. Data are reported as fold changes over the control of that gene 
(D1 ALG). Fold changes are shown for A) ColX, B) PTHrP, C) PTH1r and D) IHH. 
(n=2) .......................................................................................................................... 90	
Fig. 3-12. FISH analysis to examine hypertrophy over time with increasing PTH 
treatment. The fraction of ColX positive cells compared to the number of nuclei by a 
DAPI count and the count of Col2 positive cells to number of nuclei was calculated 
xvi 
 
and the ratio of the fraction of ColX positive cells to Col2 positive cells was 
reported. .................................................................................................................... 93	
Fig. 3-13. FACS analysis of cell cycle of chondrocytes encapsulated in ALG with IHH 
treatments on D1 (left) and D4 (right). D0 is representative of chondrocytes that 
were encapsulated in ALG and immediately processed for FACS, NT is 
representative of cells that were encapsulated and cultured with no treatment and 
0.05, 0.5 and 5.0 represent cells cultured with that concentration of IHH 
supplemented in the culture media. .......................................................................... 94	
Fig. 3-14. Ratio of Col2 to Col1 to explore the differentiation status of chondrocytes. In 
ALG on D1 (left) and D4 (right). Cells were encapsulated in RGD and treated with 
varying concentrations of IHH. ................................................................................. 96	
Fig. 3-15. Gene expression of chondrocytes cultured in ALG over time with no treatment 
(NT) or treatment with 0.05, 0.5 or 5.0 nM IHH. Data are reported as fold changes 
over a D0 (not shown). Fold changes are shown for A) ColX, B) PTHrP, C) PTH1r 
and D) IHH. .............................................................................................................. 97	
Fig. 3-16. FISH analysis to find ratio of the count of Col2 positive cells to the count of 
ColX positive cells between D1 and D4 in ALG with varying IHH treatments. ...... 99	
Fig. 3-17. FISH visualization of A) ColX and corresponding B) DAPI, and of C) Col2 
and corresponding D) DAPI. Scale bar is 200 µm. E) Ratio of ColX and Col 2 
positive cells to a nuclei count (DAPI) using image analysis to show differences in 
cells positive for ColX or Col2 in radially defined regions. ................................... 101	
xvii 
 
Fig. 4-1. Representative images of embryos cultured with or without encapsulation or 
TGFβ from 0 h to 96 h. C-0) Image of control embryo cultured without 
encapsulation in alginate or TGFβ is represtative of all surving control embryos with 
or without TGFβ. 0-10) Images represent embryos encapsulated in alginate without 
TGFβ, with 0.1, 1.0 or 10 ng TGFβ/mL media respectively. ................................. 117	
Fig. 4-2. Survival and rate of elongation of in vitro cultured embryos with the addition of 
TGFβ. A) Percent survival of non-encapsulated (CONT) embryos with increasing 
TGFβ  concentration and encapsulated (ALG) embryos with increasing TGFβ 
supplementation. B) Percent of all embryos that showed morphological changes and 
C) percent of surviving embryos that showed morphological changes. ................. 118	
Fig. 4-3. Device for the immobilization of double encapsulated beads for culture. 
Alginate droplets on polyethylene mesh were immobilized after crosslinking. ..... 123	
Fig. 4-4. Preliminary results of cell cycle distribution and Col2/ColX ratio for 
encapsulated chondrocytes treated with A) and D) thyroxine (THX),  B) and E) 
purmorphamine (PMP), and C) and F) bone morphogenic protein (BMP). ........... 129	
Fig. 4-5. Schematic of the calcium leaching method. Steps 1-3a, or 4a, are the methods to 
make the homogenous inner bead specific to the calcium leaching method. The 
resulting construct is either a homogenous bead with encapsulated cells or a 
heterogeneous bead with encapsulated cells in the outer layer. .............................. 132	
Fig. 4-6. Representative phase and fluorescent images of layered beads using the calcium 
leeching method overlaid and measured using ImageJ. Beads fabricated by both A) 
keeping the alginate percentage of the inner bead and the outer layer identical and B) 
xviii 
 
keeping the inner bead at 1.5% and changing the outer layer percentage. Both 
images are of the 1.0% data points discussed below. The scale bar is 100 µm. ..... 133	
Fig. 4-7. Changing alginate percentage to modulate layer thickness. All figures show 
results of using the calcium leaching method. A) and B) keep the inner and outer 
alginates at the same percentage while C) and D) keep the inner bead at 1.5% while 
modulating the outer layer percentage. B) and D) are the deviations in the thickness 
of the layers of the results shown in A) and B) respectively. ................................. 135	
Fig. 4-8. The role of calcium concentration on the layer thickness. There is no effect seen 
in our system. .......................................................................................................... 136	
Fig. 4-9. ELISA results of PTH plasmid transfection with varying concentrations of 
plasmid per well over 48 hours of HEK 293T cells. ............................................... 138	
xix 
 
LIST OF TABLES 
Table 2-1. Survivability and morphological change data for all treatment types.  Values 
are reported as the least-squares mean ± SEM as determined using GLIMMIX 
analysis for the main effect of treatment. Significance for the effect of treatment was 
determined using Chi-squared analysis. († indicates the comparison between the 
described condition and CONT, ‡ indicates the comparison between the described 
condition and ALG and    indicates the comparison between the described 
condition and SPP1). ................................................................................................. 43	
Table 2-2. Summary of morphometric analysis along with proliferation data of all 
embryo treatments divided into subsets of morphometrically changing embryos (+) 
and non-changing embryos (-). Values are reported as the least-squares mean ± SEM 
as determined using Mixed procedure analysis. ....................................................... 44	
Table 2-3. Detailed gene expression data with RQ and upper and lower SEM given for all 
treatment groups. ....................................................................................................... 49	
Table 2-4. Estrogen and total protein concentration in the media of embryos cultured for 
all treatment groups reported with means and SEM. ................................................ 51	
Table 3-1. Sequence of primers used for ddPCR amplification. ...................................... 72	
Table 3-2. Cell cycle distribution by FACS analysis. Reported in this table are the 
geometric means with SEM for each phase of the cell cycle and replicate number for 
each treatment group. ................................................................................................ 80	
xx 
 
Table 3-3. Fold change in transcripts of genes of interest as compared to the D1 ALG of 
each column. Reported in this table are the geometric means with SEM and replicate 
number for each treatment group. ............................................................................. 83	
Table 3-4. Cell cycle distribution by FACS analysis. Reported in this table are the 
geometric means with SEM and replicate number for each treatment group ........... 87	
Table 3-5. Fold change in transcripts of genes of interest as compared to the NT of each 
column. Reported in this table are the geometric means with SEM and replicate 
number for each treatment group. ............................................................................. 92	
Table 3-6. Cell cycle distribution by FACS analysis. Reported in this table are the 
geometric means with SEM and replicate number for each treatment group. .......... 95	
Table 3-7. Fold change in transcripts of genes of interest as compared to the D0 NT of 
each column. Reported in this table are the geometric means with SEM and replicate 
number for each treatment group. ............................................................................. 99	
Table 4-1. Summary of embryo survival and morphological changes observed after 96 
hours of culture of alginate encapsulated embryos and non-encapsulated control (C) 
embryos with TGFβ incorporated in the culture media. ......................................... 119	
 1 
 Thesis Introduction and Background CHAPTER 1-
1.1.  Introduction 
The development of in vitro culture models using tissue engineering techniques is 
a promising approach to answer biological questions about a given tissue system. Tissue 
engineering is classically defined by Langer and Vacanti as applying “the principles of 
biology and engineering to the development of functional substitutes for damaged tissue” 
with the main objective being the development of whole organs for transplantation to 
circumvent the overwhelming scarcity of donated organs [1]. While this task remains 
daunting to this day, tissue engineering has evolved from this strict definition and has 
taken on many roles, such as becoming an invaluable tool for the study of biological 
development.  
Currently, there are two well-established representations of tissue systems- two-
dimensional (2-D) cell culture and animal models. While a wealth of knowledge has thus 
far been gained through cell culture and animal models, it is recognized that 2-D cell 
cultures are not representative of the physiology of real tissues and animals are not 
completely representative of human tissue [2].  A reduction in the gap between cell 
culture and animal studies can be facilitated via 3-D cell cultures and tissue culture 
models [2]. By utilizing tissue engineering techniques- the combination of scaffolds, 
factors and cells- models of development can be established to answer crucial questions 
necessary to advance our understanding of biological systems. These models, or in vitro 
culture models, are representations of in vivo biological systems but are independent of 
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any living organism. In vitro culture models allows for the isolated study of whole tissues 
or organs without the necessity of animal models, thus bridging the gap between 2-D cell 
culture and animal model experimentation. This thesis focuses on the development of in 
vitro culture models with the use of alginate hydrogels. 
Hydrogels, or polymeric materials that exhibit the ability to swell and retain water 
within their structure without degrading in water, are ideal scaffold systems to use in the 
engineering of tissues or in vitro culture models due to their close resemblance to the 
extracellular matrix (ECM) of many native tissues [3]. In particular, alginate, a 
polysaccharide derived from brown algae, is one such material that forms hydrogels 
when crosslinked in the presence of divalent cations (i.e. Ca2+, Ba2+, etc.). These three-
dimensional (3-D) hydrogel structures can be molded or crosslinked into many shapes 
and sizes [4]. After crosslinking, the mechanical properties of alginate hydrogels can 
exhibit a range of Young’s moduli, but can be tailored toward a specific stiffness that 
correlates to many different tissues within the body and can even be modulated to mimic 
a particular tissue type [5]. Alginate is inherently biocompatible, which is a desirable 
property of a biomaterial when working with biological entities such as cells or whole 
tissues [6]. Not only are alginate hydrogels biocompatible, but also alginate in its basic 
chemical structure is non-fouling, or it allows for little to no protein adsorption, which 
leads to the inability for cells to adhere to the structure [7]. Thus alginate acts as a “blank-
slate” scaffold in this respect and allows for the study of specific effects that 3-D culture 
has on cell and tissue cultures. Finally, because of the simple active groups found on the 
alginate molecule, it can be easily chemically modified to present factors in a controlled 
manner to study interactions between cells and the surrounding scaffolding [8]. All of 
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these properties allow researchers to ask basic, developmental biological questions by 
first encapsulating cells or tissues within an alginate hydrogel matrix to strictly study the 
change from 2-D culture to 3-D culture. Questions can then be asked about the role that 
mechanical and/or molecular factors play in cellular maturation by introducing changes 
to these aspects within the hydrogel in a controlled manner. For this thesis, alginate was 
utilized to design 3-D scaffold for two objectives. 
For the first objective of the thesis, previously developed alginate scaffolds [9] 
were utilized as a tool to probe questions about the role of ECM ligands in porcine 
embryo elongation in vitro. Elongation is the period of porcine gestation where drastic 
embryonic morphological changes occur within a very short time period. Pre-
implantation elongation is characterized by a change in embryonic shape from a spherical 
morphology, with a radius from 0.5- to 1.5-mm in diameter, to a filamentous 
morphology, with a length of up to 100-mm, within a time frame of hours at any point 
between days 10 and 12 of gestation [10]. It is estimated that 40% of embryos are lost 
during the pre- and peri-implantation period of gestation, with approximately 20% due to 
deficiencies in the elongation process described above. However, the mechanisms behind 
the success or failure of elongation remain largely unclear [11]. Therefore, the first 
objective of this thesis was to improve upon the existing in vitro model by introducing 
known factors into the scaffold itself, including factors such as Osteopontin (SPP1) and 
the specific integrin binding motif found in SSP1, Arginine-Glycine-Aspartic acid 
(RGD), in order to understand their specific role in elongation.  
For the second objective of the thesis, alginate hydrogel scaffolds were designed 
to mimic an ECM for growth plate chondrocytes to establish an in vitro model of growth 
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plate cartilage. Growth plate cartilage, found at the ends of long bones during 
prepubescent development, is the cartilaginous structure responsible for the longitudinal 
growth of bones [12]. During development, distinct zones of the growth plate emerge 
with each zone containing chondrocytes with a specific phenotype. From the ends of the 
long bones to the beginning of ossification, the zones have distinct characteristics. The 
resting zone is made up of immature, quiescent chondrocytes that have low instances of 
proliferation and are round in morphology [13]. As the chondrocytes begin to mature, 
they flatten into coin-like shapes and initiate an increase in proliferation [14]. Flattened, 
highly proliferative cells that form columns make up the proliferative zone, and this zone 
is of particular interest because of the manner by which proliferation takes place: 
chondrocytes divide perpendicular to the axis of growth, rearrange themselves into stacks 
and repeat, leading to longitudinal growth [15]. Once the chondrocytes mature further, 
the process of hypertrophy begins. In the prehypertrophic and hypertrophic zones, 
chondrocytes take on an enlarged morphology and initiate apoptosis leading to bone 
formation [16]. Growth plate cartilage is not capable of repairing or regeneration once 
injured or diseased. In prepubescent long bones, growth plate cartilage is the softest part 
of the bone during development and is therefore the most susceptible part of the bone to 
injury. An injury to this fragile cartilage, particularly within the proliferative zone, results 
in severe deformities and long-term pain in the worst cases. In addition to the inability of 
growth plate cartilage to heal itself, there are currently few therapeutic options for 
patients with these injuries. By developing an in vitro culture model for growth plate 
cartilage, the specific mechanisms behind zonal arrangement and the resulting 
architecture can be elucidated, leading to a better understanding of the developmental 
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process of the growth plate and in turn leading to the investigation and identification of 
therapeutic techniques to treat injuries. Therefore, the second objective of this thesis is to 
use an alginate hydrogel scaffold system to develop an in vitro culture system to 
determine the basic signaling factors necessary for the development of the zonal 
architecture seen in vivo within growth plate cartilage. 
By designing and optimizing these two in vitro culture systems, the knowledge 
and understanding of physiological processes will be advanced, and the scientific 
community will gain a useful tool to study reproduction in a controlled setting and to 
study degenerative cartilage diseases leading to the availability of better therapeutic 
treatments.  The remainder of this introduction is arranged as follows- the basic principles 
and advances in tissue engineering are covered, then the significance of alginate to this 
thesis is described, followed by a more thorough explanation of in vitro culture models, 
and finally, the development of the two in vitro culture models covered in this thesis, a 
model of porcine embryo elongation and growth plate cartilage development, are 
introduced.  
 
1.1.1.  Tissue Engineering 
The main goal when tissue engineering was emerging as a prevalent field of study 
within biology and engineering was to build new organs for patients relying on scarce 
donors for whole organ transplantation. The field of whole organ engineering must 
advance further before the necessity of organ donors is no longer, however tissue 
engineering has made great strides in advancing the field’s knowledge of the intricacies 
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of tissue development and viability in order to keep working toward this overall goal. 
Since Langer and Vacanti first defined tissue engineering, it has been further described as 
the combination of its fundamental aspects: cells or tissue, scaffolding and bioactive 
signals [17]. The first necessity, cells, can be collected from many sources including from 
animal sources, patient’s own tissues, and the cells may be fully differentiated or be 
derived from or be stem cells [1]. Second, the scaffolding can be used to mimic the native 
ECM or environment surrounding the cell. Since the emergence of tissue engineering, 
research groups have taken many different approaches in designing the scaffolds for a 
specific tissue type. For example, some choose to decellularize an existing donated organ 
before introducing the patient’s own cells to the ECM [18]. By using this method, the risk 
of negative immune responses is lessened due to the fact that the patient is receiving their 
own cells. However, the risk is not completely mitigated since the surrounding ECM is 
still foreign. Others have utilized naturally- or artificially-derived biomaterials to design a 
base ECM scaffold within which cells can be cultured [7]. Many types of biomaterials, 
including ceramics (e.g hydroxyapatite (HA) or tri-calcium phosphate (TCP)), synthetic 
polymers (e.g. poly-l-lactic acid (PLA) or polyethylene glycol), and natural polymers 
(e.g. collagen or alginate), are used in tissue engineering approaches [19]. Rigid materials 
like HA or TCP are utilized in bone tissue engineering due to their chemical and 
mechanical similarity to the targeted tissue [20]. Other biomaterials such as polyurethane, 
collagen or alginate have been used in models because of their mechanical similarity to 
soft tissues [21-23]. Alginate has been used in many tissue engineering applications to 
date including as an injectable cell delivery vehicles [24] as well as wound dressings 
[25], dental impressions [26], and immobilization matrices because of its 
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biocompatibility, tunable mechanical properties and easy modification, which will be 
discussed further below [7]. Finally, bioactive signals are vital to the success of the 
development of engineered tissues. Signals such as proteins like fibronectin (FN) or 
osteopontin (SPP1) allow for scaffold-cell interaction that mimics the in vivo cell-matrix 
interaction within a tissue system that drive cellular growth and differentiation to guide 
the cells toward a specific function [27]. It has been shown that without bioactive signals, 
the loss of cellular phenotype and differentiation into unintended phenotypes occurs in 
vitro [28].  All three of these aspects, scaffold, cells and bioactive signals are explored 
and optimized in this thesis in two different models to study growth plate cartilage 
development and embryo elongation in vitro. 
By utilizing tissue engineering techniques to develop in vitro culture models from 
the ground up, researchers have been able to better understand the basic environment 
necessary for tissue development in order to eventually repair, maintain or enhance tissue 
function for regenerative and replacement therapies [29]. Additionally, by building these 
tissue systems to function in an in vitro environment, the possibility emerges of using 
these engineered tissues for drug discovery, therapeutic testing, or injury investigations in 
place of 2-D cell culture systems or animal models [2]. In this thesis, alginate hydrogels 
were utilized as the natural polymer for the scaffold to support embryo elongation and 
growth plate cartilage development in vitro. 
1.1.2.  Alginate 
Alginate is a biocompatible, naturally-derived, linear polysaccharide that was 
originally thought to be produced strictly by algae such as M. pyrifera and A. nodosum, 
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Fig. 1-1. Chemical structure and ionic crosslinking of alginate. Alginate is made of M 
and G blocks and it ionically crosslinks with divalent cations such as Ca2+ to form 
hydrogels (Reprinted from Andersen et al., Carbohydr. Chem, 2012) 
but it has since been proven to be isolated from bacterial sources such as P. Aeruginosa 
as well [30, 31]. Currently, alginate is used in a wide range of applications including the 
commercial food industry, cosmetics production industry, and medical and 
pharmaceutical materials, further supporting the FDA’s claim of safety (GRAS) [31-33]. 
More relevant to this thesis, alginate has been used in biomedical applications as wound 
dressings, dental implants and tissue engineering [34].  
1.1.2.1.  Properties of Alginate 
Alginate is a block copolymer that is comprised of varying ratios of L-guluronate 
(G) and D-mannuronate (M) residues depending on the natural source (Fig. 1-1) [35]. 
The crosslinking of sodium alginate in the presence of divalent cations such as calcium 
(Ca2+) or barium (Ba2+) produces hydrogels, or water-swollen and crosslinked networks 
of hydrophilic polymer chains produced by a simple reaction between two chains that 
will not dissolve in water [36]. It is believed that only the G-blocks of alginate participate 
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in intermolecular crosslinking to form hydrogels, as shown in Fig. 1-1, indicating the 
M:G ratio has a significant impact on the mechanics of crosslinking [32, 35]. The most 
critical advantages of using alginate to develop in vitro culture models are perhaps its 
biocompatibility and non-immunogenicity, however other advantages such as mild 
gelation conditions, tunable mechanical properties and ease of functionalization also add 
to its appeal as a biomaterial scaffold [6]. 
Among many other synthetic or naturally occurring biomaterials, alginate is 
widely used in tissue engineering as a scaffolding material. Because it is known to be 
biologically inactive, in the sense that protein adsorption and cell attachment to 
unmodified alginates are low due to hydrophilcity and charge, this polymer is well suited 
to be implanted into or even merely in contact with the human body [37]. It has even 
been shown that alginates with a G-content of 50% or above are recognized as not 
eliciting an immune response [37]. Without modifications, this nonfouling characteristic 
allows alginate to serve as a “blank slate”, acting only as a mechanical support system to 
study the effects 3-D culture has without any other interference. Additionally, the 
mechanical properties and adhesion potential of the alginate hydrogels can be easily 
modulated to fit specific needs of the target system. 
1.1.2.2.  Modulation of Alginate Mechanical Properties 
Tissues of the body have a wide range of stiffness, making the ease of the control 
of the mechanical properties of biomaterials used for in vitro culture models essential. 
The Young’s moduli of alginate hydrogels can be modulated by changing the 
concentration of alginate in solution, the chemical makeup of the alginate molecule, the 
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solvent used to dissolve the alginate, the gelation temperature and also by changing the 
divalent cation used for crosslinking [5, 29, 35, 38]. For example, alginate has been 
modified with sodium periodate to induce degradability of the hydrogel by oxidation for 
better control of changes in mechanical properties in alginate [39]. Another way to 
change alginate mechanical properties and to obtain an alginate hydrogel with a lower 
Young’s modulus (< 10 kPa), one could choose to dissolve the alginate at lower 
percentage (w/v) and/or a use an alginate with a lower G content, dissolve the alginate in 
PBS, and/or gel the solution at a higher temperature [23, 40]. On the other hand, if the 
goal is to employ an alginate hydrogel with higher Young’s modulus (>40 kPa), a higher 
percentage of alginate and/or a higher concentration of G blocks should be used, the 
solution should be made with Ca2+ free DMEM with a low phosphate concentration 
and/or should be gelled at a lower temperature [39, 40]. With all of these control 
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mechanisms, the compressive modulus for alginate hydrogels can range from less than 1-
kPa to over 1000-kPa, with lower moduli being used as an ECM mimic for tissues like 
smooth muscle, while the higher moduli being used in bone tissue engineering 
applications [5]. For the purposes of this thesis, alginate hydrogels with a Young’s 
modulus ranging from 5- to 20-kPa were used, prepared by varying the density (w/v) of 
medium viscosity (>200 mPa) alginate (Fig. 1-2). Although the mechanical properties of 
alginate can be varied with relative ease, there are a few disadvantages of using alginate 
in its unmodified form. For instance, alginate does not degrade in a controllable fashion, 
and because of the inability of proteins to adsorb to the surface of alginate, cell adhesion 
is not promoted in unmodified alginate gels. In order to address these concerns, many 
modifications to the alginate molecule and hydrogel have been explored, as described 
next. 
1.1.2.3.  Alginate Modifications 
To modulate aspects such as bioactivity, degradation rate and mechanical 
properties, chemical modifications can be made to the alginate molecule, allowing for 
greater control over the design of the hydrogel, specifically for tissue engineering uses. 
Calcium crosslinked alginate hydrogels slowly and uncontrollably degrade in 
physiological conditions due to ion exchange, and it has been proven that covalent 
crosslinking yields hydrogels with much higher stability over time [40]. By introducing 
oxidation points into the alginate molecule by using γ-radiation and/or periodate 
oxidation in combination with molecular weight modulation, it has been shown that the 
degradation rate of the alginate hydrogels can be strictly regulated without changing the 
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initial physical properties of the gel [39-41]. 
While controlling degradation rate is an important aspect of scaffold design, the 
ability of the encapsulated cells to interact with the surrounding matrix is also crucial. 
Mammalian cells do not have receptors for alginate polymers, which makes alginate 
relatively inert, however, cell adhesion is a basic requirement for cell survival [6, 42]. 
Cell adhesion molecules such as fibronectin (FN), collagens, laminin, and osteopontin 
(SSP1) bind cell surface receptors such as integrins and syndecans [43] and can be easily 
blended within the alginate solution prior to crosslinking to incorporate them within the 
gel. However, the covalent modification of alginate with any of these full proteins poses 
many problems: proteins must be isolated and purified to not induce an immune response, 
the length of time these proteins are active is very short making replacement necessary, 
the position of the whole molecule to present the active portion is difficult, and it is very 
difficult to control the kinetics of functionalization with whole proteins and alginate [44]. 
One of the most ubiquitous integrin binding motifs found in these proteins is the peptide 
sequence RGD [44, 45]. It has been shown that the use of only this short sequence can 
stimulate different cell responses not only by modulating the average concentrations of 
ligands, but also by presenting the ligands in a way that allows or even triggers integrin 
aggregation and mechanotransduction from the surrounding matrix [46]. The conjugation 
of RGD to alginate has been utilized extensively in tissue engineering [28, 47, 48]. For 
example, RGD modification to alginate at varying densities showed that the inclusion of 
the adhesion peptide at specific densities enhanced the functionality of baby hamster 
kidney fibroblasts; fibroblasts demonstrated higher rates of proliferation and secreted 
more VEGF over time when encapsulated in RGD-alginate than in unmodified alginate, 
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indicating cell adhesion was crucial to the functionality of these fibroblasts [49]. 
Additionally, RGD modification to alginate aided in the guidance of adipose-derived 
adult stem cells down a chondrogenic line and has even been used to pattern cellular 
growth on alginate surfaces and within alginate scaffolding [50-52]. Tissues such as 
cardiac muscle, cartilage, and bone have all been engineered with the use of the RGD 
peptide conjugated with alginate [47, 52]. The utilization of such a small sequence 
negates the aforementioned disadvantages that come with whole protein conjugation, 
allowing for controlled, reproducible conjugation densities while still presenting cell 
adhesion moieties. In this thesis, the RGD peptide was conjugated to the alginate using 
carbodiimide chemistry to explore the effects of cell adhesion on both of the two culture 
systems.  
Alginate has proven to be a suitable biomaterial for tissue engineering; the 
material is biocompatible and inert, the mechanical properties can be modulated for both 
of our applications, and the cell-scaffold interactions can be easily tuned for our models. 
For these reasons, alginate hydrogel scaffold systems were designed and optimized for 
the purposes of developing in vitro culture models of both porcine embryo elongation and 
growth plate cartilage development. An introduction on in vitro culture models follows. 
1.1.3.  In Vitro Culture Models 
The development of in vitro culture models utilizes the techniques of tissue 
engineering (i.e. scaffolds, cells and provision of bioactive signals) to produce 
biologically suitable substitutes for organ systems or tissues, which can in turn be utilized 
for pharmaceutical, diagnostic or research purposes [53]. Until recently, most early-stage 
 14 
experiments that ranged from exploring fundamental biological mechanisms to high-
throughput drug screenings were conducted using immortalized, mono-layered cell lines. 
While the use of cell lines in 2-D culture remains an important tool in many research 
endeavors, it is generally accepted that this mode of culture is highly divergent from 
native tissue physiology [2]. Culturing in two dimensions (2-D) leads to the loss of cell 
polarity, a lack of cell-cell and cell-matrix interactions, a change in gene expression, and 
a tendency to induce dedifferentiation that would not be experienced in 3-D culture 
models [54, 55]. Animal models have also been used to study biological development as 
well as the efficacy and safety of drugs and drug delivery methods. However, while 
animal models have been integral in studying many in vivo mechanisms, this approach 
Fig. 1-3. The principles of in vitro culture models. Tissue engineering techniques, 
or the combination of cells, scaffolds and signals, are utilized in the development 
of in vitro culture models. These models act as the bridge between cell culture 
models and animal models, giving researchers another tool for studying 
pharmaceutical, diagnostic or developmental mechanisms. 
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too can have shortcomings. The disadvantages of using animal models include the 
inability to model drug therapeutic responses accurately or induce stem-cell 
differentiation, the incompetence in accurately mimicking human responses, as well as 
the ethical concerns with using live animals for research [2, 54].   
In order to bridge the gap between cell culture and animal studies (Fig. 1-3), in 
vitro culture models have been developed using tissue engineering techniques, which 
uses cells, scaffolds and bioactive molecules to develop simulations of tissues in vitro. 
Models have been developed using cells of many different types, scaffolds made of 
varying materials and a wide range of bioactive signals to design the construct for a 
specific purpose. Applications for in vitro culture models include the exploration of 
various aspects of disease dynamics, drug discovery, diagnostics, and developmental 
biology. Recently developed 3-D culture models have already proven to be more 
physiologically relevant than either cell culture or animal models and have showed 
improvement in the response of the developed model to controlled stimuli [56]. For 
example, 3-D in vitro culture models have been extensively utilized in the study of cancer 
and metastasis, as well as other diseases, and have probed for the response of tissues to 
therapeutic and pharmacological agents [57-60]. Models of cancers in the bladder, 
breasts, kidneys, lungs, ovaries, pancreas and prostate have utilized 3-D in vitro cultures 
to better understand the development, metastasis, vascularization and response to 
therapeutic drugs of these cancers [61, 62]. For instance, Bissell et al. used 3-D cultures 
within reconstituted basement membrane, or Matrigel, and bioactive signals to show the 
significant role of the extracellular context in tumorigenesis [2]. Additionally, 
osteoarthritis has been studied in vitro to understand the degradation and calcification of 
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articular chondrocytes for example, by treating with factors known to be involved in the 
disruption of articular cartilage [63]. Tissue engineered 3-D models of gastrointestinal 
inflammatory disease, rheumatoid arthritis, heart disease, and of many more organ system 
disorders have proven to demonstrate markers such as gene expression and protein 
excretion reminiscent of the tissue disease, which their monolayer counterparts were 
unable to do [21, 63-65]. All of these culture models have utilized a variety of different 
scaffold materials that were chosen carefully for their functions. In order to develop in 
vitro culture models to study both porcine embryo elongation and growth plate cartilage 
development, alginate was extensively utilized in this thesis because of the many 
desirable characteristics of the biomaterial, as described previously. First, alginate was 
employed to encapsulate and culture porcine embryos for the study of RGD and SPP1 in 
elongation in vitro. 
1.2.  In Vitro Model of Porcine Embryo Elongation 
In swine bred for food production, the average number of eggs released from the 
ovaries per estrus cycle is 19-20,with around 18-19 being fertilized [66]. The amount of 
oocytes released during estrus is >20 and the fertilization rate is greater than 90%, 
however after 114 days of gestation the average litter size is only 10.5 piglets [67]. It is 
estimated that of the almost 50% embryonic loss, 20% is due to deficiencies in or 
asynchronous elongation [68]. Elongation is the rapid and dramatic change in 
morphology after the blastocyst hatches from the zona pellucida and begins to prepare for 
implantation (see Fig. 1-4) [67]. It has been shown that between days 10 and 12 of 
gestation, the embryo rapidly (3-4 hours) elongates from a sphere of around 1.5 mm in 
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diameter to a 100 to 150 mm filamentous form and it has been shown to be associated 
with cellular reorganization and remodeling in the pig, rather than hyperplasia like in 
ruminants [69]. During elongation, estrogen production by the embryo increases in order 
to modulate the production and secretion of other proteins downstream and to signal for 
the recognition of pregnancy [69]. It is hypothesized that an upregulation of the immune 
responsive cytokine, interlekin-1β (IL1B) contributes to rapid trophoblast elongation and 
pregnancy establishment in pigs [70, 71]. Also throughout elongation and along with 
estrogen production by the embryo, changes in the expression of steroidogenic gene 
transcripts such as steroidogenic acute regulatory protein (STAR), cytochrome P450 side 
Fig. 1-4. Schematic of the timeline of porcine embryo elongation. Embryo elongation begins at any 
point between days 9 and 10. By day 12, the embryo has elongated and is now filamentous with a 
length of over a centimeter. Additionally, the secretion of estrogen and the secretion of 
steroidogenic transcripts increase as the embryo elongates while the total protein and rate of 
proliferation remains constant throughout the process. 
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chain cleavage (CYP11A1), and aromatase (CYP19A1), have been observed [72-74].  
Many molecular signaling factors are known to play a role in the initiation of this 
elongation process, both from the uterine wall and from the embryo itself. Fibroblast 
growth factor 7 (FGF7), transforming growth factor-betas (TGFβ), osteopontin (SPP1), 
fibronectin (FN), and laminin (LN) are all present in the uterine milieu and have been 
implicated in maternal interactions during elongation and implantation [75, 76]. More 
specifically, the glycoprotein SPP1 has been shown to be upregulated within the uterine 
milieu as the embryo initiates elongation [75]. Evidence also suggests that the activation 
of alpha 5 and beta 3 integrins on the embryonic trophectoderm by the specific integrin 
binding sequence RGD found in SPP1, FN and LN induces cytoplasmic reorganization 
during embryo development and elongation by stimulating cell-cell adhesion and 
promoting cell migration [77-79]. Furthermore, it has been shown in vitro that SPP1 
added exogenously to the culture media enhances the development of early porcine 
embryos to the blastocyst stage [80].  Porcine blastomeres were cultured on dishes that 
were coated with FN and an enhancement of the development to the blastocyst stage over 
the non-coated control was observed [81]. These studies suggest a role of cell adhesion 
proteins on early embryonic development. 
Several factors have been associated with embryonic mortality in porcine 
gestation that include the proper timing of the secretion of hormones like estrogen and the 
subsequent induction of the production and secretion of signaling molecules like FN and 
LN that are involved in elongation and implantation [82]. Any disruptions in the 
presentation of these signaling factors can lead to deficiencies in elongation and cross-
talk between the mother and the embryo, as well as asynchronies in elongation between 
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litter-mates [83]. Complete failure of the blastocyst to undergo elongation results in 
embryonic loss [73]. Because of the potential for asynchronies in elongation, along with 
the wide span of time rapid elongation could take place, it is difficult to study the 
initiation of elongation in vivo.  
Many attempts to culture and promote the elongation of porcine embryos in vitro 
have been unsuccessful; however, some success has been achieved in other species. For 
example, the culture of bovine embryos in vitro has been demonstrated using a gel tube 
made of agar [84]. While evidence of elongation was observed in this study, the 
embryonic disc failed to develop and the morphological changes observed were more 
likely due to the incomplete encapsulation of the embryo [85, 86]. Moreover, porcine 
embryo elongation had not yet been witnessed in vitro until an alginate hydrogel culture 
system was developed in our lab [9]. Using a double layer alginate encapsulation 
technique, porcine embryos were encapsulated in alginate and were cultured in basal 
media for up to 96 hours. Elongation was observed only in encapsulated embryos, 
demonstrating the initiation of elongation in vitro for the first time [9]. However, the 
occurrence of a morphological change was not the only evidence of successful 
elongation. The expression of pertinent transcripts such as STAR, CYP11A1, CYP19A1 
and IL1B was elevated only in the embryos that elongated in vitro, demonstrating a 
pattern in gene expression that resembled the pattern seen in in vivo produced embryos 
[9]. Additionally, the increase of the secretion of estrogen, which is necessary for the 
recognition of pregnancy, was observed only in the in vitro produced embryos that 
showed morphological changes [9]. Furthermore, the protein levels of all encapsulated 
embryos as well as the controls remained constant throughout culture, regardless of the 
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state of morphological change, validating the idea that the elongation process is of 
rearrangement and remodeling and not that of proliferation [87]. All of these data 
combine to suggest that porcine embryo elongation is possible in vitro with the utilization 
of the aforementioned alginate hydrogel system and it could then be used as a valuable 
tool to study mechanisms behind the initiation and maintenance of elongation in Chapter 
2 of this thesis. In order to explore the effects of cell adhesion on elongation and survival 
in vitro, the ECM protein SPP1 was mechanically mixed into the scaffold prior to 
crosslinking, exposing the embryo to the protein during culture. Additionally, the RGD 
peptide was conjugated to alginate using previously described methods to explore the 
differences between whole protein interactions and small peptide sequence interactions 
and effect on elongation and survival. The information gained from these studies will 
shed light on the impact of SPP1 and RGD on elongation. Understanding the role of these 
molecules will lead to further improvements of this system in order to continue to study 
embryo elongation in vitro. This alginate culture system, while ideal for the study of 
porcine embryo elongation, was also employed in the development of an in vitro culture 
model for growth plate development, which is introduced in the following section.  
1.3.  In Vitro Model of Growth Plate Cartilage 
Many bones in the human body, particularly long bones, grow longitudinally via 
endochondral ossification of growth plate cartilage. This hyaline, or growth plate, 
cartilage is responsible for controlling the rate of growth of these bones from the 
beginning of development until puberty. The growth plate is arranged into zones, each 
with its own specific phenotype (Fig. 1-5). The resting zone contains slowly proliferating, 
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rounded, stem-like cells randomly distributed throughout the zone and chondrocytes in 
Fig. 1-5. A) Schematic of growth plate showing zonal arrangement. B) Depiction of an overview of the 
signaling pathways between PTHrP and IHH. (Recreatd from Deckelbaum et al., 2002) 
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this zone are responsible for renewing the pool of proliferative chondrocytes [88]. These 
chondrocytes produce parathyroid hormone-related protein (PTHrP) [89]. As they 
mature, resting zone chondrocytes begin to flatten into a coin-like shape and proliferate at 
a high rate where daughter cells arrange themselves into columns, giving rise to the 
architecture of the proliferative zone [89]. This zone is characterized by an increase in 
collagen type 2 (Col2) expression and after many mitotic cycles, chondrocytes begin to 
hypertrophy [16]. In the hypertrophic zone, chondrocytes increase in size, an increase in 
Indian hedgehog (IHH) expression is observed, and cells produce a calcified matrix rich 
in collagen type X (ColX), indicating the initiation of ossification [88, 90]. The   
chondrocytes are terminally differentiated at this point and begin to secrete specific 
proteins like VEGF to attract osteoblasts, initiate programmed cell death and osteoblasts 
invade the matrix, leading to bone formation [12, 89]. A wide range of signaling factors 
and matrix proteins are responsible for the zonal arrangement of the growth plate and for 
the columnar arrangement of the proliferative zone, however the specific mechanisms by 
which this architecture is formed have remained unclear [12].  
Generally, however, it is known that systemic factors such as growth hormone, 
parathyroid hormone, thyroxine, oestrogen, androgen, vitamin D and glucocorticoids in 
conjunction with locally produced factors such as bone morphogenetic proteins (BMPs), 
Wnts, fibroblast growth factors (FGFs), hedgehog proteins, insulin-like growth factors, 
and retinoids play a role in growth plate development [12]. Precise combinations of many 
of these factors tightly regulate the entry into and exit from each stage of chondrocyte 
differentiation, which correspond to the well-defined resting, proliferative, 
prehypertrophic and hypertrophic zones [91]. Any disruptions in this exact coordination 
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of signaling factors can lead to bone deformities ranging from slight to severe and 
crippling in nature. It has been identified that the interplay between PTHrP expression 
and IHH signaling takes on a significant role in maturation and ultimately zonal 
arrangement (Fig. 1-5) [91]. PTHrP synthesized by immature chondrocytes acts as a 
signaling ligand on the PTH/PTHrP receptors located on the surface of more matured 
chondrocytes aiding in the delay of further differentiation into hypertrophic chondrocytes 
[92]. IHH is synthesized by chondrocytes that have just stopped proliferating, but also 
induces the expression of PTHrP in periarticular perichondrium [93]. This feedback loop 
between PTHrP and IHH serves to regulate the pace of chondrocyte differentiation and 
the hypothesis is that a tight regulation of spatial and temporal presentation of these two 
signaling factors aids also in the formation of the columnar architecture of the 
proliferative zone. A depiction of the potential mechanism of PTHrP and IHH signalling 
is shown in Fig. 1-5.   
Attempts have been made to engineer many types of cartilage in vitro including 
fibrocartilage, found in the intervertebral discs, hyaline, which includes articular 
cartilage, and epiphyseal cartilage, also known as the growth plate by using many 
different approaches and scaffolds. For example, articular cartilage cultures have been 
designed free of scaffolds (seeded in a monolayer on osteogenic calcium phosphate), in 
cell pellets, in natural scaffolds like agarose gels, gelatin or hyaluronic acid sponges, as 
well in synthetic scaffolds like PGA/PLA [94-98]. More pertinent to this thesis, articular 
cartilage has been cultured extensively in alginate hydrogels. For example, alginate has 
been utilized to culture articular chondrocytes and to present factors to promote cell 
viability, cell proliferation and matrix synthesis, demonstrating that the addition of 
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factors to the culture induced specific changes in survivability and proof of differentiation 
and maintenance of chondrocytic phenotypes [99, 100]. Furthermore, cultured 
chondrocytes have even been implanted into osteoarthritic model animals after first being 
cultured in vitro in either pellets or in alginate hydrogels, showing an improvement in 
osteoarthritic healing in alginate cultures over that of both control models and implants 
from pellet cultured chondrocytes [101]. Although the goal of this thesis is to culture 
growth plate chondrocytes, strategies such as the culture using alginate encapsulation can 
be taken from the culture models developed for articular cartilage development and 
applied to the culture of growth plate chondrocytes. 
While there are much fewer examples of in vitro culture models for growth plate 
cartilage development as compared to those of articular cartilage in the literature, key 
studies have been conducted that hint at the underlying mechanisms of zonal arrangement 
and columnar formation. For instance, pellet cultures, which are chondrocytes that have 
been centrifuged at high speeds to form a densely packed aggregation of cells and are 
cultured in that form, have been used to study the effects of serum factors on columnar 
architecture development in growth plate chondrocytes [102, 103]. While the apparent 
alignment of the chondrocytes in the pellet was noted, other forms of characterization 
such as fate mapping or fluorescent in situ hybridization (FISH) to visualize gene 
expression distribution was not utilized to confirm the true lineage of the chondrocytes or 
the zonal arrangement characteristic of growth plate cartilage [102, 103]. Furthermore, 
distinct zones of maturation were not observed in pellet cultures [102, 103]. These studies 
have suggested that specific factors such as thyroxine can effect developmental or 
morphogenic processes within the growth plate and groups have claimed to recapitulate 
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the in vivo formation columnar structures, but thyroxine alone was not sufficient to 
produce zonal architecture [102, 103].  Much like organoid cultures of epithelial cells, 
pellet cultures tend to self-organize regardless of the experimental manipulations, and 
these results have not since been reproduced in the literature. Furthermore, unlike 
controlled tissue engineering studies described in this thesis, pellet cultures are unable to 
present crucial factors in a controlled and precise manner, nor in a way that allows for 
spatial distribution of the presentation of these factors. The results seen in these studies 
could be the result of the indirect effects of the exposure of strictly outer cells to media 
factors. In addition to pellet cultures, alginate hydrogels have been utilized to influence 
the directionality of proliferation in chondrocytes. Aydelotte, et al. used sodium alginate 
crosslinked in a calcium chloride (CaCl2) solution with no sodium chloride (NaCl) 
included, which formed small radial channels within the bead [104]. While chondrocytes 
appeared to align within the channels, no other characterization was performed on the 
chondrocytes to explore proliferation rates or gene expression that may be indicative of 
the proliferative phenotype. There is a necessity both for better design of in vitro model 
systems and for improved techniques to characterize the system to elucidate mechanisms 
behind zonal and columnar formation in the growth plate. In this thesis (Chapter 3), an in 
vitro culture model of growth plate cartilage was developed using alginate hydrogels in 
order to explore the effects of interaction with both scaffold ligands like RGD and factors 
such as PTH and IHH on growth plate phenotype. 
1.4.  Thesis Objectives 
In this thesis, the natural biomaterial alginate is utilized in the design of scaffolds 
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for the development of in vitro culture models of both porcine embryo elongation and 
growth plate development. The approaches taken here have led to advancements in the 
knowledge of both of these systems. The remainder of this thesis is laid out in the 
following manner: the background, methods, results and conclusions for the development 
of an in vitro porcine embryo elongation models are presented in Chapter 2, the 
background, methods, results and conclusions for the development of an in vitro growth 
plate model are described in Chapter 3, and finally the overall conclusions of this thesis, 
along with ideas for future improvements of both of these systems can be found in 
Chapter 4. 
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 Using 3-D Alginate In Vitro Culture System to Explore the Role of CHAPTER 2-
SPP1 and RGD on the Initiation of Preimplantation Porcine Embryo Elongation 
2.1.  Introduction 
During the pre-implantation period of pregnancy, the pig embryo undergoes a 
dramatic transformation from spherical (~1-2 mm) through the transitional ovoid (~4-5 
mm) and tubular (<10 mm) morphologies and finally to a long thin, filament (<100 mm) 
between day 9 and 12 of gestation [10, 69, 82, 105]. Once initiated, the process of 
embryo elongation is very rapid, with remodeling of the trophoblast and changes in 
conceptus length occurring at a rate of 35-40 mm per hour on day 11-12 [106]. As a 
result, the morphological transition between a tubular and filamentous embryo typically 
occurs within 2-3 hours and has been shown to be associated with cellular reorganization 
and remodeling in the pig, rather than hyperplasia like in ruminants [69, 87]. The 
majority of early embryonic mortality in the pig occurs during this period, and is 
characterized by deficiencies in embryo elongation [66, 82, 107]. 
Proper timing of the presentation and secretion of critical molecular factors in the 
embryo, as well as within the uterine environment, is vitally important to the initiation of 
the elongation process (day 9-12 of gestation), as well as the developmental competence 
of embryos during the pre-implantation period of pregnancy [10, 68, 69]. The secretion of 
many uterine-specific factors like osteopontin (SPP1) have been shown to be up-
regulated within the uterine milieu as the embryo initiates elongation and has been 
suggested to play a role in conceptus-maternal interactions during elongation and 
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implantation [75, 76, 108]. SPP1, a glycoprotein produced by the uterine lumen as early 
as day 9 of gestation, has been shown to stimulate cell adhesion both within the embryo 
and between the embryo and the epithelial cells of the uterus [109]. The ligand binding 
affinity is modulated within the embryonic cells via cytoplasmic domain transduction of 
intracellular signals [109]. Cell adhesion within the embryo and between the conceptus 
and the uterus leads to cytoplasmic reorganization and focal adhesions, which are 
necessary for elongation [109]. Disruptions or delays in the presentation of uterine 
specific factors can lead to asynchronies or deficiencies in the initiation of elongation, 
which can be detrimental to the survival of pig embryos and can influence within-litter 
birth weight variability [83]. 
Prior research has identified many specific signaling factors in addition to SPP1 
that may affect elongation and implantation [75, 110, 111]. However, elucidating the 
exact mechanisms by which these factors affect the initiation of the elongation process 
has remained a challenge. This deficiency in knowledge is attributed primarily to the 
inability to study porcine embryo elongation in vitro, due to both the short amount of 
time this dramatic transformation takes to complete, and also the lack of adequate in vitro 
culture systems capable of replicating the uterine environment that could allow for 
continuous real-time evaluation of this process. Previous attempts to culture porcine 
embryos have been unsuccessful in facilitating the crucial elongation process, mainly due 
to the disruption of normal maturation by two-dimensional (2-D) culture [84]. Recently, 
our group has developed a novel embryo culture system, using an alginate hydrogel 
network that creates a three-dimensional (3-D) system that encapsulates embryos, 
maintains viability and embryo architecture, and facilitates morphological changes with 
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corresponding increases in expression of steroidogenic transcripts and estrogen 
production, consistent with the initiation of elongation in vitro [9].  
The objective of the present study was to expand our alginate culture system and 
incorporate a key uterine factor, SPP1, thought to play a role on elongation, such that we 
can begin to investigate the role of SPP1 on the initiation of elongation in the pig.  In 
addition to presenting the complete SPP1 protein within our alginate system, we also 
investigated the presentation of the integrin receptor binding amino acid sequence, Arg-
Gly-Asp (RGD), the specific active ligand of SPP1. 
2.2.  Materials and Methods 
2.2.1.  Production and Collection of Embryos 
All animal protocols were approved by the U.S. Meat Animal Research Center 
(USMARC) Animal Care and Use Committee and met the Federation of Animal 
Societies [112] guidelines for the care and use of agricultural animals in research. White 
crossbred gilts consisting of Landrace, Yorkshire, and Duroc genetics were checked daily 
for estrus. Following first detection of estrus (designated as d 0), gilts were artificially 
inseminated with semen from pooled terminal Duroc sires collected from a commercial 
boar stud and again 24 h later with the same pool of semen. In 11 independent replicate 
collections, 39 pregnant gilts were slaughtered at the USMARC abattoir at d 9 of 
gestation. Following slaughter, reproductive tracts were removed immediately and each 
uterine horn was flushed with 20 mL (~37° C) of 25 mM Hepes-buffered RPMI-1640 
media (Invitrogen, Carlsbad, CA) containing 1x antibiotics/antimycotics (Sigma-Aldrich, 
St Louis, MO). Embryos (n = 340) were recovered and classified according to size and 
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morphology using a standard stereomicroscope (Nikon Instruments, Inc., Melville, NY). 
Embryos were then washed with Hepes-buffered RPMI-1640 media containing 1x 
antibiotics/antimycotics and 10% heat-inactivated fetal bovine serum (FBS; Invitrogen). 
Embryos from litters containing consistently spherical embryos (~1 mm in diameter with 
a range of 0.5 to 1.5 mm) were recovered and were randomly assigned to the in vitro 
culture treatments for encapsulation, as described next. 
2.2.2.  Alginate Solution and Modification 
Sodium alginate (Pronova UP MVG, >60% guluronic acid, 200,000 – 300,000 
g/mol, NovaMatrix, Sandvika, Norway) was dissolved in sterile 1X phosphate buffered 
saline (PBS; Sigma Aldrich, St. Louis, MO) at a concentration of 0.7% w/v. Embryos 
encapsulated in unmodified alginate solution, as described below, were labeled ALG.  
For some conditions, whole molecule SPP1 (R&D Systems, Minneapolis, MN) was 
mechanically mixed into the 0.7% alginate solution prior to cross-linking at a 
concentration of 0.1 µg/mL alginate solution. Embryos encapsulated in this alginate 
solution were labeled SPP1. As a second type of modification, alginate was covalently 
modified with a glycine-arginine-glycine-aspartic acid-serine-proline (GRGDSP) peptide 
(Anaspec, Fremont, CA) to a concentration of 4 µmol/g alginate using carbodiimide 
chemistry, as previously described [42]. Embryos encapsulated in this alginate solution 
were labeled RGD. Briefly, two grams of sodium alginate were added to 200 mL of MES 
buffer (0.1M MES, 0.3M NaCl, pH 6.5) and the alginate was allowed to dissolve for 7-8 
hours on a stir plate. 1-ethyl-(dimethylaminopropyl) carbodiimide (EDC; Sigma Aldrich) 
was added to activate 5% of the uronic acids of the alginate polymer backbone in order to 
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form amide linkages with the peptide. To stabilize the reactive EDC intermediate against 
a competing hydrolysis reaction, N-hydroxy-sulfosuccinimide (sulfo-NHS; Pierce, 
Rockford, IL) was also added to the solution at a 2:1 EDC to NHS ratio. Lastly, the 
GRGDSP peptide was incorporated into the solution, conjugating to the alginate 
backbone via the terminal amine of the peptide. After 20 hours of reacting, the 
conjugation reaction was quenched through the addition of hydroxylamine hydrochloride 
(Sigma Aldrich). The alginate solution was then dialyzed (3.5 kD MWCO, 45 mm flat-
width dialysis tubing; Spectrum Laboratories, Rancho Dominguez, CA) in a salt solution 
(NaCl in ddH2O) with stirring over the course of 3 days. The dialysis salt solution was 
replaced with decreasing salt solutions, starting with a concentration of 6.75-g/L followed 
by 5.25-, 3.75-, 2.25-, 0.75-, and 4 washes of 0-g/L NaCl in ddH2O every 8 hours. The 
resulting alginate solution was frozen to -80°C, lyophilized to dryness and was dissolved 
in PBS as described above prior to encapsulation. To verify successful conjugation of the 
GRGDSP peptide to the alginate polymer backbone, NMR spectroscopy was used to 
characterize the samples. Unmodified alginate and GRGDSP-alginate were dissolved in 
deuterium oxide (D2O; Sigma Aldrich) and placed in separate NMR tubes. The 1H-NMR 
spectra of the samples were recorded on a Bruker DRX-500 500 MHz NMR spectrometer 
at an operating frequency of 500.13 MHz. Embryos encapsulated in this modified 
alginate were labeled RGD.  
2.2.3.  Embryo Encapsulation and Culture 
After collecting and washing embryos as described above, all embryos were 
placed into a petri dish containing Hepes-buffered RPMI-1640 media containing 1x 
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antibiotics/antimycotics and 10% FBS, and were randomly assigned to 4 groups: 
encapsulated in unmodified alginate hydrogels (ALG), encapsulated in RGD-modified 
alginate hydrogels (RGD), embryos encapsulated in alginate hydrogels supplemented 
with SPP1 (SPP1) or non-encapsulated, 2-D cultured controls (CONT). Embryos 
assigned to all groups besides CONT were encapsulated within their respective alginate 
hydrogel using a double encapsulation method described previously and described below 
[9]. Briefly, unmodified or modified (see above) sodium alginate was dissolved in sterile 
PBS to a final concentration of 0.7% (w/v). 30-µL droplets of warmed, sterile alginate 
solutions were placed onto polystyrene culture dishes. A single embryo was pipetted into 
each droplet of alginate in a minimal amount of the media in which they were held prior 
to encapsulation as to not dilute the alginate solution. Each droplet was then pipetted into 
a warmed, sterile cross-linking solution (50 mM CaCl2, 140 mM NaCl) and allowed to 
gel for 3 minutes. 
The resulting alginate beads with encapsulated embryos were then rinsed twice in 
Hepes-buffered RPMI-1640 media containing 1x antibiotics/antimycotics and 10% FBS. 
Following the rinse, each bead was encapsulated in a second layer of alginate, using 
identical methods as described above with the exception of 45-µL of alginate was used as 
the base droplet to completely submerge the initial bead, to ensure thorough 
encapsulation of each embryo. The final resulting double-layered beads, along with the 
CONT embryos, were then washed once with pre-gassed culture media containing 
Hepes-buffered RPMI-1640, 1x antibiotics/antimycotics and 10% FBS. ALG, RGD, 
SPP1 and CONT embryos were cultured in individual wells of 4-well NUNC plates 
(Thermo-Scientific, Rochester, NY) with 1-mL of culture media for 96 h at 38.5°C and 
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5% CO2 in air with 100% humidity.  Every 24 hours, 500 µL of media was removed for 
estradiol quantification and 500-µL of fresh media was added to each well at that time. 
2.2.4.  Characterization of Embryo Viability and Morphology 
Every 24 h, an image was recorded of each embryo by photographing with a SMZ1500 
stereomicroscope (Nikon Instruments, Inc.). Embryo survival was determined by 
assessment of blastocyst fragmentation [9], in which surviving embryos were 
characterized with no apparent sign of cellular degeneration, whereas dying embryos had 
significant cellular degeneration resulting in blastocyst compaction and darkening of the 
embryo. Embryos undergoing morphological changes were characterized by a tubular 
formation of the embryo within the gel and subsequent flattening of this tube, with many 
of these embryos migrating out of the gel forming a secondary spherical structure once 
freely in the culture media. Based on visual appraisal of these images, surviving embryos 
were classified into the following treatment groups: CONT (non-encapsulated control 
embryos, none of which exhibited any morphological change and thus did not warrant 
further classification), ALG+ (embryos encapsulated in alginate with observable 
morphological changes), ALG- (embryos encapsulated in alginate with no observable 
morphological change), RGD+ (embryos encapsulated in RGD modified alginate with 
observable morphological changes), RGD- (embryos encapsulated in RGD modified 
alginate with no observable morphological change),  SPP1+ (embryos encapsulated in 
alginate supplemented with SPP1 with observable morphological changes), or SPP1- 
(embryos encapsulated in alginate supplemented with SPP1 with no observable 
morphological change). Morphometric evaluations (i.e., diameter and area) were 
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measured using the Bioquant Nova image analysis software (Bioquant, Nashville, TN) on 
surviving embryos from CONT embryos and those that underwent observable 
morphological changes within the encapsulated treatments. 
2.2.5.  Cellular Proliferation 
At the termination of the 96 h culture period, a subset of surviving embryos from 
each of the treatment groups (n = 3 per treatment) were snap frozen in liquid nitrogen to 
be used to assess cellular proliferation. Cellular proliferation was assessed by measuring 
the total DNA content from each embryo using the CyQUANT Cell Proliferation Assay 
Kit, according to manufacturer protocol (Molecular Probes, Inc., Eugene, OR).  An 
additional subset of surviving embryos from each condition (i.e., CONT, ALG-, ALG+, 
RGD+, n=2; RGD-, SPP1-, SPP1+, n=1) were used for confocal microscopy 
confirmation of proliferation. For that analysis embryos were fixed in 4% 
paraformaldehyde (EMSDiasum, Hatfield, PA) at 4°C overnight, then were stored in 
70% Ethanol in ddH2O. At the time of processing, embryos were rehydrated in 1X PBS 
and ddH2O.The embryos were then washed twice in a wash buffer (WB) consisting of 
0.05% Tween-20 (Thermo Fisher Scientific, Waltham, MA) in 1X PBS. The embryos 
were permeabilized in 0.1% Triton X-100 (Thermo Fisher Scientific) in 1X PBS for 30 
minutes at room temperature and were again washed twice in the aforementioned WB. A 
blocking solution consisting of 1% BSA (Sigma-Aldrich) in 1X PBS was applied to the 
embryos for 30 minutes at room temperature, and then the embryos were incubated in the 
primary antibody buffer consisting of 1% BSA, 0.01% Triton X-100, 0.01% Tween-20 
and the Ki67 polyclonal primary antibody (Life Technologies, Santa Cruz, CA) at a 
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1:250 dilution in 1X PBS for 2 hours at room temperature. After the primary antibody 
incubation, the embryos were washed 3 times in WB for 10 minutes. In order to 
incorporate the secondary antibody, the embryos were incubated in a solution containing 
1% BSA with 0.01% Tween-20 and AlexaFluor 488 goat anti-rabbit secondary antibody 
(Life Technologies) in 1X PBS at a 1:100 dilution for 2 hours at 37°C. After the 
secondary antibody incubation, a solution of DAPI at 1:2,000 and rhodamine-phalloidin 
(EMD Millipore, Billerica, MA) at 1:500 and 0.01% Tween-20 in 1X PBS was applied 
for 30 minutes. The embryos were finally washed with 1X PBS for 30 minutes, mounted 
individually on slides and imaged using an Olympus FV500 Inverted confocal 
microscope.  Images were used to qualitatively observe the extent of cellular proliferation 
to confirm the extent of cellular proliferation measured by the CyQUANT Cellular 
Proliferation Assay. 
2.2.6.  Transcript Expression Analysis 
At the termination of the 96-h culture period, an additional subset of surviving 
embryos from each of the treatment group (n = 3 per treatment group) were snap frozen 
in liquid nitrogen to be used to assess transcript expression levels. Whole-cell RNA 
(wcRNA) was extracted from individual embryos using the RNeasy Microkit (Qiagen, 
Valencia, CA) with on-column DNase-I treatment as described by the manufacturer. 
Quantification of the wcRNA was performed with RiboGreen as indicated by the 
manufacturer (Molecular Probes, Inc).  
Using porcine-specific primers previously validated to amplify mRNA specific 
for the long form variant of steroidogenic acute regulatory protein (STAR) [113], 
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aromatase (CYP19A1), interleukin-1β (IL1B) [72, 82], and glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH) [114], transcript expression levels were assessed using a two-
step, real-time quantitative PCR (qPCR) method with a Chromo4 real-time PCR 
detection system (Bio-Rad, Hercules, CA). Briefly, reverse transcription was performed 
with 1 ng of wcRNA from embryos in the corresponding treatment groups using the 
iScript cDNA Synthesis kit (Bio-Rad) according to the protocol of the manufacturer. 
Each qPCR was assayed in duplicate and consisted of 50 pg equivalents of cDNA, 0.25 
µM of the appropriate forward and reverse primers, and 12.5 µL of 1x iTaq SYBR Green 
Supermix with ROX (Bio-Rad) in a 25 µL reaction. All PCR conditions included 
denaturation (95°C for 2 min) followed by amplification (95°C for 15 sec, 60°C for 15 
sec and 70°C for 45 sec) for 40 cycles. Melt-curve analysis and gel electrophoresis were 
used to confirm amplification of a single product of the predicted size.  
Expression levels for each transcript were based on the threshold cycle (CT) 
values determined using the Opticon Monitor 3 software (Bio-Rad). For each transcript, 
one assay was performed containing equal representation of all embryo treatment groups. 
After converting the exponential CT to the linear CT using the formula 2-CT [115], the 
intraassay CV for each transcript was determined by averaging all samples from the 
assay. The intra- assay CVs for STAR was 14.4%; ; CYP19A1  was 14.8%; IL1B was 
16.8%; and GAPDH was 17.0%. Preliminary analysis of the relative expression level (2-
C
T) for GAPDH indicated constitutive expression between the treatments (data not 
shown); therefore, GAPDH was used as the reference control transcript. Calculation of 
the relative quantity (RQ) value was determined using the comparative CT method [115]. 
RQ values are expressed as arbitrary units.  
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2.2.7.  Estradiol-17β and Protein Assays 
Analyses of Estradiol-17β (E2) and protein content in the culture medium were 
performed in samples obtained after 96 h from basal media and cultures containing 
embryos represented in the cellular proliferation assays and qPCR analysis (i.e., CONT, n 
= 8; ALG+, n = 7; ALG-, n = 11; SPP1+, n = 9; SPP1-, n = 11; RGD+, n = 15; RDG-, n = 
7). Culture media were measured for E2 using a radioimmunoassay procedure described 
previously and validated in swine [82, 116]. Culture media were measured for E2 in 
duplicate in five assays with inter- and intra-assay CVs of 11.97% and 3.73%, 
respectively. In addition, culture media were measured for total protein content using a 
bicinchoninic acid protein assay (Pierce). The protein content in the culture media was 
measured in duplicate in five assays with inter- and intra-assay CVs of 16.9% and 7.24%, 
respectively 
2.2.8.  Statistical Analyses 
Proportional data for embryo survival and morphological changes following 
culture were analyzed using the Chi-square test and were reported as least-squares means 
± standard error of the mean (LSM ± SEM) after calculating with GLIMMIX model 
procedures [117, 118]. Morphometric analysis, cellular proliferation, transcript 
expression data, and culture media E2 and protein levels were analyzed using MIXED 
model procedures and results are reported as LSM ± SEM [117, 118]. When a significant 
F- statistic was generated, means were separated using Dunnett’s multiple comparison 
test [117, 118]. Means were considered statistically different at P ≤ 0.05 and tendencies 
between P = 0.051 and P = 0.10. Morphometric analysis, cellular proliferation, and 
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transcript expression data were categorized into treatment groups corresponding to 
CONT, ALG+, ALG-, RGD+, RGD-, SPP1+, and SPP1- embryos and the model 
included the fixed effects of treatment, the covariate of initial embryo size, and the 
random effect of gilt within treatment. Culture E2 and protein data were categorized into 
treatment groups (i.e., MEDIA, CONT, ALG+, ALG-, RGD+, RGD-, SPP1+, and SPP1-) 
and the model included the fixed effects of treatment, replicate, the covariate of initial 
embryo size, and the random effect of gilt within treatment by culture time interaction. 
To remove skewness and normally distribute the data, all transcript expression and E2 
Fig. 2-1. (1) After flushing from the uterus, embryos are placed in RPMI media. A single embryo is pipetted 
up and (2and 3) is pipetted into an alginate droplet. (4) The droplet is pipetted into calcium solution to 
crosslink. (5) The formed bead is washed twice in RPMI before (6) being placed into another droplet of 
alginate solution. (7) The droplet including the bead is pipetted up and into calcium solution for crosslinking. 
(8) The entire layered construct is washed in RPMI before (9) being placed into one of the four wells of the 
plate for culture. (Recreated from Sargus-Patino et al.) 
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data were log-transformed prior to statistical analysis and back- transformed to report 
observed means.  
2.3.  Results 
2.3.1.  Confirmation of RGD Modification 
To explore the effect of cell adhesion molecules and specifically the effect of integrin 
activation via RGD on elongation, embryos were encapsulated in either alginate (ALG), 
SPP1 supplemented alginate or RGD-conjugated double-layered beads and cultured in 
vitro over 96 hours (Fig. 2-2). To accomplish this project objective, the RGD peptide had 
to be covalently conjugated to the alginate molecule. To confirm the successful 
conjugation of the RGD peptide to alginate prior to use in encapsulation studies, 1H-
S D R G 
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Fig. 2-2. 1H-NMR spectra to confirm conjugation of RGD peptide to ALG molecule. ALG (top) and RGD 
(bottom) with peaks noted for possible corresponding amino acids: glycine (G), arginine (R), aspartic acid 
(D), serine (S), proline (P) and potential β–hydrogens (β). 
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NMR was utilized. Fig. 2-2 shows the 1H-NMR spectra of unmodified alginate (top 
spectrum) and GRGDSP-conjugated alginate (bottom spectrum).  New peaks between 
δ2.5 and δ3.5 were distinctly detected in the spectrum of RDG-alginate compared to 
unmodified alginate. Additional peaks were specifically detected in the RGD-conjugated 
alginate compared to the unmodified alginate between δ0.8 and δ1.2 and may be 
representative of β-hydrogens of the peptide. Based on previous 1H-NMR studies 
involving RGD peptide, these peaks have been labeled as the predicted amino acid (Fig. 
2-2) [119].  
2.3.2.  Evaluation of Embryo Viability, Morphology and Morphometry 
Fig. 2-3 shows representative phase images of embryos from all treatment groups at all 
time points as examples of images used to evaluate viability, assess morphological 
changes and perform morphometric analyses. Statistical analysis of the survivability and 
percent of embryos showing morphological changes at the termination of culture within 
all treatment groups is shown in Fig. 2-4 and further detailed in Table 2-1.  
After 96h of culture, the blastocysts were examined for degeneration and it was 
determined that while there was a tendency for differences in survivability between 
treatment groups (P= 0.0667), the addition of SPP1 to the hydrogel network prior to 
encapsulation yielded a tendency to increase survivability (37.43% ± 5.48%) when 
compared to CONT (23.2% ± 4.79%; P< 0.10). Furthermore, the presentation of RGD 
via the hydrogel scaffold also revealed a tendency to increase survivability (42.99% ± 
5.72%) when compared to the control (P< 0.10) (Fig. 2-4A and Table 2-1).  
Embryos were also classified for morphological changes, which are characterized as 
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when a spherical embryo changes into a more tubular shape followed by the elongation 
and flattening of this tube over time. All encapsulated treatment groups contained 
embryos that showed morphological changes in vitro (bottom 3 panels of Fig. 2-3), while 
none of the CONT embryos exhibited morphological changes (top panel of Fig. 2-3). 
Differences in the percentage of embryos showing morphological changes by 96h in 
culture are illustrated in Fig. 2-4B and C and more detailed data can be found in Table 
2-1. Significant differences in the percentage of embryos that showed morphological 
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Fig. 2-3. Representative images of embryo morphological changes in culture. Embryos were cultured without 
encapsulation (CONT) or within double-layered, 0.7% alginate hydrogels: unmodified alginate hydrogel 
(ALG), alginate with SPP1 (SPP1), or RGD-modified alginate (RGD). Images are taken of each embryo every 
24 hours for 96 hours. Scale bar is 1-mm in length. 
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changes by 96h were observed (P< 0.0001) when considering all embryos within the 
treatment groups (Fig. 2-4B). The percentage of embryos that underwent morphological 
changes was significantly higher when encapsulated in RGD (23.81% ± 4.65%) than in 
either ALG or SPP1 (10.71% ± 3.38% and 13.64% ± 3.66%, respectively; P< 0.05). 
Significant differences between treatment groups (P< 0.0005) were observed when only 
considering the percent of morphologically changing embryos out of those that survived. 
Of only the surviving embryos (Fig. 2-4C), RGD had the highest percentage of 
morphologically changing embryos at nearly 60% (55.56% ± 8.28%), which tended to be 
greater than ALG (31.03% ± 8.59%; P< 0.10).  
In order to explore differences in gene expression, proliferation, and E2 and protein 
production between embryos that survived and showed morphological changes and those 
that did not have morphological changes, each surviving embryo within encapsulated  
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Fig. 2-4. Survival rates and percent of embryos showing morphological changes in culture for all treatment 
groups.  A) Survival rates for all treatment groups. Encapsulation in RGD facilitates significantly higher 
survivability than non-encapsulation, as does encapsulation in SPP1. B) Percent of all embryos that 
underwent morphological changes. No CONT embryos showed morphological changes. Encapsulation in 
RGD demonstrated a significant increase in the percentage of embryos showing morphological changes over 
ALG while it only tended to be increased over SPP1. C) Percent of surviving embryos that underwent 
morphological changes. Encapsulation in RGD tended to lead to an increase in morphological changes over 
ALG. (*indicates a tendency with p< 0.10, ** indicates significance with p< 0.05) 
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Table 2-1. Survivability and morphological change data for all treatment types.  Values are reported as the 
least-squares mean ± SEM as determined using GLIMMIX analysis for the main effect of treatment. 
Significance for the effect of treatment was determined using Chi-squared analysis. († indicates the 
comparison between the described condition and CONT, ‡ indicates the comparison between the described 
condition and ALG and ✳  indicates the comparison between the described condition and SPP1). 
CONT ALG P-value SPP1 P-value RGD P-value
Number of 
Embryos 64 64 64 64
0.0495† 0.0088†
0.6819‡ 0.2643 ‡
0.4698 ✳
0.9728† 0.9716†
0.5597‡ 0.0288‡
0.0909✳
0.9728† 0.9716†
0.5597‡ 0.0288‡
0.0909✳
0.9657† 0.9638†
0.6593‡ 0.0533‡
0.1154✳
55.56 ± 8.28
Morphological 
change from all 
embryos (%)
0 10.71 ± 3.38 0.9733† 13.64 ± 3.66 23.81 ± 4.65
Morphological 
change from 
surviving 
embryos (%)
0 31.03 ± 8.59 0.9663† 36.36 ± 8.37
76.19 ± 4.65
Embryo Survival 
(%) 23.2 ± 4.79 34.35 ± 5.47 0.1202
† 37.43 ± 5.48 42.99 ± 5.72
No 
morphological 
Change from all 
embryos (%)
100 89.29 ± 3.38 0.9733† 86.36 ± 3.66
 
treatment groups was partitioned into those that had changes (+) and those that did not (-) 
and morphometric data were measured (Table 2-2) regarding initial and final diameters as 
well as initial and final areas of each surviving embryo. The diameter and the area of all 
embryos at 0h averaged to be 0.79 mm and 38 mm2 were not significantly different 
across the treatment groups or between embryos that showed morphological changes and 
those that did not by 96h. However, by the end of culture those embryos that had changes 
observed in both diameter and area (P< 0.0001) were statistically different across 
treatment groups. For example, the final average diameter of embryos cultured in ALG 
that showed morphological changes (ALG+) was 1.887 mm, and given that the average 
diameters of those embryos at 0h was 0.839 mm, this morphological change represents an 
increase in diameter of over 150% (155.66% ± 26.25%). Conversely, the final average  
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Table 2-2. Summary of morphometric analysis along with proliferation data of all embryo treatments divided 
into subsets of morphometrically changing embryos (+) and non-changing embryos (-). Values are reported as 
the least-squares mean ± SEM as determined using Mixed procedure analysis. 
CONT ALG+ ALG- SSP1+ SSP1- RGD+ RGD-
Number of 
Embryos 14 7 16 9 18 14 13
Initial Diameter 
(mm) 0.934 0.839 0.778 0.611 0.908 0.711 0.785
SEM (upper) 0.098 0.125 0.088 0.09 0.096 0.088 0.086
SEM (lower) 0.089 0.109 0.079 0.078 0.087 0.078 0.078
Final Diameter 
(mm) 0.957 1.887 0.891 1.234 0.922 1.64 0.929
SEM (upper) 0.113 0.32 0.113 0.206 0.111 0.228 0.116
SEM (lower) 0.101 0.274 0.1 0.176 0.099 0.2 0.103
Δ Diameter (mm) 0.039 1.449 0.11 0.737 0.008 1.154 0.127
SEM 0.151 0.227 0.161 0.214 0.16 0.172 0.166
Δ Diameter (%) 4.26 155.66 15.59 113.76 5.05 173.57 20.33
SEM 17.5 26.25 18.56 24.75 18.56 19.84 19.17
Initial Area 
(mm2) 48.417 39.939 31.55 24.417 52.979 29.704 38.539
SEM (upper) 12.508 14.939 8.824 9.071 13.779 8.945 10.416
SEM (lower) 9.94 10.872 6.895 6.614 10.935 6.841 8.2
Final Area (mm2) 47.764 104.208 40.43 75.84 48.495 78.415 43.351
SEM (upper) 12.077 38.386 11.046 27.602 12.402 23.585 11.527
SEM (lower) 9.604 8.052 8.676 20.237 9.876 18.131 9.106
Δ Area (mm2) 12.27 70.29 14.87 69.09 -88.45 57.15 12.47
SEM 11 15.61 11.76 15.26 11.26 12.78 11.65
Δ Area (%) 7.71 218.33 32.46 248.92 1.37 224.72 36.61
SEM 29.11 43.67 30.88 41.17 20.88 33.01 31.89
Proliferation (µg 
DNA) 0.454 0.331 0.137 0.51 0.653 0.979 0.413
SEM (upper) 0.646 0.351 0.145 0.54 0.929 1.037 0.437
SEM (lower) 0.267 0.17 0.07 0.262 0.384 0.503 0.212  
diameter of embryos cultured in ALG that did not show morphological changes (ALG-) 
was 0.891 mm, which compared to an initial average diameter of 0.778 mm, only 
represents an increase in diameter of about 15% (15.59% ± 18.56%). Thus, the change in 
diameter of ALG+ embryos was significantly different (P< 0.05) than the change in 
diameter observed in ALG-. Holding the same trend as change in diameter, the final 
average area of ALG+ embryos was 104.208 mm2, while this same population of 
embryos began the culture with an average area of 39.939 mm2, which is an increase in 
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area of almost 220% (218.33% ± 43.67%). Conversely, the final average area of embryos 
cultured in ALG that did not show morphological changes (ALG-) was 40.430 mm2 
while that same population began culturing with an average area of 31.550 mm2, which is 
an increase in area of only just over 30% (32.46% ± 30.88%). Therefore, the change in 
area of ALG+ embryos was significantly different (P< 0.05) than the change in diameter 
observed in ALG- embryos. The trend of drastic increases in the average diameters and 
areas for encapsulated embryos that showed morphological changes after 96h holds true 
across all treatment groups (Table 2-2): the diameter of SPP1+ embryos increased by 
113.76% ± 24.75% and the area increased 249.92% ± 41.17% during the culture period, 
and the diameter of RGD+ embryos increased 173.57% ± 19.84% while the area 
increased 224.72% ± 33.01% throughout the culture period. Conversely, the lack of 
appreciable change in average diameter or area in encapsulated embryos that did not 
show morphological changes by 96h is also observed across all treatment groups: the 
diameter of SPP1- embryos increased by only 5.05% ± 18.56%, while the area increased 
by only 1.37% ± 20.88% during the culture period, and the diameter of RGD- embryos 
increased by 20.33% ±19.17% while the area increased by 36.61% ± 31.89% throughout 
the culture. The average change in diameter and area was significantly different (P< 0.05) 
for morphologically changing groups (i.e., ALG+, SPP1+, RGD+) when compared to 
their non-changing counterparts (i.e., ALG-, SPP1-, RGD-) and when compared to 
CONT. However, there were no statistical differences observed between any of the 
treatment groups with morphologically changing embryos (i.e., ALG+, SPP1+, RGD+).  
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2.3.3.  Cellular Proliferation  
Cellular proliferation was first assessed by the total amount of DNA in each  
embryo at the end of culture. As shown in Fig. 2-5C and in Table 2-2, there were no 
significant differences (P= 0.655) in DNA content across treatment groups or between 
non-changing and morphologically changing embryos. The average DNA content per 
embryo in every treatment group remained low, or below 1 µg in total, with the lowest 
group, ALG-, having on average only 0.137 µg of DNA per embryo, while the group 
with the highest amount, RGD-, had 0.979 µg of DNA per embryo on average. CONT 
embryos averaged 0.454 µg of DNA each, which was close to the overall average of all 
treatments. These data suggest that any morphological change observed in embryos was 
not due to an increase in proliferation. To qualitatively examine the distribution of 
proliferation within embryos cultured in vitro, confocal microscopy probing for the 
nuclear proliferation marker Ki-67 was performed (Fig. 2-5A and B). A low abundance 
of nuclei (estimated to be 5% for all treatment groups) were positive for Ki-67, 
supporting the quantitative proliferation results (Fig. 2-5C). Representative confocal 
images taken at 60X magnification of embryos stained to visualize total nuclei (blue), 
proliferating cells (green), and cytoskeletal structure (red) are shown in Fig. 2-5A. Blue 
arrows point to nuclei of cells that are not proliferating, while green arrows indicated 
proliferating cells. Interestingly, in all of the treatment groups besides CONT, the 
resemblance of an intact embryonic disc can be observed at a lower magnification. A 
representative image of an embryo at 10X magnification is shown in Fig. 2-5B, with a 
green arrow pointing to a small portion of the embryo with cells abundantly proliferating, 
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Fig. 2-5. Representative images and quantitative data for proliferation. A) Representative images of embryos 
at 60x magnification stained for DAPI to visualize nuclei, rhodamine-phalloidin to visualize F-actin and Ki-67 
to visualize proliferating cells. Images are shown for embryos that underwent morphological changes (+) an 
those that did not (-) for all treatment groups. Blue arrows point to examples of Ki-67 negative nuclei while 
green arrows point to examples of Ki-67 positive nuclei. Scale bar is 20 µm. B) Representative image at 10x 
magnification of potential embryonic disc on an embryo encapsulated in ALG that underwent morphological 
changes by 96h. Scale bar is 100 µm. C) Quantitative cellular proliferation data indicating total µg of DNA 
per embryo in each treatment group. 
 
  
as would be observed in an embryonic disc.  
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2.3.4.  Transcript Expression Analysis 
To explore the gene expression profile of embryos encapsulated in ALG, SPP1, 
RGD or non-encapsulated CONT, qPCR was used. The relative level of expression of 
transcripts of STAR, CYP19 and ILB were quantified. The expression of STAR mRNA 
shown in Fig. 2-6A and described further in Table 2-3 revealed a tendency in differences 
between treatment groups (P= 0.0875). The highest expression of STAR was observed in 
ALG+ embryos with an RQ of 17.50 and only tended to be different (P< 0.10) than the 
lowest expression seen in SPP1- embryos, with an RQ of 1.52. The expression of CYP19 
mRNA as shown in Fig. 2-6B and Table 2-3 revealed significant differences between 
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Fig. 2-6. Transcript expression of A) STAR, B) CYP19 and C) IL1B determined by qPCR from in vitro 
produced embryos encapsulated in modified or unmodified ALG hydrogels. (n=3) 
  
 
 49 
treatment groups (P< 0.01). More specifically, the expression of CYP19 was significantly 
increased in ALG+ and RGD+ embryos over both of their respective (-) counterparts and 
over CONT (P< 0.05), while the CYP19 expression level in SPP1+ embryos only tended 
to be higher (P< 0.10) than SPP1-, but was not significant when compared to CONT. The 
highest RQ for CYP19 expression was seen in ALG+ embryos at 11.05, and then RGD+ 
with 10.86 and the lowest level of expression was SPP1- with an RQ of 0.24. 
Additionally, IL1B mRNA expression levels shown in Fig. 2-6C and Table 2-3 revealed 
significant differences (P< 0.001) between treatment groups. While the expression only 
tended to be higher (P< 0.10) in RGD+ embryos than in RGD-, with the highest RQ 
value of 215.38, the expression of IL1B in RGD+ embryos was significantly higher (P< 
0.05) than SPP1+, ALG+, and CONT embryos. There were no statistical differences 
between either SPP1+ or ALG+ and CONT. 
 
Table 2-3. Detailed gene expression data with RQ and upper and lower SEM given for all treatment groups.  
Pr> F CONT ALG+ ALG- SPP1+ SPP1- RGD+ RGD-
STAR 
RQ 13.646 17.498 6.59 4.898 1.524 10.94 4.325
SEM (upper) 10.013 11.143 5.438 3.792 1.192 8.027 3.226
SEM (lower) 5.775 6.808 3.051 2.137 0.8669 4.63 1.848
CYP19 
RQ 0.952 11.054 0.262 2.82 0.244 10.864 0.406
SEM (upper) 0.968 11.504 0.279 3.898 0.259 11.064 0.561
SEM (lower) 0.48 5.637 0.135 1.636 0.125 5.482 0.235
IL1β 
RQ 0.093 0.082 0.099 0.198 19.143 215.278 11.376
SEM (upper) 0.173 0.127 0.275 0.391 38.667 401.317 21.509
SEM (lower) 0.06 0.05 0.073 0.131 12.804 140.116 7.441
0.0875
0.0111
0.0004
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2.3.5.  Analysis of E2 and Protein Content 
Media was collected every 24h of culture and was analyzed for E2 production of 
the embryos as well as the total protein production. Samples from 0h-72h were not 
analyzed in this study. For samples taken at the termination of culture, significant 
differences (P< 0.05) were observed in the level of E2 in the culture media between 
treatment groups (Fig. 2-7A). The amount of E2 produced was significantly higher (P< 
0.05) in the subsets of treatment groups of embryos that exhibited morphological changes 
(i.e., ALG+, SPP1+, RGD+) than media gathered from wells containing CONT. RGD+ 
embryos produced the most E2 in culture, and this level of secretion only tended (P< 
0.10) to be higher than that of RGD- embryos. No significance was found between either 
ALG+ or SPP1+ and their (-) counterparts, although the mean values of E2 were higher 
for morphologically changing embryos. Conversely, the total protein content (Fig. 2-7B) 
in the media gathered from culturing embryos was not statistically different (P= 0.7555) 
between any treatment groups nor between control media, suggesting an increase in the 
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Fig. 2-7. A) Estradiol secretion by 96h in all treatment groups as determined by RIA assay. B) Total protein 
production by 96h in all treatment groups, as well as an additional culture media control. 
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secretion of E2 by morphologically changing embryos is not due to an overall increase in 
protein secretion. 
Table 2-4. Estrogen and total protein concentration in the media of embryos cultured for all treatment groups 
reported with means and SEM. 
Media CONT ALG+ ALG - SPP1+ SPP1- RGD+ RGD-
E2 
Concentration 
(pg/mL)
0 12.12 82.89 32.33 81.621 28.366 118.413 30.74
SEM (upper) 0 9.428 67.183 21.771 56.291 17.185 63.138 24.57
SEM (lower) 0 5.303 37.107 33.315 10.702 41.655 41.181 13.655
Total Protein 
(mg) 14.719 15.692 15 16.238 12.716 15.732 14.78 14.843
SEM 1.113 1.569 1.372 1.326 1.681 1.247 1.482 0.297  
2.4.  Discussion 
  In this study, alginate hydrogels were used both to present factors known to play 
a role in embryo elongation, and as a 3-D scaffold to support the culture of and observe 
the successful initiation of elongation of pre-implantation porcine embryos. Alginate 
hydrogels have been used in the development of in vitro culture systems for reproduction 
studies in multiple species. For example, alginate has been developed for use as a 3-D 
scaffold to support ovarian follicle culture, both from mice and non-human primates [29, 
120-124], to promote development of the zona pellucida in mouse morulae [125] and to 
aid in development of early bovine blastocysts [126, 127]. Recently our lab has used 
alginate to encapsulate porcine embryos in order to facilitate and study the natural 
progression of development (i.e. elongation) in vitro. The double encapsulation method 
was developed in our lab and utilizes a 3-D alginate scaffold to fully encapsulate the 
developing blastocyst, showing elongation of the porcine embryo for the first time in 
vitro [9]. With this tool, researchers are able to move past the once unsurpassable barrier 
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of in vitro development onto further investigations into the mechanisms behind the 
initiation of elongation. In this present study, we aimed to utilize and build upon this base 
scaffold system to ask what role preimplantation embryonic and uterine specific factors 
like SPP1 and the integrin binding initiated by the RGD sequence in SPP1 play in 
elongation.  
SPP1 is a glycoprotein secreted by the endothelial cells of the uterus, and its 
secretion is signaled by the E2 production from the embryo during elongation [109]. 
SPP1 is reported to stimulate cell-cell adhesion, increase ECM interactions and promote 
cell migration, which are all important to the successful initiation of elongation [78, 108, 
109]. Evidence also suggests that the activation of integrins on the embryonic 
trophectoderm by the specific integrin binding sequence in SPP1, RGD, induces 
cytoplasmic reorganization during embryo development and elongation by stimulating 
cell-cell adhesion and promoting cell migration [77-79]. Additionally, it was 
demonstrated that both SPP1 and RGD stimulated migration of porcine trophectoderm 
cells specifically via haptotaxis, further supporting the idea that SPP1 mediates cell 
migration during elongation [77, 78].  
Given the evidence of the involvement of SPP1 and particularly the RGD 
sequence in embryo development, the whole protein as well as the peptide sequence was 
integrated into an alginate scaffold system to encapsulate embryos, and the effect of the 
presentation of these factors on survival, morphological changes, cellular proliferation, 
gene expression, and E2 and protein production was explored. When encapsulating 
embryos in ALG, RGD and alginate mixed with whole molecule SPP1, a tendency of 
increased survivability emerged between embryos cultured in RGD over those cultured in 
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2-D (CONT). The survivability of embryos encapsulated in RGD is significantly greater 
than the CONT group, while those embryos in ALG or SPP1 were not significant over 
CONT, suggesting that the presumably higher density presentation of the RGD peptide 
(compared to SPP1) to the culturing embryos may provide the embryos with the 
necessary physical and biological stimuli for survival [42]. However, given that 
survivability in RGD was nearly 43%, which is much lower than the survival rate of 
embryos in vivo in the preimplantation period of pregnancy (up to 80%), integrin binding 
and cell adhesion cannot be the only mechanism that is involved in survival [66].  
While incorporation of RGD into the alginate hydrogel showed some 
improvements in embryo survivability, its effect on embryonic morphological changes 
was also greater. In this study, we observed a significant increase in the percentage of 
embryos undergoing morphological changes if they were encapsulated within RGD 
modified alginate scaffolds when compared to embryos encapsulated in either ALG or 
ALG supplemented with SPP1. The increase in morphologically changing embryos 
supports previous evidence that suggest SPP1, or more likely the RGD sequence in SPP1, 
interacts with receptors (i.e. integrins) on the conceptus to promote embryonic 
development, as well as migration and signaling within the uterus, supporting the 
initiation of elongation [79, 109]. We demonstrated that 23% of embryos in RGD-
modified ALG hydrogels elongated, but when only considering the percentage of those 
that elongated in RGD as a percentage of only those embryos that survived, 55% of 
embryos showed morphological changes. The elongation rate of embryos in ALG in our 
previous study out of those that survived was only 38%, indicating the addition of RGD 
to the scaffold improves upon the previous studies. To compare to other studies, it has 
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been shown that bovine embryos cultured in vitro have shown the initiation of elongation 
of anywhere between 50-88% of cultured embryos [84]. However, in that study, a 
cylinder hydrogel was used, which could force directional growth of the embryos, and no 
other endpoints demonstrated signs of elongation by the same mechanisms seen in vivo 
[84]. In our current study, success in elongation was observed in spherical hydrogels with 
no particular directional mechanical influence, indicating the initiation and continuation 
of elongation within this system are truly driven by the embryo’s ability to elongate.  
Each treatment group (i.e. ALG, SPP1 and RGD) was further divided by whether 
the embryo within that group did or did not show morphological changes by 96h and was 
denoted by (+) or (-), respectively. To better quantify morphological changes, 
morphometric data such as initial and final diameter and area of all surviving embryos 
were measured. As expected, by the end of the culture period, the difference in 
morphological changes (both diameter and area measurements) was significantly greater 
in the (+) treatment groups (i.e. ALG+, SPP1+, and RGD+) than the (-) subsets of 
individual treatment groups (i.e. ALG-, SPP1-, and RGD-). We used this partitioning 
method to observe the differences in gene expression, proliferation and E2 and protein 
production between (+) and (-) subgroups moving forward. 
In the pig, the elongation process is known to be characterized by rapid cellular 
remodeling and differentiation in contrast to hyperplasia, that is, the trophoblast does not 
undergo proliferation while the embryonic disc is still undergoing development, but 
rather cells of the trophoblast remodel and migrate in a way that leads to morphological 
changes. [128]. The synthesis of DNA is highly regulated within the cells of the embryo 
and an increase in total DNA within the embryo is indicative of an increase in cell 
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number, or proliferation. When examining the total DNA content of individual embryos, 
no statistical differences were observed between any of the treatments or any of the 
subgroups, indicating that although the morphologically changing subgroups showed 
increased diameters and areas (i.e. RGD+, SPP1+, ALG+), there was no increase in total 
DNA as compared to non-changing subgroups, meaning the morphological changes were 
not due to proliferation, confirming previous findings [66, 128]. Another utilized method 
of assessing the proliferation status of the embryos involves the use of confocal 
microscopy and a Ki-67 antibody[128]. The expression of Ki-67, a protein ubiquitously 
expressed during the G1, S and G2 phases of the cell cycle, but not during the G0 phase, 
would indicate an increase in proliferation, and the presence of Ki-67 within the embryo 
was compared to the total number of nuclei via DAPI staining [87]. Qualitative 
assessment of proliferation via Ki-67 staining [129] confirmed that there were no notable 
increases in proliferation across treatments. Additionally, only about 5% of the total 
nuclei were also positive for Ki-67, which further supports studies that show that low 
levels of proliferation are observed in elongating embryos [128]. Interestingly, evidence 
of a potential embryonic disc was observed in embryos of all treatments and subgroups 
except for CONT, and the maintenance of this cluster of proliferating cells suggests that 
the potential to become a viable organism is maintained in encapsulated embryos [87].  
Along with morphological changes, pig embryo elongation is characterized by 
changes in transcriptional markers such as steroidogenic transcripts (STAR, CYP19) and 
immune response related transcripts (IL1B) [72-74]. It has been previously reported that 
transcription levels of STAR, a major initiator of steriodogenesis [130] are increased in 
tubular embryos when compared to levels in spherical and ovoid embryos [72, 73]. In this 
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study, the expression of STAR tended to be higher in ALG+ embryos than in the SPP1- 
embryos, which were encapsulated embryos with the poorest elongation outcomes, 
suggesting the increase in STAR mRNA expression in ALG+ embryos are more similar to 
in vivo produced ovoid embryos than SPP1- are [9]. However, unlike the results shown in 
our previous study [9], there were no statistical differences between any of the treatment 
groups in the expression of STAR, which could indicate the embryos in our system 
showed gene expression levels that are more similar to ovoid embryos [72, 73]. CYP19 is 
a gene that encodes for the enzyme aromatase cytochrome P450, which catalyzes 
estrogen synthesis [131] and a significant increase in the expression of CYP19 was 
observed in morphologically changing subgroups (i.e. ALG+, SPP1+, RGD+) when 
compared to their corresponding, non-changing counterparts (i.e. ALG-, SPP1-, RGD-). 
It has also been shown that an upregulation of this gene is seen in tubular conceptuses 
compared to spherical and ovoid conceptuses, suggesting that the expression of CYP19 in 
the in vitro produced morphologically changing embryos is similar to that of in vivo 
elongating embryos, and aligns with the slight increase in CYP19 expression in 
morphologically changing embryos that was shown in our previous study [9, 72, 132]. 
IL1B a gene that is also related to maternal-conceptus communication and it is 
hypothesized that an upregulation of IL1B contributes to rapid trophoblast elongation and 
pregnancy establishment in pigs [70]. The production of this inflammatory mediator by 
the conceptus is hypothesized to activate inflammatory pathways in the uterine 
endometrium, allowing the uterine endometrium to become further receptive to 
implantation by mediating the maternal immune response [133]. The increase in mRNA 
expression for IL1B was only observed to be upregulated in embryos from the RGD+ 
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group. The significant increase in the expression of IL1B in embryos encapsulated within 
RGD-alginate further supports the idea that those embryos that are elongating within 
RGD-alginate are developing similar to later stage in vivo produced embryos (i.e., 
tubular) [9]. Additionally the RGD+ embryos are generating the appropriate signaling 
cascade, thereby allowing for proper communication with the uterus, which is essential 
for survival and progression through the elongation process [128]. The upregulation in 
the IL1B mRNA expression was not observed in any other treatment group or subgroup, 
which may suggest that the presumably high concentration of RGD peptide presented to 
the embryos is capable of activating the signal cascade involved in IL1B transcript 
production.  
Not only is the preimplantation elongation process characterized by notable 
changes in transcript expression and dramatic morphological changes, but also it is also 
associated with increased E2 synthesis [69, 134]. During this period of gestation, the 
conceptus secrets E2, which is responsible for maternal recognition, the establishment of 
pregnancy and for the preparation of the uterine lining for superficial implantation by the 
stimulating the production and secretion of many endometrial secretory proteins [10, 128, 
135]. The significant increase in the secretion of E2 from embryos showing 
morphological changes (i.e. ALG+, SPP1+, RGD+) over CONT embryos demonstrates 
the similarities between those embryos and in vivo elongating embryos. In addition, this 
upregulation of E2 in the in vitro culture media of ALG+, SPP1+, and RGD+ over the 
CONT embryos was independent of production of total protein within the culture 
medium. Sargus-Patino et al demonstrated that increases in total protein were observed in 
uterine flushings but were not observed in culture media, suggesting an upregulation of 
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steroidogenesis and estrogen production may be independent of maternal-embryo cross-
talk [9]. Similarly, the independence of E2 production and changes in protein production 
(or lack thereof) support the hypothesis that E2 is produced by elongating embryos 
regardless of total uterine protein secretion [9]. Additionally, these results correspond 
with the increased expression of the steroidogenic transcript CYP19 in the ALG+, SPP1+, 
and RGD+ embryos, which supports previous findings of a direct relationship between 
that transcript and E2 synthesis in the embryo [72, 131].  
 In conclusion, this study demonstrated that a encapsulation within a supportive 
alginate matrix modified with the integrin binding sequence RGD found in adhesion 
molecules like SPP1 leads to changes in survivability, morphology, gene expression, and 
protein secretion within encapsulated embryos that emulates those changes observed in in 
vivo elongating embryos. Our study validated the use of alginate hydrogels for the in 
vitro culture of porcine embryos, as well as demonstrated that this culture system can be 
used to probe mechanisms behind elongation by systematically presenting factors known 
to play a role in elongation. Greater understanding of what is necessary for the success of 
elongation could lead to strategies to reduce embryonic loss due to disruptions in the 
initiation and maintenance of elongation. An improvement in survival of preimplantation 
embryos will lead to overall increases in litter size, significantly impacting the 
profitability of swine production. Furthermore, this culture system could even be utilized 
in other time points of gestation or in other species to elucidate the mechanisms behind 
the intricacies of animal gestation.
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 3-D In Vitro Culture Model of Growth Plate Cartilage using Alginate CHAPTER 3-
Hydrogel Scaffolds  
3.1.  Introduction 
During embryonic and adult skeletal development, the shape and length of bones 
is determined by the activities of the growth plate cartilage, a spongy tissue capping the 
ends of every long bone [136]. The growth plate controls elongation of long bones 
through endochondral ossification, a maturation process that results in chondrocytes 
being partitioned into functionally and morphologically distinct zones (Fig. 3-1) [137]. 
The most immature resting zone is a reservoir of quiescent progenitor cells that are 
collectively responsible for the proliferative potential (and thereby total growth potential) 
of cartilage by restraining terminal differentiation and maintaining the cell cycle of 
chondrocytes residing in neighboring zones [89]. Resting zone chondrocytes eventually 
mature into a zone of high proliferation, where cell shape changes and acquisition of 
planar cell polarity results in the formation of a unique cytoarchitecture, where discoid 
cells become arranged into columns that resemble stacks of pennies [15]. The extent of 
column formation in the proliferative zone specifically potentiates the ability of cartilage 
to elongate as compared to thickening oppositional growth, promoting the long and 
slender morphology of the endochondral bones with high length/width ratios. Once 
columnar architecture is established and as the lengthening of the proliferative zone 
pushes chondrocytes further from the resting zone, cells begin to become less 
proliferative and start to swell, making up the small pre-hypertrophic zone [138] Finally, 
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chondrocytes undergo terminal differentiation into a hypertrophic zone featuring 
complete cell cycle withdrawal, massive cell swelling, and the construction of a 
specialized extracellular matrix that serves as a template to be remodeled into bone [12]. 
The hypertrophic zone is the effector of bone elongation, as the rate of hypertrophy is 
directly related to the extent of bone growth [16].  
One of the major responsibilities of these growth plate chondrocytes is to produce 
an extracellular matrix (ECM) of defined shape and size that is characteristic of each 
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Fig. 3-1. Schematic of zonal architecture during growth plate development. The name of the 
zone is to the left of the schematic and major markers of each zone are shown to the right, with 
a depiction of the PTHrP/IHH feedback loop overlaid on the proliferative zone. 
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particular zone of the growth plate [139]. The ECM of the growth plate is made up of 
several cell matrix proteins that promote cell adhesion [139, 140]. It is known that cell 
shape, proliferation, and differentiation are all affected by cell adhesion, and 
chondrocytes in different zones of the growth plate secrete different amounts and types of 
adhesion proteins, leading to the hypothesis that the type of ECM surrounding 
chondrocytes in the growth plate affects chondrocyte behavior [48, 141]. For example, 
collagen type II (Col2) is expressed everywhere in the growth plate as the most abundant 
protein in the cartilage, while collagen type X (ColX) is only expressed in the early 
hypertrophic and hypertrophic zones [89]. Interestingly, there are many other proteins 
within the growth plate, including fibronectin (FN) and laminin (LN), which activate 
integrin binding via their arginine-glycine-aspartic acid (RGD) peptide sequence. It has 
been previously shown that cell adhesion and integrin binding are essential not only to 
survival and morphology, but also to the function of chondrocytes specifically within the 
resting and proliferative zones of the growth plate [142, 143].  
Along with the aforementioned cell-matrix interactions, paracrine interactions 
between chondrocytes within the growth plate help to determine chondrocyte behavior. 
While it is known that many vectors are involved in growth plate development and 
maturation, a complex paracrine signaling network seems to be fundamentally rooted in 
reciprocal interactions between two major pathways, Indian hedgehog (IHH) and 
Parathyroid-related protein (PTHrP) [89, 92, 136]. Periarticular resting zone cells secrete 
PTHrP, which diffuses through the growth plate to produce a gradient of signaling 
activity, which is crucial to maintain the proliferative potential and columnar organization 
of the proliferative zone, as demonstrated by severe growth defects and aberrant tissue 
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architecture phenotypes exhibited by PTHrP null cartilage in mouse [144]. Additionally, 
PTHrP signaling suppresses the rate of cartilage hypertrophy by promoting the 
phosphorylation of Sox9 to restrain maturation of proliferative zone cells, and is thought 
to be the major signaling effector of resting zone chondrocytes [145]. The crosstalk 
between PTHrP and IHH signaling is important for the establishment and maintenance of 
zonal arrangement of chondrocytes in cartilage, and remains to be fully elucidated. IHH 
is secreted by prehypertrophic chondrocytes between proliferative and hypertrophic 
zones and is thought to promote PTHrP expression, although IHH has never been directly 
observed to diffuse into the zone of maximal PTHrP expression [144]. Nevertheless, loss 
of IHH signaling results in a loss of PTHrP expression and premature hypertrophy, 
associated with a complete loss of the proliferative zone and related column formation as 
shown by the chondrodysplasia-like phenotype of IHH knockout mutant mice and 
cyclopamine inhibitor treatment in organotypic culture of growth plate explants [146, 
147].  
While in vivo knockout models have elucidated many factors that are involved in 
the development of functional growth plate cartilage, there are questions to be answered 
that cannot rely on such studies, and in vitro culture studies have been attempted. It has 
been well established that two-dimensional (2-D) culture of chondrocytes leads to a loss 
of chondrocytic phenotype and dedifferentiation over time [148, 149]. More recently, 
attempts have been made to avoid the characteristic 2-D dedifferentiation by culturing 
growth plate chondrocytes in 3-D in vitro by using suspension cultures, pellet cultures or 
biomaterial scaffolds [103, 150, 151]. Perhaps most significant of in vitro growth plate 
chondrocyte culture to-date, Randall et al. demonstrated the use of a pellet culture 
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technique to induce what resembled columnar alignment (mimicking the proliferative 
zone) in vitro by transiently transfecting chondrocytes to upregulate or down regulate the 
response to factors within the growth plate prior to pelleting and culturing cells with or 
without that specific factor treatment [103]. While the daughter cells could be traced from 
the origin in semi columnar formations, downfalls still exist in this model. Most notable, 
the ability to modulate growth, and more specifically zonal arrangement, in pellet and 
suspension cultures is limited as a result of difficulties in inducing bioactive gradients 
that can promote cell polarity and/or regions of localized signal transduction, and so it 
follows that advancing in vitro culture models of coordinated tissue growth using tissue 
engineering principles is critical to further growth plate cartilage research [152].  
Tissue engineering involves the use of tissues or cells, scaffold materials and 
bioactive signals to develop functional organ tissues in vitro and has become a tool for 
engineers and developmental biologists to develop and model tissue development [1, 56]. 
Tissue engineering has been employed to extensively study and regenerate articular 
cartilage, and groups have attempted to culture articular chondrocytes in protein-, 
polysaccharide-, and synthetic-based biomaterials in vitro and most relevant to this thesis, 
alginate has been extensively studied for this use [153]. Alginate is a linear 
polysaccharide that forms hydrogels when crosslinked in the presence of divalent cations. 
It is widely used in tissue engineering applications because of its inherent non-fouling 
nature and ease of functionalization of the alginate molecule, and because the pore size of 
alginate hydrogels allows for the diffusion of waste out and nutrients and growth factors 
into the tissue engineered construct [7, 47, 154]. Tissue engineers have also utilized 
alginate when encapsulating growth plate chondrocytes. For example, growth plate 
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chondrocytes have been encapsulated in “semi-solid” alginate beads and when cultured in 
vitro it was found that the cells maintained their rounded phenotype, indicating that the 
chondrocytes were not entering into the proliferative zone nor entering hypertrophy, 
showing a maintenance of phenotype over time [155]. More recently, groups have 
utilized alginate to inject growth plate chondrocytes into mice for long-term culture, and 
have even observed zonal arrangement and column formation [28]. However, no specific 
questions concerning the effects of any particular growth factor within the system were 
able to be identified, as the induction of zonal arrangement was most likely caused by 
factors present in vivo. Therefore, a method to culture growth plate chondrocytes that 
allows for the presentation of specific factors in a controllable manner to investigate the 
necessary factors to induce zonal arrangement of chondrocytes in vitro is still needed. 
In the present study alginate hydrogels were used to develop a 3-D in vitro culture 
system to study the development and zonal arrangement of growth plate cartilage. The 
objectives were two-fold: 1) To explore the effect of culturing growth plate chondrocytes 
in alginate hydrogels (ALG) and RGD-modified ALG scaffolds (RGD) on viability, 
matrix formation (Col4, Col6 and F-actin), cell cycle distribution, differentiation status 
(Col2/Col1 ratio), changes in ColX, PTHrP, PTH1r and IHH transcript expression, as 
well as the Col2/ColX ratio via fluorescent in situ hybridization (FISH); and 2) To better 
understand the role of the PTHrP/IHH feedback loop in zonal arrangement by introducing 
soluble factors such as PTH or IHH to the culture media and  studying changes in cell 
cycle distribution, differentiation status (Col2/Col1 ratio), changes in ColX, PTHrP, 
PTH1r and IHH transcript expression, as well as the distribution of the expression of 
Col2 and ColX via FISH.  
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3.2.  Materials and Methods 
3.2.1.  Alginate Formulation 
Alginate solutions were prepared by dissolving sodium alginate power (Pronova 
UP MVG, >60% guluronic acid, 200,000 – 300,000 g/mol; NovaMatrix, Sandvika, 
Norway) or RGD-modified alginate (see below) in sterile 1X phosphate buffered saline 
(PBS; Thermo Fisher, Waltham, MS) to a concentration of 1.5% (w/v). After alginate 
was allowed to dissolve for up to 8 hours, the solution was filtered using disposable 
Rapid-Flow PES filters with a pore size of 0.20-µm (Thermo Fisher) to ensure sterility. 
To conjugate RGD to the alginate molecule, previously described carbodiimide 
chemistry was utilized [42]. Briefly, 2 grams of sodium alginate were added to 200-mL 
of MES buffer (0.1M MES, 0.3M NaCl, pH 6.5) and the alginate was allowed to dissolve 
for up to 8 hours on a stir plate. 1-ethyl-(dimethylaminopropyl) carbodiimide (EDC; 
Sigma Aldrich, St. Louis, MO) was added to activate an estimated 5% of the uronic acids 
of the alginate polymer backbone in order to form amide linkages with the peptide. To 
stabilize the reactive EDC intermediate against a competing hydrolysis reaction, N-
hydroxy-sulfosuccinimide (sulfo-NHS; Pierce, Rockford, IL) was also added to the 
solution at a 2:1 EDC to sulfo-NHS ratio. Finally, the glycine-arginine-glycine-aspartic 
acid-serine-proline (GRGDSP) peptide (Anaspec, Fremont, CA) was added to the 
solution at a concentration of 4-µmol/g alginate, conjugating the peptide to the alginate 
backbone via the terminal amine of the peptide. After 20 hours of reacting, the 
conjugation reaction was quenched via the addition of hydroxylamine hydrochloride 
(Sigma Aldrich). The alginate solution was then dialyzed (3.5 kD MWCO, 45 mm flat-
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width dialysis tubing; Spectrum Laboratories, Rancho Dominguez, CA) in a salt solution 
(NaCl in ddH2O) with stirring over the course of 3 days. The salt solution was replaced 
with decreasing salt solutions with a starting concentration of 6.75-g/L followed by 5.25-, 
3.75-, 2.25-, 0.75-, and four washes of 0-g/L NaCl in ddH2O every 8 hours. The resulting 
alginate solution was frozen to -80°C, lyophilized to dryness and was dissolved in PBS as 
described above. To verify successful conjugation of the GRGDSP peptide to the alginate 
polymer backbone, 1H-NMR spectroscopy was used to characterize the samples. 
Unmodified alginate and GRGDSP-alginate were dissolved in deuterium oxide (D2O; 
Sigma Aldrich) and placed in separate NMR tubes. The 1H-NMR spectra of the samples 
were recorded on a Bruker Avance III-HD 700 MHz NMR spectrometer. 
3.2.2.  Chondrocyte Isolation  
Neonatal Swiss Webster mice (Jackson Laboratories, Sacramento, CA) at 
postnatal day (P) 4, (P0 being the day of birth), were used for the collection of growth 
plate chondrocytes. All procedures performed on animals were consistent with regulatory 
agency policies and were approved by the Institutional Care and Use Committee at the 
University of Nebraska Medical Center (UNMC). Pups were euthanized and the growth 
plate cartilage from the two hind limbs was rapidly harvested into 1X Hank’s Balanced 
Salt Solution (HBSS; Thermo Fisher), and then transferred into Dulbecco’s Modified 
Eagle Medium (DMEM, Invitrogen, Carlsbad, CA) with 10% fetal bovine serum (FBS; 
Atlanta Biologicals, Flowery Branch, GA) and 1% glutamine/penicillin/streptomycin 
(GPS; Invitrogen); collagenase (Sigma Aldrich) was added to the media at a 
concentration of 0.25%. The growth plates in the collagenase solution were maintained in 
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a passively humidified incubator at 37°C and 8% CO2 for 4 hours to dissolve the existing 
extracellular matrix (ECM). After incubation the solution containing the growth plates 
was pipetted against a petri dish to further break up the tissue, releasing the chondrocytes. 
The chondrocytes were pelleted by centrifugation at 125 x g using a Sorvall Legend RT 
centrifuge (Kendro Laboratories, Newtown CT) for 5 minutes and resuspended in 
DMEM with FBS and GPS to relieve the cells of collagenase. The extracellular debris 
was allowed to settle by gravity for one minute and the remaining cells in the supernatant 
were moved to another tube and were counted using a hemacytometer prior to moving on 
to encapsulation. The isolated primary chondrocytes were centrifuged at 125 x g for 5 
minutes, counted using a hemacytometer, and divided into aliquots depending on the 
number of different scaffold types used (described further below). All cells were 
maintained in the incubator until time for alginate encapsulation.  
3.2.3.  Alginate Encapsulation  
Chondrocytes were encapsulated in alginate (ALG) or RGD modified alginate 
(RGD) beads prior to culturing. Homogenous alginate beads were formed using the basic 
“drop” method previously described by other investigators [9, 120]. The concentration of 
chondrocytes in alginate solution was 8,000,000-cells/mL of alginate. Therefore, each 10-
µL bead was made to contain 80,000 primary growth plate chondrocytes. Collected 
growth plate chondrocytes were counted, the appropriate amount of cells was pelleted by 
centrifugation at 125 x g for 5 minutes, and the remaining media was aspirated. The 
calculated amount of either ALG or RGD was mechanically mixed into the cell pellet, 
 68 
pipetting up and down only once. The entire solution was gently vortexed to ensure 
complete mixing.  
Prior to chondrocyte-alginate hydrogel formation, a crosslinking solution was 
prepared with ddH2O, calcium chloride, and sodium chloride (50-mM CaCl2/140-mM 
NaCl; Sigma Aldrich) and was used to gel the cell-alginate mixture. In a 24-well plate, 2-
mL of crosslinking solution was pipetted into each well, and the entire plate was placed 
into the incubator to warm before being used for bead fabrication. To create the alginate 
beads, 10-µL of alginate-cell solution was drawn up into a pipette tip. The tip was wiped 
with a Kimwipe to ensure the alginate could drop freely from the tip. Hovering 2-3 inches 
over one well containing crosslinking solution, the plunger was rapidly depressed, 
allowing the alginate to fall from the tip and into the solution. If the alginate bead did not 
break the surface of the crosslinking solution, the crosslinking solution was pipetted 
gently on top of the bead until it became submerged, and the alginate-cell solution was 
allowed to crosslink forming a hydrogel bead. While each bead was crosslinking, the 
procedure was repeated, dropping alginate-cell solution into individual wells. After 2 
minutes, the remaining crosslinking solution was removed from the well and the resulting 
bead was moved to a different well plate containing wells with 2-mL of DMEM with 
FBS and GPS for up to 10 minutes to wash away any remaining free calcium ions. The 
bead was washed again in a serum free MEM-alpha medium without Phenol Red (α-
MEM; Invitrogen) for up to 10 minutes to rid the bead of any remaining wash media and 
serum. After both washes, the bead was placed into cartilage culture media (described 
below) for long-term culture.  
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3.2.4.  Culture Conditions 
Cartilage culture media was prepared using previously described methods [15]: α-
MEM supplemented with 50-µL/mL GPS, β-glycerophosphate (10-mM; Sigma Aldrich), 
and L(+) ascorbic acid (50-µg/ml; EMD, Darmstadt, Germany). In addition, 
dexamethasone (1-nM; Sigma Aldrich), proline (1-mg/mL; Sigma Aldrich), antioxidant 
(1:100; Sigma Aldrich), sodium pyruvate (1-mM; Gibco Lifetech, Grand Island, NY), 
nonessential amino acids (1:100; Thermo Fisher), and Insulin-Transferrin-Selenium+3 
media supplement that includes linoleic and oleic acids, and bovine serum albumin (ITS 
+3; 1:100; Sigma Aldrich) were added to the media. For treatment conditions, 
parathyroid hormone (PTH; Sigma Aldrich) or Indian hedgehog (IHH; R&D, 
Minneapolis, Minnesota) were added to the culture media in the concentrations described 
in the experimental design. Beads were cultured in a 48-well plate within a humidified 
incubator at 37°C and 8% CO2 for up to 7 days.  
3.2.5.  Evaluation of Viability 
The viability of cells encapsulated in alginate and RGD-alginate was evaluated 
using a Live/Dead Cell Viability kit (Invitrogen). After culture for 0 to 7 days, beads 
were removed from media and then incubated in a solution of 2 µM Calcein AM/4 µM 
ethidium homodimer-1 in PBS for 30 minutes in the dark. After the incubation, the 
solution was replaced with PBS and beads were imaged with fluorescence on a Leica 
DMI6000B inverted microscope to visualize live and dead cells. The overall level of 
viability was qualitatively assessed for any excessive cell death. Images are 
representative of 3 replicates. 
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3.2.6.  Immunofluorescent Imaging  
For immunofluorescence (IF) analysis of beads containing chondrocytes, all 
reagent and wash solutions contained 2mM CaCl2 to maintain the cross-linked alginate. 
After 0 to 7 days of culture, beads were fixed with 4% paraformaldehyde (PFA, Sigma 
Aldrich) for 20 minutes, permeabilized with 1×Tris-Buffered Saline (TBS) made with 
15-mM Tris-HCl (Fisher Scientific) and 136-mM NaCl (JT Baker, Center Valley, PA) 
plus 0.1% Triton X-100 (1×TBST, Triton from EMD, Darmstadt Germany), and blocked 
for 2 hours with 10% heat-inactivated sheep serum (HISS, Sigma Aldrich). The beads 
were incubated with gentle rocking at 4º C in either rabbit-anti-Collagen VI (1:500; 
Abcam, Cambridge, UK) or rabbit-anti-Collagen IV (1:500; Abcam) primary antibody in 
2% HISS/TBST overnight. The beads were then incubated in a secondary anti-mouse 
AlexaFluor 647 antibody (1:1000; Jackson Laboratories) and phalloidin-labeled 
AlexaFluor 488 (1:100; Invitrogen) for 2 hours in 2% HISS/TBST. After washing in 
TBST 3 times for 5 minutes, the coverslips were mounted with gelvatol or with Prolong 
Gold antifade reagent with DAPI (Invitrogen).  
For the IF analysis of cell cultures, the data are representative of n=3 beads.  All 
factors within the alginate gel were visualized using a Zeiss 710 laser scanning confocal 
microscope. Optical sections (line averaging of 2, scan speed of 4 or 5, and typical 
resolution of 1024×1024) were collected at 1.8-µm intervals for between 15 and 25 
sections (total depth of 30-40-µm).  
3.2.7.  Transcript Expression Analysis 
Immediately after crosslinking (D0) or after 1 (D1), 4 (D4) or 7 (D7) days of culture, 4 
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beads were harvested and were immediately placed in 50-µL of 50-mM 
ethylenediaminetetraacetic acid disodium salt dihydrate (EDTA; Fisher Chemical, Fair 
Lawn, New Jersey) in ddH2O to dissociate the chondrocytes from the alginate matrix. 
RNA was isolated using the NucleoSpin® RNA Plus kit (Thermo Fisher) according to 
the manufacturer’s instructions. Quantification of RNA was performed using a Thermo 
Fisher Scientific NanoDropOne spectrophotometer. RNA was converted to cDNA using 
Superscript IV (Thermo Fisher) according to the manufacturer’s instructions and 
resulting cDNA was quantified again after the reaction using the spectrophotometer. 
ddPCR was performed according to the manufacturer’s protocol (Bio-Rad Laboratories, 
Inc., Pleasenton CA). Using mouse-specific primers (Table 3-1) (IDT, Coralville, IA), 
transcript expression levels for Actin, RPL13a-2, and HPRT were used as 
housekeepering genes. Transcript expression levels of collagen 1 (Col1), collagen 2 
(Col2), collagen X (ColX), parathyroid hormone related protein (PTHrP), parathyroid 
hormone receptor (PTH1R), and Indian hedgehog (IHH) were assessed. Thermal cycling 
conditions were 95°C for 10 min; 40 cycles of 94 °C for 30 seconds, 60°C for 60 
seconds, 98°C for 10 minutes, and a 4°C hold. The transcript count of each gene of 
interest was normalized with a geometric average of the transcript count of the 
housekeepers. Data from this analysis are reported as fold change in the geometric mean 
± SEM over the transcript count of the non-treated control and significance was 
calculated using two-way ANOVA analysis using Prism software (GraphPad Software, 
Inc, La Jolla, CA). The number of replicates for each treatment group is reported in the 
tables corresponding to the figure. 
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Table 3-1. Sequence of primers used for ddPCR amplification. 
Gene 
Forward Sequence 
5’ à  3’ 
Housekeeping  
Actin CCCATCTACGAAGGTTACGCC 
HPRT CTGGTGAAAAGGACCTCTCG 
RPL13-a ATCCCTCCACCCTATGACAA 
Target  
Col1 CACTGGTGATGCTGGTCCTG 
Col2 AATGGGCAGAGGTATAAAGATAAGGA 
ColX TTCTGCTGCTAATGTTCTTGACC 
PTHrP AGTTAGAGGCGCTGATTCCTACA 
PTH1r AGGTGGTTCCAGGGCACAA 
IHH CCCCAACTACAATCCCGACA 
 
3.2.8.  Flow Cytometry 
Fluorescence-activated cell sorting (FACS) was used to analyze cell cycle 
distribution in cultured chondrocytes. Alginate beads were dissociated using 200-µL of 
50-mM EDTA in polypropylene tubes (Becton Dickinson Labware, Cedex, France) for 5 
minutes. Using a sterile transfer pipette (VWR, West Chester, PA), the tubes were filled 
completely with 0.1-µm sterile filtered PBS (Hyclone, Logan, Utah) and centrifuged at 
125 x g for 5 minutes. The supernatant was removed using the same transfer pipette 
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making sure to keep 200-µL of volume left in the bottom of the tube to ensure the cell 
pellet was not disrupted during pipetting, and the pellet was resuspended by vortexing 
using a Vortex Genie 2 (Thermo Fisher). As cells vortexed they were fixed by adding ice-
cold 90% ethanol using a transfer pipette dropwise, one drop per second, to 
approximately 3-mL total volume. Fixed cells were maintained at -20°C for anywhere 
from 24 hours to 7 days, and subsequently stained with propidium iodide (Molecular 
Probes, Eugene OR) (0.05 mg/mL) in Telford’s reagent for 1 hour at 4°C in the dark to 
label DNA. Labeled cells were filtered through 5-mL Filter-cap polypropylene Falcon 
tubes (Corning Labs, Tamaulipas, Mexico) and were immediately analyzed on a BD 
FACSCaliber 2 flow cytometer (BD, Franklin Lakes, NJ). Resulting cell cycle 
distribution was analyzed by the UNMC flow cytometry research core facilities. The 
resulting cell cycle data was represented as stacked bar graphs of the geometric mean ± 
SEM of percentage of cells in each phase of the cell cycle and significance was 
calculated using a two-way ANOVA using GraphPad Prism software. The number of 
replicates is reported in in the tables corresponding to the figure. 
3.2.9.  FISH 
3.2.9.1.  Hybridization Technique 
For fluorescence in situ hybridization (FISH) analysis of gene expression in cell 
cultures, whole alginate beads containing chondrocytes were fixed in 4% 
paraformaldehyde in TBS containing 5mM CaCl2 overnight at 4°C, infiltrated and 
embedded in 37.5:1 40% acrylamide (JT Baker, Center Valley, PA) overnight at 4ºC to 
ensure structural integrity of the sample, bathed overnight at 4°C in 30% sucrose (Sigma 
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Aldrich) and embedded for cryosectioning using Tissue-Tek Optimum Cutting 
Temperature embedding medium (OCT; Thermo Fisher). FISH was performed according 
to product instructions (TSA Plus, Perkin Elmer, Waltham Massachusetts) with ColII and 
ColX RNA probes using DNA templates cloned from mouse and generated using 
fluorescein label as described [143]. Slides were mounted using Prolong Gold antifade 
reagent with DAPI (Life Technologies, Eugene, OR).  Images were captured with 
fluorescence on a Leica DMI6000B inverted microscope to visualize hypertrophic and 
non-hypertrophic chondrocytes, as well as nuclei using DAPI. For each image, a tiled, 
stitched, z-stacked image (5-µm slices, 3 total slices, 15 total width of the z-stack) was 
produced to show the entire section of the bead for downstream quantification, described 
next.  
3.2.9.2.  Statistical Analysis for FISH 
Resulting FISH images were subjected to batch processing analysis using a macro 
programmed in FIJI software (http://fiji.sc/) to count total number of cells labeled for 
ColX, and DAPI using particle analysis. The macro performed the following functions: 
The name of each image was stored, and z-stacks and channels were split into separate 
images. Each image was automatically set to binary, such that cells appeared black on a 
white background, and the software ran a particle analysis including particles only within 
size range 50-1000, as determined optimal by analyzing the size distribution of cells from 
our images. The particle analysis determined counts for each image, which were summed 
across images of similar conditions. Typically, each image yielded cell counts of 
approximately 1000, and each condition resulted in approximately 10,000 cell counts in 
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total. Summed cell counts for each gene were divided by DAPI counts to produce the 
values of fraction of total cells. To calculate the ColX/Col2 ratio, the geometric mean of 
the Col2/DAPI ratio for each replicate (n=3 or 4 sections for each replicate) was divided 
by the geometric mean of the ColX/DAPI ratio for each replicate (n=3 or 4 sections for 
each replicate) to control for total cell number. The ratio is reported as the geometric 
mean of the ColX/Col2 ratio for each replicate ± SEM. The number of replicates for each 
treatment group is reported in the table corresponding to the figure. For regional/spatial 
gene expression analysis of FISH images, bead diameter was measured in ImageJ using a 
circular region of interest (ROI). The bisection of each bead radius was used to demarcate 
inner and outer regions of each bead. Each image was duplicated and cropped to include 
only the inner or outer regions. The resulting images were analyzed by particle counting 
as described above to determine the amount of cells expressing the target gene within the 
ROI. The distribution of gene expression was examined for spatial differences.  
3.3.  Results  
3.3.1.  RGD Conjugation Confirmation 
One of the objectives of this paper was to explore the effect of cell adhesion and 
specifically the effect of integrin activation via RGD; chondrocytes were cultured in vitro 
in either ALG or RGD-modified ALG beads (Fig. 3-2). The successful conjugation of 
RGD to ALG was confirmed via 1H-NMR, which is shown in Chapter 2 (Fig. 2-2). 
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3.3.2.   The effect of scaffold on chondrocyte behavior 
The first objective of this study was to explore the difference in chondrocyte 
behavior when exposed to different encapsulating scaffolds: ALG and RGD. 
Chondrocytes encapsulated in ALG or RGD-modified ALG were cultured for up to 7 
days and FACS, ddPCR and FISH were all utilized to investigate changes in chondrocyte 
cell cycle distribution and gene expression.  
3.3.2.1.  Encapsulation and Viability 
To culture primary growth plate chondrocytes in 3-D, a homogenous 
encapsulation method was used. Fig. 3-2 is a schematic showing the method of 
encapsulation.  In order to ensure the bead fabrication process did not cause harm to the 
Fig. 3-2. Schematic of the “drop” method to produce homogenous chondrocyte-alginate beads.  
 77 
primary growth plate chondrocytes and to ensure a homogenous distribution of cells 
throughout the bead, Live/Dead stain was used to visualize the viability of the 
chondrocytes, with live cells fluorescing green and dead cells fluorescing red. Fig. 3-3 
shows an even distribution of cells throughout the bead, as well as many cells stained 
green, while very few cells stained red. The distribution of live cells and low amounts of 
dead cells remained consistent throughout a 7-day culture period.  
3.3.2.2.  IF Visualization of Matrix Deposition  
In order to ensure the encapsulation and culture processes did not impede the 
ability of chondrocytes to deposit an ECM, visualization of the matrix deposition within 
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Fig. 3-3. Representative images of Live/Dead stain of chondrocytes encapsulated in beads. A-D) 
Chondrocytes are encapsulated in alginate and are stained A) immediately after encapsulation, or are 
cultured and stained after B) 1 day, C) 4 days or D) 7 days in culture. E-H) Chondrocytes are 
encapsulated in RGD-alginate and are stained E) immediately after encapsulation, or are cultured and 
stained after F) 1 day, G) 4 days or H) 7 days in culture. Scale bar = 50-µm. (n=3) 
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the alginate bead was accomplished through IF imaging of both Collagen type VI (Col6) 
and Collagen type 4 (Col4), as well as with staining for DAPI and F-actin. As shown in 
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Fig. 3-4. Representative images of immunofluorescence visualization of ECM deposition. Neither ALG nor 
RGD encapsulation cause any disruptions of either Col4 or Col 6 matrix deposition over time in culture. 
However, a slight difference in actin organization between ALG and RGD is observed, and is highlighted by 
the white arrows.  Scale bar = 5 µm. 
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Fig. 3-4, the deposition of both Col4 and Col6 was observed and maintained throughout a 
4-day culture period. However, a slight difference was observed in the structure of the   
actin fillaments between chondrocytes encapsulated within ALG and RGD: Arrows in 
Fig. 3-4 point to F-actin within the chondrocyte lacune, and a qualitative assessment of 
the F-actin seen in cells encapsualted within ALG appear to be disrupted and less intense 
than the F-actin highlighted in the image of chondrocytes encapsulated within RGD, 
which appear to have greater organization and prominance of F-actin.  
3.3.2.3.  FACS Analysis 
To ensure that the 
encapsulation of chondrocytes in 
hydrogels did not cause dramatic 
changes in the cell cycle 
distribution, FACS analysis was 
used to measure the overall 
distribution of cell cycle status. 
Fig. 3-5 shows the cell cycle 
distribution of chondrocytes 
encapsulated in either ALG or 
RGD and cultured for up to 7 days. 
As outlined Table 3-2, the cell 
cycle distribution at D0 was mostly 
in G0G1 (85%), with small 
Fig. 3-5. FACS analysis of cell cycle of chondrocytes 
encapsulated in ALG and RGD. D0 is representative of 
chondrocytes that were encapsulated ALG and were briefly 
held in culture media before being harvested for analysis. D1, 
D4 and D7 are representative of chondrocytes cultured for 1, 4 
or 7 days, respectively, in their respective scaffold: Right: 
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amounts of cells in either S or G2M (9% and 7%, respectively). On D1, chondrocytes 
encapsulated in ALG showed a decrease in the percentage of cells in G0G1 to 79% when 
compared to D0, with a corresponding increase seen in the proliferative phases: the 
amount of cells in G2M phase accounted for 13% of cells, and S for 8%, or 21% 
collectively. On D4 and D7, the percentage of cells encapsulated in ALG in G0G1 phase 
remained around that of D1 (76% and 78%, respectively) and the percentage of cells in 
the proliferative phases also remained collectively similar to D1 (23% and 22%, 
respectively). However, no differences in cell cycle distribution of chondrocytes 
encapsulated in ALG were statistically significant over time.  
Table 3-2. Cell cycle distribution by FACS analysis. Reported in this table are the geometric means with SEM 
for each phase of the cell cycle and replicate number for each treatment group. 
 
Cells encapsulated within RGD showed a similar cell cycle distribution as those 
encapsulated in ALG on D1, with the percentage of cells in G0G1 at 76% and a 
combination of G2M and S phases at 24%. However, by D4, cells encapsulated in RGD 
showed less cells in G0G1 (71%) and significantly more cells (P< 0.01) in the 
combination of G2M and S phases (28%), when compared to D0. By D7, cells 
encapsulated in RGD showed a decrease in G0G1 phase when compared to previous time 
points (68%) and a corresponding and significant increase (P< 0.001) in the amount of 
Mean SEM n Mean SEM n Mean SEM n
D0 84.579 0.813 3 6.652 0.184 3 8.697 0.692 3
D1 ALG 78.840 1.930 3 7.742 0.577 3 13.120 1.598 3
D1 RGD 75.629 2.769 3 9.954 2.419 3 13.699 1.260 3
D4 ALG 76.205 3.510 3 10.342 0.689 3 12.590 2.842 3
D4 RGD 70.790 4.101 3 8.634 0.939 3 19.164 4.901 3
D7 ALG 77.892 2.143 3 15.127 0.909 3 6.613 1.239 3
D7 RGD 66.981 1.598 3 16.836 1.135 3 16.057 0.468 3
Phase
G0G1 S G2M
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cells in the combination of G2M and S phases (33%). Overall, a trend in the decrease in 
the percent of cells encapsulated in RGD in G0G1 phase with a significant increase in the 
combination of G2M and S phases was observed over time. This trend was not observed 
in ALG after D1.  
3.3.2.4.  Transcript Expression 
ddPCR was utilized to explore the effect of scaffolding and the addition of cell 
adhesion ligands on the gene expression of chondrocytes encapsulated in alginate 
hydrogels. Table 3-3 shows the geometric means along with SEM and replicate number 
(n) for all gene expression data. First, the ratio of the fold change in transcript counts for 
Col2 to the fold change in transcript counts for Col1 was determined to ensure significant 
dedifferentiation did not occur within the culture system. Fig. 3-6 shows the results for 
this dedifferentiation ratio. For culture 
in ALG, the ratio only slightly 
decreased from D1 to D4 from 1 to 0.9 
and by D7, the ratio decreased again, 
with an average ratio of 0.9 over all 7 
days of culture in ALG. There were no 
significant differences (P> 0.05) 
observed across days in ALG. The 
Col2/Col1 ratio for cells encapsulated 
in RGD on D1 was higher than the 
ratio measured for cells in ALG 
Fig. 3-6. Ratio of Col2 to Col1 to explore the 
differentiation status of chondrocytes. Cells were 
encapsulated in either ALG or RGD. (n=2) 
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(average value of 1.7). The average ratio was 1.6 over all 7 days of culture in RGD and 
there were no significant differences observed over time. Additionally, the difference in 
Col2/Col1 ratios between ALG and RGD was not significant over time, indicating 
dedifferentiation was not observed in either scaffold system.  
To observe changes in the expression of chondrocyte and zonal specific genes, 
ColX, PTHrP, PTH1r and IHH expression was observed over time in both scaffold 
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Fig. 3-7. Gene expression of chondrocytes cultured in ALG or RGD over time. Data are reported as fold 
changes over the control of that gene (D1 ALG). Fold changes are shown for A) ColX, B) PTHrP, C) PTH1r 
and D) IHH. (n=2)  
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systems.  Table 3-3 outlines all data for gene expression analysis and Fig. 3-7 shows the 
fold change in transcript expression for the genes of interest. The most dramatic of the 
four genes, ColX (Fig. 3-7A) showed both significant differences between scaffolds 
overall when compared to each other (P< 0.01) and significant differences within the 
individual treatments (i.e. ALG and RGD) between days (P< 0.0001). In ALG, ColX 
expression decreased significantly on both D4 and D7 when compared to chondrocytes 
encapsulated in ALG on D1. However, no other significant changes in gene expression 
were quantifiable for PTHrP, PTH1r or IHH in ALG. The ColX expression of 
chondrocytes encapsulated in RGD decreased significantly (P< 0.001) from D1 to D4 
and decreased again on D7 when compared to D1. In both IHH and PTH1r, a noticeable 
decrease in expression was observed in cells encapsulated in RGD when compared to D1, 
although these changes were not significant. Overall, cells encapsulated in both ALG and 
RGD show a statistically significant decrease in ColX expression over time, and the 
decrease in ColX expression in of cells within ALG was statistically higher (P< 0.01) 
than the decrease expression of cells in RGD. However, no other day or scaffold effects 
were significant in the expression of PTHrP, PTH1r or IHH in either scaffold system over 
time.  
Table 3-3. Fold change in transcripts of genes of interest as compared to the D1 ALG of each column. 
Reported in this table are the geometric means with SEM and replicate number for each treatment group. 
 	
Mean SEM n Mean SEM n Mean SEM n Mean SEM n Mean SEM n Mean SEM n
D1 ALG 1 0 2 1 0 2 1 0 2 1 0 2 1 0 2 1 0 2
D1 RGD 0.512 0.098 2 0.683 0.187 2 0.556 0.052 2 1.46 0.36 2 1.163 0.23 2 0.881 0.17 2
D4 ALG 0.59 0.238 2 0.525 0.202 2 0.085 0.031 2 1.296 0.686 2 0.788 0.165 2 0.586 0.332 2
D4 RGD 0.639 0.041 2 0.748 0.11 2 0.073 0.014 2 1.698 0.74 2 0.5 0.198 2 0.584 0.193 2
D7 ALG 0.913 0.104 2 0.574 0.239 2 0.043 0.014 2 1.534 1.187 2 0.751 0.63 2 0.933 0.584 2
D7 RGD 0.496 0.212 2 0.684 0.187 2 0.036 0.019 2 1.544 1.284 2 0.357 0.351 2 0.363 0.352 2
IHH
Target Gene
Col1 Col2 ColX PTHrP PTH1r
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3.3.2.5.  FISH Analysis 
FISH was used to visualize the distribution of gene expression of chondrocytes 
cultured in ALG or RGD hydrogels. Representative images of FISH are shown in Fig. 
3-8A and B. In Fig. 3-8A DAPI and ColX are visualized in one section of an ALG bead, 
and in Fig. 3-8B, DAPI and Col2 are visualized.  
 To better understand the rate of hypertrophy within the system, the ratio of ColX 
to Col2 expression was analyzed through image analysis across 9 images of cells 
encapsulated in ALG or cells encapsulated in RGD in three separate experiments (Fig. 
3-9C). On D1, the ColX/Col2 ratio for cells cultured in ALG was 0.463 ± 0.058, but by 
D4 the ratio decreased to 0.251 ± 0.148; however, this was not significant due to large 
D1 D4 D1 D4
0.00
0.25
0.50
0.75
1.00
1.25
Time Point
R
at
io
Hypertrophic Ratio
ColX/Col2
ALG RGD
A 
B 
DAPI 
ColX 
DAPI 
Col2 
C 
Fig. 3-8. FISH analysis to visualize distribution of A) 
ColX gene expression and B) Col2 gene expression 
within the ALG bead on D0. C) Ratio of the count of 
Col2 positive cells to the count of ColX positive cells. 
Scale bar is 500 µm. 
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error on D4. Conversely, on D1 the ColX/Col2 ratio for cells cultured in RGD was 0.321 
± 0.167, and the ratio increased by D4 to 0.603 ± 0.389. However, no statistically 
significant differences (P> 0.05) were observed due to error in ratios observed in cells 
encapsulated in RGD. Overall, no sidgnificance in the ColX/Col2 ratio was observed 
over time or between the scaffold types.  
3.3.3.  The effect of soluble factors on chondrocyte behavior 
The next objective of this study was to examine the effect of the addition of 
soluble factors known to play a role in chondrocyte maturation. The effects of both PTH 
and IHH on chondrocytes 
encapsulated in only ALG were 
studied, along with the PTH 
inhibitor H89. 
3.3.3.1.  PTH 
3.3.3.1.1.  FACS Analysis 
To explore the effect of the 
addition of PTH on chondrocytes, 
the media used to culture 
encapsulated chondrocytes was 
either untreated (NT), or 
supplemented with PTH at a 
concentration of 10, 100, or 1000 
Fig. 3-9. FACS analysis of cell cycle of chondrocytes 
encapsulated in ALG cultured in cartilage culture media (NT) 
or with increasing PTH treatments on D1 (left) and D4 (right). 
D0 is representative of chondrocytes that were encapsulated in 
ALG and immediately processed for FACS.  
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nM PTH. An additional condition was evaluated with 1000 nM PTH and the addition of 
10 µM H89, a known inhibitor of PTH. FACS analysis was used to measure the overall 
distribution of cell cycle status. Fig. 3-9 shows the cell cycle distribution of chondrocytes 
with no added PTH (NT) or added PTH treatments, and Table 3-4 outlines the specific 
values for each cell cycle state, the associated errors with the replicates, and the number 
of replicates.  
On D0, the overall distribution of cell cycle was about 84%:7%:8% 
(G0G0:S:G2M) and all treatment groups were compared to D0 or to cells cultured with 
NT on the corresponding day. On D1 there were significant treatment effects observed 
(P< 0.0001), and when compared to D0, cells in G0G1 phase that were cultured with 10, 
100, 1000 nM PTH as well as with 1000 nM PTH + 10 µM H89 were all significantly 
decreased (0.01 with H89 and P< 0.0001 for all others). However, when comparing cells 
cultured with NT on D1 with 1000 nM PTH + H89, the amount of cells in G0G1 was not 
significantly different. There were significant differences observed between treatments in 
the percentage of cells in the combination of S-phase and G2M on D1: cells harvested on 
D0 and cells cultured with NT on D1 were significantly different from each other (P< 
0.0001) and cells cultured with 10, 100 and 1000 nM PTH as well as with 1000 nM PTH 
+ 10 µM H89 treatments had significantly increased percentage of cells in the 
combination of S and G2M phase over the D0 (P< 0.0001for all) for each treatment. 
Overall on D1, the percentage of cells in G0G1 phase decreased significantly over D0 
with increasing PTH treatment and when compared to D1, H89 treatment included with 
the highest PTH dose showed no significant increase over D1. Conversely, the percentage 
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of cells that were in the S and G2M phases on D1 increased significantly with increasing 
PTH treatment.  
Table 3-4. Cell cycle distribution by FACS analysis. Reported in this table are the geometric means with SEM 
and replicate number for each treatment group 
Mean SEM n Mean SEM n Mean SEM n
D0 83.61 0.245 4 8.145 0.284 4 8.219 0.214 4
D1 
NT 75.42 1.81 4 9.49 1.183 4 14.68 1.135 4
10 36.55 1.789 3 18.07 1.852 3 18.04 1.225 3
100 63.88 0.866 4 18.09 1.273 4 17.73 1.308 4
1000 62.04 0.494 3 17.82 1.74 3 19.79 1.863 3
1000 + H89 70.65 1.968 4 13.21 0.873 4 15.6 1.996 4
D4
NT 45.26 1.93 3 22.89 1.65 3 31.44 5.547 3
10 30.79 3.99 2 19.59 1.345 2 49.03 5.335 2
100 26.94 3.38 2 20.08 3.815 2 51.83 7.095 2
1000 29.99 6.53 2 21.38 1.745 2 47.13 8.275 2
1000 + H89 41.15 6.161 3 21.7 0.642 3 34.93 6.607 3
Phase
G0/G1 S G2/M
 
By D4, significant (P< 0.0001) dose effects were evident. When compared to D0, 
the percentage of cells in G0G1-phase on D4 that were cultured with NT and with 10, 
100, 1000 nM PTH, as well as 1000 PTH with H89, were all significantly decreased  (P< 
0.01 for NT, 0.0001 for all others). When observing changes in the percentage of cells in 
the combination of S-phase and G2M, the percentage of cells cultured with NT was 
significantly increased (P< 0.01) when compared to D0. Cells cultured in all treatment 
groups on D4 showed significant increases in S and G2M phases over cells on both D0 
(P< 0.0001 for all treatments) and on D4 with NT (P< 0.001 for all treatments except 
with H89 with P< 0.05). Overall on D4, the percentage of cells in G0G1-phase decreased 
significantly and cells in the proliferative phases (i.e. S and G2M phases) increased 
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significantly with increasing PTH treatment, which were more pronounced than the trend 
seen on D1. The most prominent shift in cell cycle from the D0 distribution was seen 
with the 100 nM PTH treatment on D4.  
3.3.3.1.2.  Transcript Expression 
ddPCR was utilized to measure the effect of treatment with varying PTH 
concentrations on the gene expression of chondrocytes encapsulated in ALG at two time 
points (D1 and D4). Table 3-5 shows the geometric means along with SEM and replicate 
number (n) for all gene expression data. First, the ratio of the fold change in transcript 
counts for Col2 to the fold change in transcript counts for Col1 was determined to ensure 
significant dedifferentiation did not occur within the culture system. Fig. 3-10 shows the 
results for this dedifferentiation 
ratio. There were no statistical 
differences across treatments or 
across days (P>0.05). On D1, 
the 100 nM PTH treatment 
showed an increase in this ratio 
when compared to NT; 
however, this was not 
significantly different when 
compared to any other 
treatment.   
Fig. 3-10. Ratio of Col2 to Col1 to explore the differentiation status 
of chondrocytes. In ALG on D1 (left) and D4 (right). Cells were 
encapsulated in RGD and treated with varying concentrations of 
PTH. 
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To observe changes in the expression of chondrocyte and zonal specific genes, 
ColX, PTHrP, PTH1r and IHH expression was observed on D1 and D4 in ALG with the 
aforementioned treatments. Table 3-5 outlines all data for gene expression analysis and 
Fig. 3-11 shows the fold change in transcript expression for the genes of interest. The 
expression of ColX (Fig. 3-11A) on D1 and D4 showed a significant (P< 0.001) 
treatment effect of PTH and PTH with H89. When compared to NT on D1, cells cultured 
with 10, 100 and 1000 nM PTH treatments showed a significant decrease (P< 0.05, 0.01 
and 0.05, respectively) in ColX expression. However, while the treatment with 1000 nM 
PTH + 10 µM H89 on D1 showed a slight decrease in ColX expression, the decrease was 
not statistically different than NT on D1. Additionally, there were no statistical 
differences within PTH or PTH + H89 treatments on D1. When compared to NT on D4, 
10, treatment with 100 and 1000 nM PTH caused a significant decrease (P< 0.05 for all) 
in ColX expression. Unlike on D1, the treatment with 1000 nM PTH + 10 µM H89 on D4 
showed a significant decrease when compared to NT (P< 0.01) in ColX. Additionally, 
there were no statistical differences within PTH or PTH + H89 treatments on D4 or 
overall between D1 and D4. 
Next, when observing the change in expression of PTHrP (Fig. 3-11B) on D1 and 
D4, a significant (P< 0.01) treatment effect of PTH and PTH + H89, as well as a 
significant (P< 0.001) day effect between D1 and D4 emerged. When compared to NT on 
D1, treatment with 10, 100 and 1000 nM PTH caused a significant decrease (P< 0.05 for 
all) in PTHrP expression. Likewise, 1000 nM PTH + 10 µM H89 treatment showed a 
significant decrease (P< 0.05) in PTHrP expression on D1. Furthermore, there were no 
statistical differences within PTH or PTH + H89 treatments on D1. When compared to 
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NT on D4, treatment with 10 nM PTH did not cause any change in PTHrP expression, 
while treatment with 100 nM PTH caused a significant decrease (P< 0.05) in expression. 
Treatment with 1000 nM PTH on D4 caused a significant decrease when compared to 
culturing with NT (P< 0.05) in PTHrP expression. Likewise, treatment with 1000 nM 
PTH + 10 µM H89 on D4 showed a significant decrease when compared to culturing 
Fig. 3-11. Gene expression of chondrocytes cultured in ALG with or without PTH treatments over time. Data 
are reported as fold changes over the control of that gene (D1 ALG). Fold changes are shown for A) ColX, B) 
PTHrP, C) PTH1r and D) IHH. (n=2) 
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with NT (P< 0.05) in PTHrP expression. Furthermore, there were no statistical 
differences within PTH or PTH + H89 treatments on D4. The expression of PTHrP was 
significantly higher overall for all conditions taken together (P< 0.001) on D4 than it was 
on D1.  
Next, when observing the change in expression of PTH1r (Fig. 3-11C) on D1 and 
D4, a significant (P< 0.05) treatment effect of PTH and PTH + H89 as well as a 
significant (P< 0.01) day effect between D1 and D4 emerged. When compared to NT on 
D1, treatment with 10, 100 and 1000 nM PTH caused a decrease in PTH1r expression, 
although the decrease was not significant. While treating encapsulated cells with 1000 
nM PTH + 10 µM H89 caused a slight decrease in expression when compared to NT on 
D4, the decrease was not significantly different than NT on D1. On D1, there were no 
statistical differences between any treated or untreated groups. When compared to NT on 
D4, treatment with 10 nM PTH caused a slight increase in PTH1r expression, while 
treatment with 100 nM PTH did not cause any changes in PTH1r expression. The 1000 
nM PTH treatment on D4 caused a slight decrease in PTH1r expression. Additionally, 
treatment with 1000 nM PTH + 10 µM H89 on D4 showed a significant decrease (P< 
0.05) in PTH1r expression when compared to treatment with 10 nM PTH. Furthermore, 
there were no other statistical differences within PTH or PTH + H89 treatments on D4. 
The expression of PTH1r was significantly higher overall for all treatments together (P< 
0.01) on D4 than it was on D1.  
Finally, when observing the change in expression of IHH (Fig. 3-11D) on D1 and 
D4, a significant (P< 0.01) treatment effect of PTH and PTH + H89 as well as a 
significant (P< 0.01) day effect between D1 and D4 emerged. When compared to NT on 
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D1, cells encapsulated and cultured with treatments of 10, 100 and 1000 nM PTH caused 
a significant decrease in IHH expression (P< 0.01 for 100 nM PTH and P< 0.05 for 
others). While treatment with 1000 nM PTH + 10 µM H89 caused a slight decrease in 
IHH expression when compared to NT on D1, the decrease was not significantly 
different. When compared to NT on D4, treatment with 10 nM PTH caused a decrease in 
IHH expression, while 100 and 1000 nM PTH treatment only caused slight changes in 
IHH expression. Conversely, treatment with 1000 nM PTH + 10 µM H89 on D4 showed 
a significant decrease (P< 0.05) in IHH expression when compared to NT on D4. 
Furthermore, there were no other significant differences within PTH or PTH with H89 
treatments on D4. The expression of IHH was significantly higher overall for all 
treatments taken together (P> 0.01) on D4 than it was on D1. 
Table 3-5. Fold change in transcripts of genes of interest as compared to the NT of each column. Reported in 
this table are the geometric means with SEM and replicate number for each treatment group. 
Mean SEM n Mean SEM n Mean SEM n Mean SEM n Mean SEM n Mean SEM n
D1 (nM PTH)
NT 1 <0.01 2 1 <0.01 2 0.97 0.029 2 1 <0.01 2 1 <0.01 2 1 <0.01 2
10 0.88 0.746 2 0.873 0.324 2 0.494 0.012 2 0.3 0.199 2 0.572 0.06 2 0.344 0.046 2
100 0.437 0.156 2 0.967 0.515 2 0.342 0.11 2 0.254 0.068 2 0.437 0.057 2 0.29 0.044 2
1000 0.761 0.25 2 0.873 0.321 2 0.532 0.103 2 0.272 0.107 2 0.502 0.088 2 0.431 0.123 2
1000 +
10 µM H89
D4 (nM PTH)
NT 1 <0.01 2 1 0.017 1 1 <0.01 2 1 <0.01 2 1 <0.01 2 1 <0.01 2
10 0.73 0.128 2 0.534 0.069 1 0.565 0.015 2 0.998 0.227 2 1.175 0.379 2 0.651 0.032 2
100 1.011 0.136 2 0.622 0 1 0.605 0.075 2 0.855 0.087 2 0.979 0.04 2 0.86 0.233 2
1000 0.79 0.047 2 0.395 0.02 1 0.646 0.801 2 0.726 0.096 2 0.773 0.057 2 0.778 0.026 2
1000 +
10 µM H89
IHH
Target Gene
Col1 Col2 ColX PTHrP PTH1r
0.807 0.34 2 0.834 0.078 2 0.579 0.102 20.099 2 0.191 0.081 2 0.651
1 0.398 0.019 2
0.2222 0.686
0.52 0.189 2 0.705 0.024 0.444 0.041 20.345 0.101 2 0.461 <0.01 2
  
Overall, ColX, PTHrP and IHH expression decreased with PTH treatment on D1 
and ColX and PTHrP expression decreased with PTH treatments on D4. The expression 
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of PTH1r showed slight decreases 
in expression on D1 and D4 with 
PTH treatments, but changes were 
not significant. 
3.3.3.1.3.  FISH Analysis  
FISH was used to visualize 
the distribution of gene expression 
of chondrocytes cultured with no 
PTH treatment (NT) or with 10, 
100, or 1000 nM PTH in ALG and 
to  explore the ColX/Col2 ratio that 
is indicative of hypertrophy. To 
better understand the rate of 
hypertrophy within the system, the ratio of ColX to Col2 expression was determined 
through image analysis and is reported in Fig. 3-12. On D1, the ColX/Col2 ratio slightly 
decreased with increasing PTH treatments, but no changes were significant. On D4, a 
trend of decreasing ColX/Col2 ratio with increasing PTH concentration, with the 
exception of cells treated with 10 nM PTH, was observed. The lowest ratio of ColX to 
Col2 was almost 0.04 for 1000 nM PTH on D4. However, no statistically significant 
differences were observed over time or with treatments. 
3.3.3.2.  IHH 
3.3.3.2.1.  FACS analysis  
Fig. 3-12. FISH analysis to examine hypertrophy over time 
with increasing PTH treatment. The fraction of ColX positive 
cells compared to the number of nuclei by a DAPI count and 
the count of Col2 positive cells to number of nuclei was 
calculated and the ratio of the fraction of ColX positive cells 
to Col2 positive cells was reported. 
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To explore the effect of 
IHH on chondrocytes 
encapsulated in alginate 
hydrogels in culture, media 
was supplemented with a 
concentration of 0 (NT) or, 
0.05, 0.5, or 5.0 nM IHH for 
up to 4 days. FACS analysis 
was used to visualize the 
overall distribution of cell 
cycle status. Fig. 3-13 shows 
the cell cycle distribution of 
chondrocytes with treatments 
and Table 3-6 outlines the 
specific values for each cell 
cycle state, the associated 
errors with the replicates and 
the number of replicates.  
On D0, the overall distribution of cell cycle was approximately 84%:8%:8% 
(G0G0:S:G2M) and all treatment groups were compared to D0 or to NT on that day. On 
D1, there were significant treatment effects observed (P< 0.0001), and when compared to 
D0, G0G1-phase for NT and treatment with 0.05, 0.5 and 5.0 nM IHH were all 
significantly decreased (P< 0.05, 0.001, 0.01, and 0.01, respectively). When comparing 
Fig. 3-13. FACS analysis of cell cycle of chondrocytes encapsulated 
in ALG with IHH treatments on D1 (left) and D4 (right). D0 is 
representative of chondrocytes that were encapsulated in ALG and 
immediately processed for FACS, NT is representative of cells that 
were encapsulated and cultured with no treatment and 0.05, 0.5 and 
5.0 represent cells cultured with that concentration of IHH 
supplemented in the culture media. 
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the combination of S and G2M phases across treatment groups, the amount of cells in 
these proliferative phases was statistically greater with IHH treatments: treatment with 
0.05, 0.50 and 5.0 nM IHH demonstrated more cells in S and G2M phases (P< 0.01, 0.01 
and 0.05, respectively). Overall on D1, cells desplayed a cell cycle distribution of 
increased amounts in G2M and S phaes and decreased amounts in G0G1 phases with 
IHH treatment.  
Table 3-6. Cell cycle distribution by FACS analysis. Reported in this table are the geometric means with SEM 
and replicate number for each treatment group. 
Mean SEM n Mean SEM n Mean SEM n
D0 83.61 0.245 4 8.145 0.284 4 8.219 0.214 4
D1  (nM IHH)
NT 75.42 1.81 4 9.49 1.183 4 14.68 1.135 4
0.05 69.42 4.58 2 14.66 3.895 2 15.25 0.68 2
0.5 69.9 4.575 2 14.8 3.665 2 14.68 0.915 2
5 73.49 3.986 3 11.49 3.539 3 13.8 0.642 3
D4 (nM IHH)
NT 75.42 1.18 4 9.49 1.183 4 14.68 1.135 4
0.05 47.05 - 1 19.93 - 1 33.03 - 1
0.5 49.21 - 1 16.81 - 1 34.61 - 1
5 44.63 3.56 2 29.57 0.435 2 25.46 3.13 2
Phase
G0/G1 S G2/M
 
When compared to D0, the amount of cells in G0G1 phase on D4 for NT and for 
treatment with 5.0 nM IHH were significantly decreased (P< 0.01 and 0.001, 
respectively). When observing changes in the percent of cells in the combination of S and 
G2M phases, significant increases were observed in cells with NT and with cells with 5.0 
nM IHH treatment (P< 0.01 and 0.0001, respectively) when compared to D0, and 
treatment with 5.0 nM IHH revealed significant increases (P< 0.0001) in cells in these 
phases when compared to NT. A trend of increased amount of cells in G2M and S phases 
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and a decrease in G0G1 phases were observed with 0.05 and 0.5 nM PTH treatments, but 
significance could not be calculated with 1 replicate. Overall on D4, the percent of cells 
in G0G1 phase decreased significantly with the highest dose of IHH, and the amount of 
cells that were in S or G2M phase on D4 was significantly different from D0 and NT. 
3.3.3.2.2.  Transcript expression  
ddPCR was utilized to explore changes in gene expression with treatment with 
IHH. Fold changes in gene expression are tabulated in Table 3-7. All transcript data 
reported are only an n of 1, so statistically significant differences could not be calculated. 
First, the ratio of the fold change in transcript counts for Col2 to the fold change in 
transcript counts for Col1 was determined to ensure significant dedifferentiation did not 
occur within the culture system. Fig. 3-14 shows the results for this dedifferentiation 
ratio. While some differences in 
this ratio were observed, no 
decreases in the ratio were seen 
with treatment with IHH or over 
time. 
 The gene expression of 
chondrocytes encapsulated in ALG 
with or without treatment with IHH 
was examined (Fig. 3-15). As 
shown in Fig. 3-15A, on D1, the 
fold change in expression of ColX 
Fig. 3-14. Ratio of Col2 to Col1 to explore the differentiation 
status of chondrocytes. In ALG on D1 (left) and D4 (right). 
Cells were encapsulated in RGD and treated with varying 
concentrations of IHH. 
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decreased with increasing IHH treatment, while cells cultured with NT showed similar 
gene expression as chondrocytes cultured with treatment with 0.05 nM IHH. On D4, 
ColX expression in the NT group decreased dramatically when compared to non-treated 
cells on D1, while treatment with 0.05, 0.5 and 5 nM IHH on D4 caused similar decreases 
in ColX expression when compared to cells cultured with NT on both D4 and D1.   
Studying the fold change in expression of PTHrP (Fig. 3-15B), decreases in 
Fig. 3-15. Gene expression of chondrocytes cultured in ALG over time with no treatment (NT) or treatment 
with 0.05, 0.5 or 5.0 nM IHH. Data are reported as fold changes over a D0 (not shown). Fold changes are 
shown for A) ColX, B) PTHrP, C) PTH1r and D) IHH.  
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expression relative to NT were observed on D1 in cells cultured with treatment with 0.05, 
0.5 and 5.0 nM IHH. On D4, an elevation of expression of PTHrP compared to cells 
cultured on D1 in cells encapsulated in ALG and treated with or without IHH. While 
observing changes in transcript expression of PTH1r (Fig. 3-15C), it was observed that 
transcript expression in cells cultured in ALG with NT on D1 was elevated compared to 
cells treated with IHH on D1. As the concentration of IHH increased, the fold change 
decreased when compared to NT. On D4, the expression of PTH1r was decreased in all 
groups when compared to D1, and was elevated in chondrocytes treated with 0.05, 0.5 
and 5.0 nM IHH when compared to the NT D4 control.  
Finally, while studying changes in transcript expression of IHH (Fig. 3-15D) in 
chondrocytes cultured in ALG with or without exogenous IHH treatments, it was 
observed that expression in NT on D1 was elevated compared to treatment with IHH on 
D1. As the concentration of IHH increased, the fold change in IHH transcript expression 
decreased from the NT on D1. On D4, the expression of IHH was elevated in 
chondrocytes cultured with 0.05, 0.5 and 5.0 nM IHH treatments when compared to both 
the NT on D4 and IHH treatments on D1. Overall, when compared to NT, the expression 
of ColX decreased on D1 with increasing IHH concentration and the same is true on D4.   
The expression of PThrP was elevated on D4 when compared to D1 with no dose 
dependence. PTH1r expression decreased with increasing IHH treatment on D1 when 
compared to NT and was decreased in all groups on D4 when compared to D1. The 
expression of IHH on D1 shows lower expression with higher IHH treatment when 
compared to NT, and on D4 IHH expression slightly increased with IHH dose.  
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Table 3-7. Fold change in transcripts of genes of interest as compared to the D0 NT of each column. Reported 
in this table are the geometric means with SEM and replicate number for each treatment group. 
Mean SEM n Mean SEM n Mean SEM n Mean SEM n Mean SEM n Mean SEM n
D1 (nM PTH)
D0 NT 1 0.011 1 1 0.05 1 1 0.019 1 1 0.01 1 1 0.015 1 1 0.04 1
NT 0.441 0.006 1 0.924 0.036 1 0.941 0.009 1 4.672 0.02 1 2.86 0.058 1 1.414 0.078 1
0.05 0.434 0.02 1 0.748 0.01 1 0.998 0.017 1 5.018 0.031 1 2.613 0.099 1 1.056 0.072 1
0.5 0.559 0.022 1 1.051 0.064 1 0.615 0.01 1 4.51 0.031 1 2.526 0.046 1 0.603 0.014 1
5 0.603 0.014 1 0.802 0.021 1 0.409 0.002 1 3.025 0.076 1 1.686 0.051 1 0.605 0.025 1
D4 (nM PTH)
D0 NT 1 0.054 1 1 0.014 1 1 0.019 1 1 0.092 1 1 0.016 1 1 0.033 1
NT 0.841 0.077 1 2.588 0.043 1 0.288 0.005 1 10.94 0.274 1 1.616 0.022 1 1.168 0.045 1
0.05 0.947 0.126 1 1.091 0.033 1 0.316 0.009 1 11.84 0.196 1 2.018 0.057 1 1.448 0.026 1
0.5 0.686 0.054 1 1.089 0.032 1 0.237 0.003 1 11.54 0.304 1 2.054 0.043 1 1.388 0.031 1
5 0.991 0.042 1 1.534 0.025 1 0.315 0.007 1 10.62 0.152 1 1.931 0.03 1 1.659 0.036 1
IHH
Target Gene
Col1 Col2 ColX PTHrP PTH1r
 
3.3.3.2.3.  FISH analysis 
FISH was used to visualize the distribution in gene expression of chondrocytes 
cultured in 0 (NT), 0.05, 0.5 and 5.0 nM IHH and to explore the ColX/Col2 ratio that is 
indicative of hypertrophy (Fig. 
3-16). Note that no data are 
available for 5.0 nM IHH on D1 or 
0.05 nM IHH on D4. On D1, the 
ratio of ColX/Col2 decreased with 
increasing IHH treatment with 
ratios of 0.28, 0.12, and 0.05 for 
cells cultured with NT, 0.05 and 
0.5 nM PTH, respectively. On D4, 
no trend in the ColX/Col2 ratio 
was observed with NT, 0.50 and 
Fig. 3-16. FISH analysis to find ratio of the count of Col2 
positive cells to the count of ColX positive cells between 
D1 and D4 in ALG with varying IHH treatments.  
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5.0 nM IHH having ratios of 0.22, 0.64 and 0.19, respectively. No statistically significant 
differences were observed over time or with treatments since every treatment had an n of 
1 besides NT, which was an n of 3.  
When determining ratios using FISH, it was noted that encapsulation in ALG with 
treatment of 0.5 nM IHH on D4 revealed spatially differential gene expression 
throughout the bead (Fig. 3-17). Fluorescent probes show that ColX (Fig. 3-17A) 
expression was denser around the outer edge of the ALG bead and Fig. 3-17B shows the 
same bead section with nuclei stained for DAPI in order to normalize to an overall cell 
count to inform of the proportion of total cells that were expressing ColX. In Fig. 3-17C, 
fluorescent probes showed Col2 expression was denser in the center of the ALG bead and 
Fig. 3-17D showed the same bead section with nuclei stained for DAPI to inform of the 
proportion of total cells that were expressing Col2.  Images were annotated for 
clarification: the outer white dotted oval indicates the outline of the alginate bead and the 
inner white dotted oval indicates where the “inner” and “outer” sections of the beads 
were separated when measuring the density of cells positive for the target probe. To 
quantify the difference in the amount of cells expressing the target gene in the inner or 
outer portion of the bead, image analysis was utilized and Fig. 3-17E shows that the ratio 
of ColX positive cells that were situated within the “outer” portion of the bead was higher 
than the ratio of ColX positive cells that were situated in the “inner” portion of the bead. 
Conversely, Fig. 3-17E shows that the ratio of Col2 positive cells that were situated in the 
“inner” portion of the bead was higher than the ratio of Col2 positive cells situated in the 
“outer” portion of the bead, suggesting that with IHH treatment and over time ColX was 
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more highly expressed on the outer portion of the bead while Col2 was more highly 
expressed by chondrocytes encapsulated further inside the alginate bead.  
3.4.  Discussion and Conclusion 
The overarching goal of this study was to develop a 3-D chondrocyte culture 
system using alginate hydrogels that can be used to investigate the mechanisms behind 
the formation of distinct zones within the growth plate. The first objective was to explore 
the effect of scaffold material on chondrocyte behavior by encapsulating primary growth 
Fig. 3-17. FISH visualization of A) ColX and corresponding B) DAPI, and of C) Col2 and corresponding D) 
DAPI. Scale bar is 200 µm. E) Ratio of ColX and Col 2 positive cells to a nuclei count (DAPI) using image 
analysis to show differences in cells positive for ColX or Col2 in radially defined regions. 
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plate chondrocytes in either ALG or RGD-modified ALG hydrogels. The second 
objective was to use the unmodified ALG scaffold to culture chondrocytes in treated 
media to explore the effect of PTH or IHH on chondrocyte behavior. Live/Dead staining 
was applied to ensure that chondrocytes can survive encapsulation, IF was used to 
visualize matrix deposition in the scaffolds, FACS was performed to observe any changes 
in the cell cycle distribution, ddPCR was utilized to monitor gene expression changes, 
and FISH was employed to study the distribution of gene expression throughout the bead 
constructs.  
Within the field, in vitro culture of growth plate chondrocytes has been a long-
standing goal since 1965, when Chesterman et al. explored methods to expand a supply 
of primary chondrocytes using monolayer culture conditions [150, 156].  However, since 
then it has been well established that two-dimensional (2-D) culture of chondrocytes 
leads to a loss of chondrocytic phenotype and dedifferentiation over time [148, 149]. 
More recently, attempts have been made to avoid this characteristic dedifferentiation by 
culturing growth plate chondrocytes in 3-D in vitro by using either suspension cultures, 
pellet cultures or by culturing chondrocytes in biomaterial scaffolds [103, 150, 151].  
Within this current study, Alginate (ALG) was used to develop a 3-D in vitro 
culture model to study growth plate cartilage development, as it has been widely used in 
tissue engineering and has also been thoroughly characterized for its use in articular 
cartilage engineering [157]. ALG has previously been employed in the culture of growth 
plate chondrocytes as well; it has been shown that not only does culturing growth plate 
chondrocytes in ALG allow for the maintenance of a chondrogenic phenotype, but also 
that dedifferentiated human chondrocytes undergo redifferentiation when cultured in 
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ALG beads [158]. The use of ALG as a scaffold for chondrocyte culture has many 
advantages that include mild gelation conditions, fluid diffusion of nutrients and wastes 
into and out of the construct, non-fouling properties and accessible functional groups for 
modifications [35]. In this study, we aimed to use the alginate scaffold to explore the 
effects of specific signaling factors known to play a role in zonal arrangement of 
chondrocytes. We aimed to use these factors to elicit a quantifiable response in the 
chondrocytes, in order to use the forthcoming information to build our culture model. To 
begin, we first explored how cell interaction with the hydrogel matrix in vitro affected the 
chondrocyte phenotype. To do this, we modified the alginate molecule with the cell-
adhesion ligand, RGD. 
One of the main responsibilities of growth plate chondrocytes is to produce an 
ECM that is characteristic of each particular zone of the growth [139]. Most of the matrix 
proteins secreted throughout development are collagens and sulfated proteoglycans that 
act as a substrate for cellular adhesion via integrin binding, resulting in signal 
transduction cascades that lead to distinct chondrocyte behaviors [139, 140]. While the 
majority of the secretory proteins within the growth plate are collagens, it has also been 
shown that the growth plate contains molecules such as fibronectin (FN) and osteopontin 
that are involved in cell adhesion via integrin binding with the RGD sequence within 
these proteins [159]. In the present study, in order to recapitulate the cell adhesion aspect 
of the growth plate and to explore the effect of integrin binding and cell adhesion on 
chondrocyte behavior, the RGD peptide was covalently conjugated to the ALG molecule 
before encapsulation. 
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It has been previously shown that cell adhesion and integrin binding are essential 
not only to survival and morphology, but also to the function of chondrocytes specifically 
within the resting and proliferative zones of the growth plate [142, 143]. It was shown 
that when growth plate chondrocytes were seeded onto substrates coated in Col1, Col2 or 
FN, cell spreading occurred, but if the cells were treated with free RGD peptide, 
spreading was completely reversed and proliferation decreased suggesting that the 
adhesion properties of proteins within the growth plate such as Col1, Col2 and FN which 
contain RGD are due to both β-1 integrin interactions and to mechanical stimuli due to 
these interactions that may be linked to proliferative capacity [160].  Furthermore, Aszodi 
et al. demonstrated that when the beta-1 integrin was knocked out of mice, proliferative 
zone chondrocytes did not flatten and were still very large and round and proliferation 
was reduced, indicating the necessity of this integrin binding for differentiation from 
immature to mature, hypertrophic chondrocytes [142]. It follows then that the lack of 
maturation seen in the proliferative chondrocytes of the β -1 knockout mouse towards 
hypertrophy could be because of the chondrocyte’s inability to anchor to the surrounding 
ECM. Additionally, the lack of maturation could have been caused by of actin 
rearrangement that would normally be signaled by an activation of the β -1 integrin. In 
the present study, it was shown that both Col4 and Col6 were deposited over time in both 
ALG and RGD scaffolds. However, differences were observed in the IF analysis of 
chondrocytes cultured in ALG and RGD-modified ALG hydrogels.  Chondrocytes 
cultured within RGD gels exhibited potential actin filament formation and organization 
(Fig. 3-4), while cells in ALG showed less organization of F-actin, resembling disrupted 
actin filaments. A lack of organization of actin in a hydrogel with no cell adhesion 
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functionality would be consistent with the previous results that demonstrated that without 
integrin activation of downstream signaling, rearrangement of actin during proliferation, 
hypertrophy, or simply cell spreading was disrupted resulting in punctuated actin 
distribution [142]. While this is only qualitative data, a more detailed examination of 
integrin binding could be performed using IF by specifically targeting focal adhesions or 
even integrin receptors themselves. The extent of actin formation could also be quantified 
over many IF images using image analysis software. 
In order to explore changes in cell cycle distribution between the two scaffold 
types (i.e. ALG and RGD modified alginate), FACS was performed. The cell cycle is 
exquisitely regulated and is characterized by several sequential phases. Cells are either in 
G0, where they are quiescent or they pass through an initial growth phase (G1) of the cell 
cycle before entering into S phase, where DNA is replicated in preparation for another 
obligatory round of cell division (G2M) [161]. While there were no statistically 
significant differences in cell cycle distribution over time in ALG, a more pronounced 
trend of decreasing amount of cells in G0G1 with a compensation and significant 
increase in the amount of cells in the S and G2M phases was observed. A decrease in the 
percent of cells in G0G1 indicates less of the cells are arrested, while more and more 
cells are synthesizing DNA and are going through mitosis, indicating an increase in 
proliferation [162]. An increase in proliferation in cells encapsulated in RGD follows 
with the previous description that if the β-1 integrin receptor is not activated, proliferation 
is halted, but proliferation, differentiation and maturation should continue with RGD 
interaction with the β -1 integrin [142]. The proliferative cell cycle distribution along 
with the observations noted with the IF images would suggest that culture in RGD gels 
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allows for cell-matrix interactions potentially by β-1 integrin binding, which supports 
maturation and proliferation of growth plate chondrocytes over time.  
Observing changes in gene expression of Col2 with respect to Col1 in 
chondrocytes cultured in vitro can elucidate any potential dedifferentiation that is taking 
place. Chondrocytes in the resting and proliferative zone of growth plate express Col2 
abundantly, providing the framework for the tissue growth and the structural stability to 
withstand compression [163]. However, it has been shown that when chondrocytes 
dedifferentiate in vitro, a shift from Col2 expression to Col1 expression occurs, causing 
the ratio of Col2/Col1 to decrease [164] [165]. One of the main advantages to culturing in 
3-D and in ALG hydrogels is the ability to avoid dedifferentiation in culture, but a check 
of this ratio ensures proper functioning of the chondrocytes. The ratio of the fold change 
of Col2 to the fold change in Col1 (Col2/Col1 ratio) should be 1 if no changes are 
observed in differentiation status. In cells encapsulated in ALG, the Col2/Col1 ratio 
decreased slightly over time, which could indicate dedifferentiation. On the other hand, 
the Col2/Col1 ratio was elevated compared to at all time points in RGD when compared 
to all time points of ALG, indicating the chondrocytes encapsulated in RGD did not 
dedifferentiate in culture over time. However, it is important to note that there are no 
statistical differences between scaffolds or over time in the Col2/Col1 ratio, which 
supports studies that show no dedifferentiation when culturing chondrocytes in ALG 
hydrogels [142]. 
When examining differences in the expression of other gene transcripts, similar 
trends were observed between alginate and RGD. Typical gene expression patterns of 
different zones of the growth plate as described by Kozhemyakina et al. show that ColX, 
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PTH1r and IHH are expressed primarily in the pre-hypertrophic and hypertrophic zones. 
The decrease observed in the expression of these in this current study over time suggests 
the behavior of growth plate chondrocytes encapsulated in either ALG or RGD is less 
hypertrophic, or more immature and proliferative [89]. Additionally, since PTHrP is only 
expressed in the immature resting zone chondrocytes and its expression signals a block of 
maturation (Fig. 1-5B), the slight increase in its expression of PTHrP over time suggests 
that culture in ALG or RGD promotes a more immature and less hypertrophic phenotype 
supporting the conclusion drawn from ColX, PTHrP and IHH downregulation [14, 166].  
Gene expression data was also analyzed by FISH analysis, which demonstrated a 
difference between ALG and RGD cultures. Previously, most FISH analyses were 
performed on intact tissue, and Bengtsson et al demonstrated in 2005 that probes for Col2 
and for ColX could be used to visualize hypertrophic and proliferative and resting zones, 
respectively [167]. However, a protocol for FISH in ALG hydrogel beads had to be 
optimized utilizing acrylamide infiltration for stability through processing. As previously 
stated, a decrease in ColX expression suggests the suppression of hypertrophy, but Col2 
is expressed everywhere in the growth plate until hypertrophy begins [89]. Therefore, if 
ColX decreases and Col2 increases, the ratio of ColX to Col2 the two would decrease, 
indicating an increase in hypertrophy, with the converse being true as well. The data 
gathered from FISH image analysis demonstrated a slight decrease in the ColX/Col2 ratio 
over time in ALG, suggesting a slight increase in hypertrophy in ALG, while a slight 
increase is shown in RGD over time, suggesting a slight decrease in hypertrophy in RGD 
over time. 
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Culturing chondrocytes in ALG scaffolds provided a feasible method to maintain 
a 3-D architecture for long-term culture while avoiding excessive, if any 
dedifferentiation. FACS analysis showed no significant change in cell cycle distribution, 
and gene expression indicated a more resting zone phenotype with increased PTHrP 
expression and decreased ColX, PTH1r and IHH expression over time and a slight, non-
significant decrease in the ColX/Col2 ratio. When presenting the RGD ligand to 3-D 
cultured chondrocytes, differences in actin morphology were observed, cell cycle 
distribution indicated an increased amount of cells in a proliferative state over time, and 
transcription expression and distribution showed low ColX, decreased PTH1r and IHH 
expression with slightly increased PTHrP expression, and a ColX/Col2 ratio that is not 
significantly different over time all add to the conclusion that RGD guided chondrocytes 
toward a less hypertrophic, more proliferative phenotype that resembled the proliferative 
zone more than the resting zone [142, 160, 165]. 
In order to continue to explore the ability of this system to be used as a tool to 
explore the mechanisms behind zonal arrangement, signaling molecules were introduced 
to the culture media. To begin, the effect the addition of PTH as well as the effect of the 
combination of PTH with the PTH inhibitor H89 to the culture media was explored. As 
previously stated, periarticular resting zone cells secrete PTHrP, which diffuses through 
the growth plate to produce a gradient of signaling activity, and it has previously been 
shown that PTHrP/PTH signaling suppresses the rate of hypertrophy, keeping immature 
chondrocytes in a more proliferative or resting zone state [144, 145]. Additionally, it has 
been shown that the loss of PTHrP expression in the mouse growth plate lead to 
shortened limbs and the loss of the proliferative zone, with most cells becoming 
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prematurely hypertrophic [144]. The converse is also true: it has been shown that 
treatment of chondrocytes with PTH leads to the delay in hypertrophy along with an 
increase in proliferation, while Col2 expression remains unchanged [168]. In our culture 
system, when encapsulated chondrocyte were treated with PTH, significant differences in 
cell cycle distribution were observed both between PTH doses and between days. An 
overall decrease in the percent of cells in G0G1 phase suggests more cells are 
synthesizing DNA and moving on to mitosis or are exiting the cell cycle, which is 
indicative of an increase in the percentage of cells that are proliferating, supporting 
previous in vitro data [169]. Additionally, slightly less of a decrease in the percent of 
cells in G0G1 was seen when the H89 inhibitor was included with PTH treatment, which 
indicates that the effect of PTH can be negated using a known PTH inhibitor, further 
suggesting the specificity of PTH. Again, to be sure chondrocytes were not 
dedifferentiating in culture with PTH treatment, the Col2/Col1 ratio was measured. There 
were no significant differences between treatments or days and these results follow 
closely with studies that showed that PTH treatment in 3-D culture did not disrupt 
chondrogenesis [168].  
  When examining gene expression, as predicted and described in studies of 
growth plate chondrocytes cultured in the presence of increased PTH concentrations, the 
expression of ColX was significantly lower in cells within ALG treated with PTH than 
the non-treated control, suggesting a suppression of hypertrophy, which was observed on 
both days of culture. It then follows that because the chondrocytes were being treated 
with PTH, the endogenous expression of PTHrP was significantly less than the untreated 
control on both D1 and D4.  
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Similarly, the expression of transcripts for the receptor for PTHrP decreased with 
PTH treatment, which could be explained by the receptor sites being utilized at full 
capacity due to the increased PTH molecules present leading to the downregulation of the 
PTH receptor. Additionally, PTHrP is an inhibitor of IHH, and it has been shown that the 
activity of PTH is comparable to that of PTHrP [166]. In this study, a significant decrease 
in IHH expression was observed by D1; both ColX and IHH are mostly found in the 
prehypertrophic and hypertrophic zones of the growth plate, and it was to be expected 
that if chondrocytes were treated in culture with PTH, a decrease in in the gene 
expression for both ColX and IHH would be observed, which is true of our culture 
system. Additionally, the distribution of gene expression throughout the ALG construct 
was studied using FISH, which showed that treatment with a high dose of PTH had a 
slight effect on the attenuation of maturation of chondrocytes on D1 and on D4, Other 
factors besides PTH are involved in the growth plate and to further explore the role of the 
PTHrP/IHH feedback loop in vitro, the addition of IHH to the culture system was 
explored.  
IHH is expressed in the prehypertrophic zone of the growth plate and it has been 
suggested that IHH in conjunction with PTHrP provide the necessary cues to induce 
zonal arrangement. To explore the specific role of IHH in chondrocytes cultured in vitro 
in ALG, IHH was added to the culture media and changes in cell cycle and gene 
expression were observed. On D1, no significant differences were seen in cell cycle 
distribution with IHH treatments, but by D4, a more proliferative gene expression 
distribution was seen suggesting the effects of IHH treatment become evident after longer 
culture periods, and the proliferative cell cycle distribution could be explained by IHH 
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stimulating PTHrP, leading to more proliferation. The addition of IHH to the culture 
media resulted in increased PTHrP expression on both D1 and D4, which follows with 
the current PTHrP/IHH feedback loop model, and as depicted in Fig. 3-1, PTHrP blocks 
further IHH expression, but IHH signaling pathways stimulates PTHrP expression [170]. 
Therefore, it follows that the introduction of exogenous IHH to the culture constructs 
would increase the expression of PTHrP since any inhibitory effect of PTH on IHH is not 
relevant when the IHH in the media [92]. Finally, using FISH to visualize the entire 
chondrocyte bead, preliminary studies have shown the ability to induce differential gene 
expression in chondrocytes encapsulated in ALG and treated with IHH. Two theories to 
explain why differential gene expression was observed are possible. First, the IHH 
molecule is larger than the other factors mentioned in this study, as the MW of PTH is 4 
kD and IHH is around 20 kD. It has been described that in ALG beads, molecules smaller 
than 70 kD but greater than 10 kD diffuse through ALG more slowly than smaller 
molecules, so it then follows that the diffusional characteristics of IHH could be slower 
and more hindered through ALG than molecules like PTH [154]. The encapsulated 
chondrocytes on the periphery of the bead would then encounter more IHH molecules 
than those in the inner bead, resulting in differential gene expression within the scaffold. 
However, over many hours in culture, it is likely that IHH had diffused throughout the 
bead construct [154]. Therefore, if the entire construct is exposed to IHH, then the 
chondrocytes must be upregulating the production of PTHrP endogenously [136]. The 
PTHrP produced by the cells on the periphery of the bead can readily diffuse away, while 
in the center of the bead, PTHrP can diffuse to interact with surrounding chondrocytes, 
creating a zone of PTHrP inhibition of IHH, which may lead to the increase of Col2 and 
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the decrease of ColX in the center of the bead and the opposite in the outer part of the 
bead. The next step to understanding more about this system is to utilize an IHH inhibitor 
to probe for specific pathways that can elucidate the specific mechanisms at work in this 
condition. 
In conclusion, in this study we have defined a system that allows for the 
modulation of biomaterial scaffold and culture conditions in order to modulate the cell 
cycle distribution, maturation and differentiation, and activate the PTHrP/IHH signal loop 
by using soluble factors to control hypertrophy with growth plate chondrocytes in vitro. 
The ability of ALG and RGD-modified ALG to provide a suitable supporting scaffold for 
chondrocyte culture in vitro was confirmed by the lack of dedifferentiation in either 
culture system. Additionally, it was suggested that RGD tended to promote a proliferative 
phenotype while ALG also promoted an immature, resting zone phenotype. The inclusion 
of PTH into the culture media also resulted in a proliferative, less hypertrophic phenotype 
of encapsulated chondrocytes indicated by characteristic gene expression and cell cycle 
distributions. By utilizing ALG hydrogels and the addition of IHH to the culture media, 
we have observed differential areas of highly hypertrophic chondrocytes surrounding an 
area of less mature chondrocytes- a promising first step to designing a multi-zonal, 
functioning culture model to elucidate mechanisms behind growth plate development. 
Future studies will include the testing of other factors such as Thyroxine [102, 136] and 
Nogin [171] to explore the effect that culture in ALG has on the receptiveness to factor 
manipulations. The overall success in building an in vitro culture model of the growth 
plate will give developmental biologists and engineers another tool to probe more 
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information about the mechanisms of zonal arrangement and columnar architecture and 
for future therapies.
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 Future Directions and Conclusions CHAPTER 4-
4.1.  Introduction 
In this thesis, alginate hydrogels were explored and optimized as scaffolds used 
for in vitro culture models of tissue development. Because of the demonstrated ability of 
alginate hydrogels to be manipulated to control shape, mechanical properties and 
biological activity, alginate hydrogels were specifically utilized as a scaffold for an in 
vitro culture model to study porcine embryo elongation and for the study of growth plate 
cartilage development. First, the ability of alginate hydrogels to facilitate the process of 
pig embryo elongation was validated by this study, but furthermore these hydrogels were 
used to explore the effects of known uterine factors on elongation via integration of those 
factors into the culture system by the incorporation of SPP1 into the hydrogel, as well as 
the chemical modification of the alginate with RGD. Next, alginate hydrogels were 
employed for the encapsulation of growth plate chondrocytes with the goal of designing 
an in vitro culture model of growth plate cartilage development. We demonstrated the 
ability to characterize the response of chondrocytes both to unmodified and RGD-
modified alginate encapsulation and were able to use the alginate culture system to 
present the soluble factors PTH and IHH in order to observe and visualize changes in 
gene expression to compare to zones found in native growth plate cartilage. 
 115 
4.2.  Future directions for the in vitro porcine embryo elongation model 
An alginate in vitro culture system was developed and utilized in Chapter 2 to 
mimic the native uterine environment and to allow for specific factors to signal to 
developing porcine embryos, facilitating survivability and morphological changes in base 
media. Not only did these studies validate previous studies using alginate hydrogels [9] in 
their effectiveness of facilitating survival and morphological changes, but also the 
modifications to the scaffold system outlined Chapter 2 (i.e. RGD conjugation to the 
alginate molecule) enabled a significant increase in survivability when compared to 
CONT embryos, which had not yet been reported. Additionally, RGD encapsulation 
continued to support elongation, allowing for significant increases in the percentage of 
embryos that underwent morphological changes when compared to both ALG and SPP1 
encapsulation. Furthermore, characteristic behaviors of elongation such as an increase in 
E2 production and steroidogenic transcript expression consistent with trends seen in 
elongating in vivo produced embryos [9]. This improvement demonstrated the ability to 
incorporate factors into the scaffold design, providing a tool to elucidate mechanisms 
involved in the promotion of elongation. Further improvements upon and usage of this 
model by both investigating molecular changes initiated by the interaction with these 
factors and by the combination of modified alginate scaffolds with soluble factors should 
be made moving forward. The following approaches are recommended as the next steps: 
1) investigate the effect of the addition of factors to the culture media on survivability, 
rate of occurrence of elongation and corresponding changes in gene expression and 
protein production in vitro, as well as the effect of the combination of these soluble media 
factors with the RGD-modified scaffold; 2) evaluate the differential effect of culture 
 116 
within alginate and SPP1 or RGD on the metabolomic or proteomic profile elongating 
embryos produced both in vivo and in vitro; 3) investigate the effect of the group culture 
of encapsulated embryos within the same culture dish on survivability, elongation and 
corresponding metabolic changes. Each of these approaches is described in greater detail 
below. 
First, the addition of factors to the basal culture media known to be upregulated 
within the uterine environment during early pregnancy such as transforming growth 
factor β (TGFβs) or fibroblast growth factor 7 (FGF7) should be evaluated to explore 
their individual effect on elongation, [172]. TGFβs are synthesized in the endometrial and 
conceptus tissues and levels increase with the progression through elongation and 
transplantation [172]. TGFβ can positively regulate molecules associated with cell 
adhesion, like SPP1, which can in turn direct cell attachment and therefore cross talk 
between the conceptus and the uterine lining [173]. It has been shown that alterations in 
the expression of TGFβs can affect the interaction between the conceptus and the uterus. 
For example, Caniggia et al. used antibody inhibition of TGFβ to study trophoblast 
differentiation toward an invasive phenotype, which is critical to the preparation for 
implantation of embryos [174]. It was reported that embryos exposed to elevated levels of 
TGFβ maintained an immature state of differentiation, delaying trophoblast implantation 
and placental invasion of the uterus [174]. Other studies have shown that 
supplementation with TGFβ or similar factors such as EGF during in vitro maturation 
might improve maturation of oocytes, thus resulting in an increased developmental 
competence of fertilized eggs in sheep, and pigs [175, 176]. Others have shown that in 
normal trophoblast cells, TGFβ inhibits proliferation [177]. Conversely, by inhibiting the 
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reception of TGFβ in embryos, a switch to the differentiative/invasive phenotype was 
observed via in situ hybridization and transcript expression, indicating that without 
TGFβ, embryos begin to differentiate prematurely, potentially suppressing elongation or 
promoting implantation before sufficient elongation can occur [174]. These studies 
suggest that a specific level of TGFβ is crucial during the pre- and peri-implantation 
period of gestation, and exploring the effect this particular factor has on the elongation of 
porcine embryos in vitro using our alginate system can provide useful knowledge on the 
mechanisms behind the success or failure of elongation. 
Preliminary studies have been performed to evaluate the effect of TGFβ on 
embryo survivability and elongation within the in vitro alginate hydrogel culture system. 
Using the same method described in Chapter 2, D9 porcine embryos were either 
encapsulated in ALG (ALG) or were not encapsulated (C) and were cultured for 96h with 
Fig. 4-1. Representative images of embryos cultured with or without encapsulation or TGFβ 
from 0 h to 96 h. C-0) Image of control embryo cultured without encapsulation in alginate or 
TGFβ is represtative of all surving control embryos with or without TGFβ. 0-10) Images 
represent embryos encapsulated in alginate without TGFβ, with 0.1, 1.0 or 10 ng TGFβ/mL 
media respectively. 
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the addition of the following concentrations of TGFβ in the culture media: 0, 0.1, 1.0 or 
10 ng TGFβ/ mL media. Representative images of embryos from all encapsulated 
treatment groups and from a non-encapsulated control group are shown in Fig. 4-1. 
Results from these studies indicated that not treating with TGFβ promoted the greatest 
survival in both the encapsulated and the non-encapsulated embryo groups (75%, 66% 
respectively), but with positive survival rates (> 40%) in all treatments as shown in Fig. 
4-2A and Table 4-1. In our previous studies, we have seen increases in survivability by 
encapsulating in ALG while culturing in basal media, and it might have been expected to 
see increases in survivability with growth factors such as TGFβ added to the basal culture 
media, as previous studies in mice have shown that in vitro culture with the addition of 
growth factors partially reduced apoptosis leading to greater survival [178]. However, in 
our system we see a decrease in survivability in encapsulated embryos with the addition 
of TGFβ. The mechanisms behind the negative effect of TGFβ should be explored further 
by studying apoptosis via propidium iodide and Hoechst to visualize fragmented DNA as 
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Fig. 4-2. Survival and rate of elongation of in vitro cultured embryos with the addition of TGFβ. A) Percent 
survival of non-encapsulated (CONT) embryos with increasing TGFβ  concentration and encapsulated (ALG) 
embryos with increasing TGFβ supplementation. B) Percent of all embryos that showed morphological 
changes and C) percent of surviving embryos that showed morphological changes. 
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explained by Brison et al [178]. As seen previously in the literature and in Chapter 2, no 
morphological changes were observed in non-encapsulated embryos, but encapsulation in 
alginate hydrogels allowed for elongation to take place with details tabulated in Table 
2-1. When treated with TGFβ, the concentration in the media of 1.0 ng/mL induced the 
greatest percentage of embryo morphological changes from all embryos (50%; Fig. 4-2B) 
and from surviving embryos (100%; Fig. 4-2C), while as shown in Chapter 2, the greatest 
percentage of embryos undergoing morphological changes was 24% of all embryos and 
56% of the surviving embryos that were encapsulated in RGD-modified ALG hydrogels. 
The increase in the percentage of embryos that undergo elongation with TGFβ 
supplementation in these early preliminary studies suggest that TGFβ plays a significant 
and opposing role in the rate of survival of the embryo and the rate of elongation of the 
embryo in culture, perhaps even greater than that of SPP1 or RGD explored in Chapter 2.  
Table 4-1. Summary of embryo survival and morphological changes observed after 96 hours of culture of 
alginate encapsulated embryos and non-encapsulated control (C) embryos with TGFβ incorporated in the 
culture media. 
TGFβ 
Treatment
Morph Change
(ng/mL) (n)
C-0 3 2 66.67% 0 - -
C-0.1 2 1 50.00% 0 - -
C-1.0 2 1 50.00% 0 - -
C-10 2 1 50.00% 0 - -
0 8 6 75.00% 3 37.50% 50.00%
0.1 8 5 62.50% 2 25.00% 40.00%
1 8 4 50.00% 4 50.00% 100.00%
10 8 3 37.50% 1 12.50% 33.30%
Total Embryos
Embryo 
Survival (n)
Embryo 
Survival (%)
Morph change 
from all 
embryos (%)
Morph change 
from surviving 
embryos (%)
 
These results support the results of other studies that show that mouse embryos 
without smad2, a receptor of TGFβ, fail to produce normal extraembryonic membranes 
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leading to disruptions in development, suggesting a role in pre-implantation development 
and perhaps in elongation for TGFβ [179]. The present study with TGFβ has only been 
performed once, and additional replicates are necessary for validating this response. 
Additionally, the effects of combining successful treatment groups (e.g. RGD 
encapsulation with TGFβ in the media) should be explored to investigate if the 
combination of more than one treatment can lead to even greater success in rate of 
elongation and survivability. 
In addition to adding known factors to the culture media to induce elongation in 
vitro, a more detailed investigation of the differences between embryos that successfully 
undergo elongation and those that do not should be done. In order to fully understand the 
behavior of a complex system, the response of an organism to a perturbation of that 
system must also be fully understood, on the transcriptome, proteome, and metabolome 
levels [180]. The transcriptome is a complete set of transcripts in the cell at a particular 
developmental stage or condition, and understanding it completely is essential for 
interpreting the functional elements of the genome and understanding the developmental 
process [181]. RNA-seq catalogues all species of transcripts to quantify changes in 
expression levels of each transcript of interest under different conditions. In the context 
of this study, the differences in the profile of embryos that have shown morphological 
changes and those that have not could be quantified to elucidate which genes or sets of 
genes in particular are important to the initiation and maintenance of elongation. 
Transcriptomic studies in mice have shown success in elucidating novel gene transcripts 
involved in the segregating of the inner cell mass of preimplantation embryos, leading to 
a better description of the timing of upregulation of these genes [182]. The same 
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transcriptomic approach could be applied to either in vitro or in vivo produced porcine 
embryos to expand upon what is already known about the transcriptome and to identify 
novel transcripts or the novel timing of the expression of these transcripts to further 
understand elongation. By evaluating the transcriptome of in vivo embryos, new ways to 
evaluate in vitro produced elongating embryos could emerge.  
Furthermore, metabolomics is the holistic study and/or quantification of the 
metabolites, or small molecules that function as fuel, structure, signaling, stimulatory, 
inhibitory or developmental entities related to metabolism, found within a functioning 
organism [183]. Metabolites are the downstream result of transcripts, coupling the two 
endpoints. Currently, metabolomics are being used to identify the most viable embryos 
for use in in vitro fertilization in humans. Seli et al. studied the capacity of embryos to 
survive in humans by analyzing the culture media of embryos that did and did not survive 
after implantation from IVF using metabolomic approaches. It was reported that by using 
Ramen spectroscopy and near-infrared spectroscopy, differences were observed in the 
metabolites produced by the embryo in vitro between embryos that survived and those 
that did not [184], which demonstrates that a metabolomic approach to understanding 
what determines whether or not a porcine embryo elongates in our system could be used 
[184]. By using two separate populations of in vitro-produced embryos, elongated and 
not elongated, both RNA-seq and non-targeted metabolomic readouts could provide a 
comprehensive and global picture of differences found between the two populations and 
elucidate genes and metabolites both within the embryo and the uterine/culture 
environment that are critical for the success of elongation. Once differences emerge, that 
knowledge can be used to suggest soluble factors and proteins to incorporate into our 
 122 
culture model to confirm their role in elongation and provide the gene transcripts to target 
to provide an endpoint to determine the authentication of true physiological elongation to 
ultimately improve upon our current in vitro culture model.  
In the uterine horns, embryos develop in close proximity to each other. Studies 
have shown that the distance between each embryo in the uterus ranges from 5-50 cm. 
Chen et al. aimed to correlate the spacing of pig embryos in the uterus to survival by 
measuring the distance between embryos en utero and evaluating whether or not that 
embryo survived after a certain amount of days [185]. It was reported that as the distance 
between embryos increases, so does survivability up to about 25 cm where the correlation 
was no longer seen [185]. As previously stated, the embryo secretes many factors during 
gestation including estrogen that not only signal to the uterus for the acceptance of 
pregnancy, but also to signal to embryos in close proximity to ensure proper spacing 
within the horns [186]. In vitro studies have shown in bovine models that culturing 
embryos within the same culture well improves the overall survivability of the embryos 
due to their proximity to embryotrophic factors secreted by neighboring embryos [187, 
188]. However, culturing embryos in the same well can lead to losing track of the 
specific embryo to be observed. In preliminary studies, a method to culture encapsulated 
embryos in the same well, but also to keep them stationary to track each embryo over 
time has been developed. Using a polyethylene mesh, 6 50-µL droplets of alginate were 
pipetted onto the mesh in a line, and the entire mesh was lowered into a petri dish of 
CaCl2/NaCl crosslinking solution described in Chapters 2 and 3. The droplets were 
crosslinked on top of the mesh with portions of the droplets crosslinking around the 
individual threads of the mesh, allowing the alginate to become immobilized on the 
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mesh. Fig. 4-3 shows an 
image of the apparatus. By 
placing double-layered 
alginate beads onto alginate 
droplets on this mesh, a final 
crosslinking step would 
immobilize the already 
constructed beads to the mesh, allowing for the culture of the embryos within the same 
culture media while defining the distance between the individual embryos.  
In addition to the aforementioned steps to continue the development and 
utilization of alginate hydrogels to study embryo elongation, a more detailed study of the 
timing and extent of morphological changes could be performed to better understand the 
process. For example, images of the embryos are taken every 24h and are assessed by 
96h, but some embryos may reach their peak of elongation prior to 96h. If each image 
were analyzed, the rate of elongation could be mapped over time, giving us a more 
accurate timeline in which to assess metabolomic and transcriptomic changes within our 
system.  
4.3.  Future directions for the in vitro culture system of growth plate cartilage 
development 
In order to develop alginate hydrogel scaffolds to culture growth plate 
chondrocytes to study the mechanisms behind the PTHrP/IHH feedback loop, both 
unmodified and RGD-modified alginate were used to encapsulate chondrocytes to 
Fig. 4-3. Device for the immobilization of double encapsulated beads 
for culture. Alginate droplets on polyethylene mesh were 
immobilized after crosslinking. 
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explore the effects of cell adhesion on behavior, and the addition of factors like PTH, 
IHH and inhibitors of either molecules within the culture system and their effect on 
behavior were explored. When comparing unmodified and modified alginate hydrogels, 
outputs such as the cell cycle distribution indicated that encapsulation within ALG and 
RGD gels did not cause any adverse changes to the cell cycle, supporting their use as 
scaffold materials for chondrocyte culture. Furthermore, it was shown that cells 
encapsulated in RGD gels demonstrated a significantly greater percentage of cells in the 
proliferative phases over time, suggesting RGD encapsulation promotes a more 
proliferative phenotype than ALG encapsulation over time. Additionally, no change was 
observed in the Col2/Col1 ratio in either scaffold over time, indicating the lack of 
dedifferentiation within both ALG and RGD scaffolds. A decrease in the expression of 
ColX, PTH1r and IHH and the increase in expression of PTHrP in chondrocytes 
encapsulated within both ALG and RGD scaffolds indicated that both scaffold systems 
suppress hypertrophy over time. Conversely, the utilization of FISH to observe changes 
in the ColX/Col2 ratio demonstrated that in ALG, chondrocytes remained less 
hypertrophic over time, while RGD facilitated a slight increase in the ratio; however, the 
increase was not significant. Furthermore, when chondrocytes were encapsulated in ALG 
and PTH was included in the culture media, significant changes were observed in the cell 
cycle distribution with treatment over time, suggesting that chondrocytes became more 
proliferative with increasing PTH doses over time. The Col2/Col1 ratio resulted in no 
changes with treatment or over time, indicating no dedifferentiation was observed with 
PTH, while significant decreases in ColX, PTHrP, PTH1r and IHH expression levels with 
PTH treatment suggested PTH aided in the suppression of hypertrophy in ALG, both on 
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D1 and D4, as expected [189]. This conclusion was further supported by the decrease in 
the ColX/Col2 ratio on D4 with the highest dose of PTH, demonstrating our ability to 
present soluble factors to the encapsulated chondrocytes and measure subsequent changes 
in behavior, and that PTH may help to suppress hypertrophy. Finally, with the addition of 
IHH, a significant change in cell cycle was observed on D4 with increasing dose of IHH 
that suggested IHH induced a more immature phenotype later in culture. While more 
replicates are needed for statistical significance in all outputs, we also observed no 
significant changes to the Col2/Col1 ratio, suggesting dedifferentiating was not occurring 
with treatment with IHH over time. The expression of ColX and IHH demonstrated a 
dose dependent decrease in expression on D1, indicating a decrease in hypertrophic 
markers, but the dose-dependence and decreasing trend was not observed on D4. 
Additionally the expression of PTHrP and PTH1r were slightly elevated over the control 
on D1 and D4, which was to be expected. Furthermore, the decrease in the ColX/Col2 
ratio on D1 with increasing IHH treatment further supports the conclusion that IHH 
suppresses hypertrophy, as expected. Most interestingly, by FISH we observed a 
differential pattern of the expression of ColX and Col2: ColX expression was mostly 
concentrated on the outer diameter of the alginate bead, while Col2 expression was 
concentrated mostly in the inner portion of the bead, suggesting our ability to induce 
spatial gradients in gene expression that resemble the expression of these gene transcripts 
in vivo. Taken together, the results described in Chapter 3 of this thesis demonstrate that 
modified and unmodified alginate hydrogels maintain cell cycle and aid in suppressing 
hypertrophy and promoting proliferation, while also allowing soluble factors to signal to 
the chondrocytes in vitro. While we confirmed the validity of using alginate to study 
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chondrocyte behavior in vitro, future studies are necessary to further develop this model 
in order to elucidate more mechanisms involved in the development of these tissues. The 
recommendations for moving forward are as follows: 1) Evaluate the effect of the 
addition of inhibitors of IHH to the culture media with the concentration of IHH that 
produced the differential gene expression in Chapter 3 to prove our response is because 
of the mechanistic action of IHH; 2) incorporate other factors known to play a role in the 
PTHrP/IHH feedback loop into the culture media to show the utility of our scaffold 
system in presenting factors in order to study the specific response of chondrocyte to 
those factors; 3) utilize a multi-layered alginate bead and HEK293T cells to present PTH 
to chondrocytes in a gradient manner to better recapitulate the PTHrP/IHH feedback loop 
in vitro. All of these approaches are detailed below.  
In Chapter 3, an alginate scaffold system was utilized to encapsulate chondrocytes 
and IHH was presented via the culture media, which resulted in evidence of differential 
expression of Col2 and ColX within the alginate bead. In order to confirm the hypothesis 
that IHH and the related downstream pathways that IHH activates are responsible for the 
differential gene expression seen in beads treated with IHH, the initial results must first 
be replicated and then the inhibition of IHH must be explored. IHH plays a critical role in 
coordinating endochondral ossification, which is evident by the severity of IHH knockout 
mice [146]. It has been shown that IHH upregulates PTHrP expression (although the 
mechanism remains unclear) and acts on its own to drive proliferation and IHH may also 
be necessary to drive differential growth across the longitudinal axis of the long bone 
[146]. As described throughout this thesis, PTH/PTHrP act as inhibitors of IHH [190]. 
The mechanism as understood today is depicted in Fig. 1-5 and as follows: PTHrP 
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activates the PTH receptor, PTH1r, which in turn activates protein kinase A (PKA) [166, 
189, 191]. PKA blocks Gli2/3, effectively blocking the downstream response cascade of 
IHH activation of patched (PTC) [136, 191]. Therefore, it follows that PTH could be 
utilized in conjunction with IHH treatment to effectively block IHH signal transduction. 
If the gradient in gene expression is no longer seen with co-treatment within the ALG 
bead on D4, it may be concluded that IHH played a role in the differential gene 
expression, potentially through the Gli2/3 pathway. However, it is known that PTH acts 
in other ways on chondrocytes, so this method may not be sufficient to implicate the IHH 
signal cascade as solely responsible for the results seen in Chapter 3. Therefore, another 
factor should be employed to effectively block IHH mechanisms: cyclopamine.  
Oji et al. demonstrated that the addition of cyclopamine to cultures of growth 
plate chondrocytes significantly decreased the proliferation rate of the cells, which was 
expected since IHH causes an increase in proliferation, indicating the inhibition of IHH 
signaling [147, 192]. On the cell surface, two transmembrane proteins smoothened (Smo) 
and PTC control the cellular responses to hedgehog (HH) signaling (Fig. 1-3) [193]. It 
has been shown that PTC suppresses Smo and that the binding of IHH to the PTC protein 
releases the inhibition, activating Smo, which in turn produces downstream products such 
as Gli [193]. While molecules such as IHH interact with PTC to remove the inhibition of 
Smo, cyclopamine acts to suppress Smo regardless of the status of PTC and IHH, leading 
to the successful inhibition of any effect IHH would have on the system [194]. In order to 
prove that HH signaling is in fact responsible for the radial gradient in gene expression 
described in Chapter 3, cyclopamine is one inhibitor that should be incorporated into the 
culture media. It is hypothesized that a homogenous distribution of cells expressing Col2 
 128 
and ColX will be observed using FISH when chondrocytes are encapsulated in ALG and 
are treated both with IHH and cyclopamine, similar to the example shown in the 
beginning of the results section of Chapter 3.  
In this thesis, it was demonstrated that our culture system could be used to prevent 
hypertrophy of chondrocytes by utilizing ALG or RGD hydrogels, or by utilizing PTH or 
IHH in the culture media. In order to demonstrate the utility of the alginate culture system 
to present factors and induce directed responses in chondrocytes, the next step in this 
project should be to aim to induce hypertrophy in our culture system. Soluble factors that 
should be used to induce hypertrophy include thyroxine (THX), permorphamine (PMP) 
or bone morphogenic protein (BMP). First, THX is a hormone produced in the thyroid 
gland, and its use in vitro has been proven to induce hypertrophy in chondrocytes [195, 
196]. For example, Alini et al cultured bovine growth plate chondrocytes in serum-free 
media with the addition of THX or thyroid hormone into the culture media and observed 
that at higher concentrations, the expression of ColX increased along with the production 
of alkaline phosphatase, another indicator of chondrocyte maturation, while Col2 
decreased [197]. These endpoints demonstrate the ability of THX to induce hypertrophy 
in growth plate chondrocytes, and the use of THX in our system is hypothesized to 
induce similar chondrocyte behaviors. Preliminary experiments (Fig. 4-4) were 
performed using the bead fabrication method and culture method outlined in Chapter 3 
with the addition of THX in the culture media at concentrations of 1, 5 and 20 µM THX 
for up to four days to explore the use of THX in inducing hypertrophy within our culture 
system. FACS was utilized and the preliminary results indicate that on D1, THX had little 
effect on chondrocyte cell cycle distribution when compared to the untreated D1 control, 
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while on D4, an increase in THX concentration lead to a slight decrease in the percentage 
of cells in G0G1 phase and the percentage of cells in the S and G2M phases slightly 
increased with increasing THX dose. An increase in cells in the proliferative phases (i.e. 
G2M and S) could actually indicate elevation of proliferation in the system, opposite of 
Fig. 4-4. Preliminary results of cell cycle distribution and Col2/ColX ratio for encapsulated 
chondrocytes treated with A) and D) thyroxine (THX),  B) and E) purmorphamine (PMP), and C) 
and F) bone morphogenic protein (BMP). 
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what was expected with the addition of THX. However, when examining the ColX/Col2 
ratio determined by image analysis using FISH with treatments with THX, a increase in 
the ColX/Col2 ratio on D4 with increasing THX treatment indicates hypertrophy may 
still have been induced since either ColX had to increase or Col2 had to decrease in order 
to see an increase in the ColX/Col2 ratio. These preliminary results support the further 
exploration of THX in the culture media to induce hypertrophy.  
Moving forward, PMP is a small molecule that acts as a Smo agonist and is 
regularly used to guide stem cells to osteogenic differentiation [198]. Many studies 
demonstrate PMP as an IHH pathway activator due to its upregulation of pathway 
mediators such as Smo, Ptc and Gli 1 and 2 [199]. Additionally, and the utilization of 
PMP specifically in limb bud cell cultures resulted in the upregulation of such genes, 
inducing hypertrophy [199-201]. Preliminary studies using PMP in our culture system 
were performed by culturing growth plate chondrocytes in ALG using the method 
outlined in Chapter 3. PMP was added to the culture media at concentrations of 1, 5 and 
20 µM and encapsulated chondrocytes were cultured for up to 4 days (Fig. 4-4). FACS 
was performed to observe changes in the cell cycle distribution with PMP treatment over 
time. On D1, the cell cycle distribution remained constant with increasing dose; however, 
by D4, a reduction of cells in G0G1 phase was observed and the overall percentage of 
cells in G2M and S phases increased overall with PMP treatment, but decreased relative 
to 1.0 µM PMP with increasing PMP dose. These results indicate that increasing PMP 
treatment decreases the number of cells synthesizing DNA and proliferating over time, 
suggesting a decrease in proliferation and potentially an increase in hypertrophy [16]. 
Additionally, image analysis using FISH was performed to determine the ColX/Col2 
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ratio, and while data have not yet been gathered for D1, on D4 a dose dependent increase 
in the ratio with increasing PMP concentration was observed with the highest ratio seen 
with 20 µM PMP, which suggests that increasing PNP concentrations direct encapsulated 
chondrocytes toward a more hypertrophic phenotype. The use of PMP to drive 
hypertrophy should be explored further in order to drive chondrocytes toward a more 
hypertrophic phenotype within our culture system.  
Finally, BMPs have been shown to transduce signals through heteromeric 
transmembrane receptors, but relatively little is known about the downstream signal 
transduction activated by BMP, which leads to transcriptional activation of target genes 
[202]. It was demonstrated by Volk et al. that the addition of BMP to the media in which 
explants were cultured caused a significant increase in ColX expression and ALP, along 
with a decrease in Col2 expression, all of which are markers for chondrocyte 
differentiation and hypertrophy [203]. Additionally, the highest values ColX and ALP, 
along with the lowest value for Col2 expression, were observed with the use of BMP-4, 
which should be explored in future studies [203]. In preliminary studies chondrocytes 
were again encapsulated and cultured according to the protocol detailed in Chapter 3. In 
addition to the basal cartilage culture media, the media was supplemented with 1 or 5 
ng/mL BMP-4 and hypertrophic markers such as the decrease in proliferation via FACS 
were evaluated. On D1, a slight increase in the percentage of cells in S and G2M phases 
was observed when compared to the NT control, but on D4, a dose dependent response 
was observed in the percentage of cells in the proliferative phases; the percentage of cells 
in the combination of G2M and S phases increased with increasing BMP treatment, 
suggesting that chondrocytes treated with BMP exhibit a decrease in the percentage of 
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cells in the proliferative phases, indicating hypertrophy. Additionally, image analysis 
using FISH demonstrated a lower ColX/Col2 ratio on D1 with increasing BMP dose, but 
by D4, the chondrocytes encapsulated and cultured in this system show a dose dependent 
increase in the ColX/Col2 ratio, further supporting the hypothesis that the incorporation 
of BMP induces hypertrophy in vitro.  
Finally, the last recommendation for this project is the utilization and optimization 
of a multilayer alginate construct for the presentation of factors like PTH in order to 
recapitulate the PTHrP/IHH feedback loop with factors in vitro. Multilayered alginate 
hydrogels have been used in the past to modulate the release of soluble factors. For 
example, Khanna et al. found that by first coating alginate microspheres with PLL and 
then coating the ALG-PLL microsphere again with ALG, the release profile of FGF from 
the alginate construct could be modulated by changing alginate percentage or by utilizing 
heparin sulfate to sequester the growth factor [204]. In the case of this thesis, it is our aim 
to recapitulate the PTHrP/IHH feedback loop in vitro by utilizing the alginate pore sizes 
Fig. 4-5. Schematic of the calcium leaching method. Steps 1-3a, or 4a, are the methods to make the 
homogenous inner bead specific to the calcium leaching method. The resulting construct is either a 
homogenous bead with encapsulated cells or a heterogeneous bead with encapsulated cells in the outer layer. 
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and diffusional properties to present factors in a differential pattern, within concentric 
beads, both from the inside out and outside in.  However, it has been shown that alginate 
has a pore size of up to 20 nm, so the diffusional characteristics of small molecules are 
similar to the diffusion in a liquid without the scaffold [154]. Additionally, due to the 
mass transport and fluid mechanics, the thickness of the substrate in which we aim to 
diffuse factors through makes a difference in the diffusional profile of any factor. 
Therefore, it is recommended that a method to create and modulate a multilayered 
alginate beads for encapsulation, culture and factor presentation be developed for future 
studies, and preliminary experiments have been performed.  
To begin, the original 10-µL alginate beads were fabricated according to methods 
described in Chapter 2 and Chapter 3 for further use in double encapsulation (Fig. 4-5). 
Once the initial homogenous bead was formed, all crosslinking solution was removed.  
The bead was placed onto a 10-µL droplet of alginate containing either growth plate 
Fig. 4-6. Representative phase and fluorescent images of layered beads using the calcium leeching method 
overlaid and measured using ImageJ. Beads fabricated by both A) keeping the alginate percentage of the 
inner bead and the outer layer identical and B) keeping the inner bead at 1.5% and changing the outer layer 
percentage. Both images are of the 1.0% data points discussed below. The scale bar is 100 µm.  
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chondrocytes or human embryonic kidney cells (HEK293T) cells. Then, 30-µL of the 
same alginate-cell solution was slowly pipetted over the top of the bead, ensuring 
complete submersion. The bead incubated in this cell-solution as the calcium leached out 
of the inner bead, crosslinking the surrounding alginate-cell solution for 2 minutes before 
the entire construct was picked up with forceps and dropped into crosslinking for 30 
seconds to seal the outer layer. A representative image of the multilayer bead can be 
found in Fig. 4-6. First, the effect of changing the alginate percentage used for inner bead 
and outer layer was explored (Fig. 4-6A and Fig. 4-7A and B), followed by keeping the 
inner bead alginate percentage at 1.5% as is used in Chapter 3, but varying the percentage 
of alginate used for the outer bead (Fig. 4-6B and Fig. 4-7C and D). The thickness of the 
outer layer is defined as the diameter between the inner bead and the edge of the entire 
construct. Three images were taken of every construct with 3-4 measurements of 
thickness for every image, and 3 beads of every condition were made, totaling 27-35 total 
images per condition. The thickness was measured using ImageJ. The effect of the 
percentage of alginate in solution on the thickness of this outer layer was explored first. 
For the visualization of the secondary layer of the bead, HEK cells were mixed with the 
alginate designated for outer layer formation. A shows that there is little effect of alginate 
percentage on the outer layer thickness, however as the alginate percentage increases, the 
average diameter slightly decreases. This is opposite of what others show. Others have 
shown that an increase in alginate percentage leads to greater layer thicknesses; however, 
other studies utilized low molecular weight alginate as well as the incorporation of other 
hydrogel materials, which may affect layer thickness [204]. There are no statistical 
differences in layer thickness between the alginate percentages. The deviation in the 
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measured thicknesses is shown in Fig. 4-7B to illustrate the consistency of the calcium 
leeching method with respect to layer thickness. As the alginate percentage increases, the 
deviation in the diameter decreases, indicating that the consistency of the formation of the 
outer layer is greater as the percentage is increased. Next, the percentage of alginate used 
to make the inner homogenous bead was held constant while the percentage of the 
Fig. 4-7. Changing alginate percentage to modulate layer thickness. All figures show results of using the 
calcium leaching method. A) and B) keep the inner and outer alginates at the same percentage while C) and 
D) keep the inner bead at 1.5% while modulating the outer layer percentage. B) and D) are the deviations in 
the thickness of the layers of the results shown in A) and B) respectively.  
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alginate-cell solution (i.e. outer layer) was modulated. There is no appreciable effect on 
outer layer diameter by only changing the outer layer percentage as shown in Fig. 4-7C, 
with the deviation shown in Fig. 4-7D.   
Next, the effect of calcium concentration in the crosslinking solution was 
explored to modulate the thickness of the outer layer of the construct (Fig. 4-8). It was 
hypothesized that a greater concentration of calcium ions used to crosslink the inner bead 
could lead to the availability of more ions to leach out, resulting in a difference in layer 
thickness. However, Fig. 4-8 illustrates that the calcium concentration does not affect the 
thickness of the outer layer in our developed system. Overall, no statistical differences 
were observed by modulating alginate percentage or by changing calcium concentration. 
Further tests should be done moving forward in order to begin to modulate the thickness 
of the outer layer of the construct, in order to tailor the scaffold system to present factors 
appropriately. However, the average thickness of a mouse growth plate is around 300 
Fig. 4-8. The role of calcium concentration on the layer thickness. There is no 
effect seen in our system. 
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µm, which is close to the average thickness of the outer layer of our constructs, so 
moving forward with the method described above, a method of presenting the small 
molecule PTH has been explored.  
Because PTH is only 4 kD, and the pore size of alginate hydrogels allow for the 
immediate diffusion in and out of the construct for substrates smaller than 10 kD, a 
method for presenting PTH to chondrocytes in a diffuse way must be designed [154]. 
Preliminarily, HEK293T cells have been employed for their ability to be transfected 
easily. Briefly, transfection is the delivery of exogenous DNA to a cell using non-viral 
vectors. By transfecting HEK293T cells with Lipofectamine 2000 and a plasmid that 
codes for the PTH molecule and then encapsulating the cells in alginate, the transient 
transfection and subsequent steady protein production will allow for the slow diffusion of 
PTH out of the bead. Then, the double layer method should be used to encapsulate 
chondrocytes around the inner bead containing transfected HEK293T cells, recapitulating 
the resting zone with PTH-producing HEK cells and even mimicking the prehypertrophic 
zone by adding the high molecular weight molecule IHH to the culture media [189]. The 
high molecular weight of IHH is important because the diffusion of this molecule may 
take place differentially because of its size relative to the pore size of alginate, which 
could be between 5 and 25 nm [154].  
A plasmid coding for the PTH molecule fused with a DDK flag tag (Fig. 4-9) was 
purchased and expanded using a Qiagen Mega Prep Kit according to the manufacturer’s 
instructions. Using Lipofectamine 2000 at a ratio of 1.5:1 to DNA, and a plasmid 
concentration of either 0.6 or 1.0 µg DNA/well, HEK293T cells were transfected 18 
hours after initially seeding a 24-well plate with 30,000 cells/well. Four hours later and 
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every 12 hours after that, media samples were taken and stored for further processing to 
assess secretion of the PTH produced by transfection of the plasmid. Once media was 
collected for up to 48 hours, the amount of PTH in the culture media was assessed using a 
Ray Biotech PTH (1-34) ELISA kit according to the manufacturer’s instructions. 
Representative results are shown in Fig. 4-9. As expected, the production of PTH 
by HEK293T cells increased over time. While the results reported above are 
representative of the trends shown, is important to note that consistent results using the 
ELISA method have been difficult to obtain, and new methods of quantifying PTH 
production should be explored.  
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4.4.   Conclusions 
This thesis describes the establishment of in vitro culture systems for pre-
implantation pig embryos and growth plate chondrocytes using alginate hydrogels as a 
scaffold for development. Embryos double encapsulated in alginate hydrogels continued 
to show elongation whereas control, non-encapsulated embryos did not. However, by 
encapsulating embryos in RGD-modified alginate hydrogels, a significant difference in 
survivability was seen over control (not encapsulated) embryos. RGD-alginate 
demonstrated a greater ability to facilitate elongation in encapsulated embryos than 
unmodified alginate hydrogels, which suggest that providing a specific interaction 
between the surrounding environment and the embryo is important to the elongation 
process and further verifies the RGD ligand, and by extension cell adhesion capabilities, 
is an important part of signaling molecules such as SPP1. By continuing to improve the 
scaffold and thereby the culture system, more information can be gathered to elucidate 
the mechanisms and most important molecules in regards to embryo elongation. In 
addition, alginate hydrogels were used for the encapsulation of growth plate chondrocytes 
in vitro to construct a growth plate model to study the developmental mechanisms behind 
zonal arrangement and columnar formation. It was demonstrated that encapsulation and 
culture in ALG and RGD promoted a more proliferative chondrocyte phenotype and the 
presentation of the RGD ligand in culture may further induce proliferation as well as 
suppress hypertrophy when compared to ALG. Additionally, encapsulating chondrocytes 
in ALG and supplementing the culture media with PTH or IHH resulted in a more 
proliferative and less hypertrophic chondrocyte phenotype over time.  
 140 
Overall, the information gained through in vitro culture models of development 
can be used to advance the fields of embryology and cartilage developmental biology. 
The use of the developed in vitro culture model of porcine embryo elongation can lead to 
potential improvements in pregnancy outcomes in pigs, resulting in increases in food 
production and the utilization of the in vitro culture model of growth plate cartilage could 
afford greater insight into cartilage development and maturation in order to provide better 
therapies for growth plate injuries and diseases. 
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